<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tv483709_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><I>EXECUTION VERSION</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">among:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>JUNO THERAPEUTICS, INC.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">a Delaware corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CELGENE CORPORATION,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">a Delaware corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>BLUE MAGPIE CORPORATION,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">a Delaware corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Dated as of January 21, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">THE OFFER</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 7%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 86%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Offer</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Actions</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 13E-3</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MERGER TRANSACTION</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger of Purchaser into the Company</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of the Merger</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing; Effective Time</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation and Bylaws; Directors and Officers</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion of Shares</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender of Certificates; Stock Transfer Books</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenters&rsquo; Rights</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment of Company Options, Company RSUs, Company Restricted Shares, Company PRSUs and Company Performance Restricted Shares</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Action</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due Organization; Subsidiaries, Etc</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation and Bylaws</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization, Etc</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC Filings; Financial Statements</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Changes</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title to Assets</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Property</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Legal Requirements</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory Matters</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Business Practices</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authorizations</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Matters</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Matters; Benefit Plans</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17</FONT></TD>
    <TD STYLE="width: 86%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental Matters</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings; Orders</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; Binding Nature of Agreement</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover Laws</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention; Consents</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Financial Advisor</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers and Other Advisors</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due Organization</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; Binding Nature of Agreement</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention; Consents</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Litigation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sufficiency of Funds</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership of Shares</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement by Parent and Purchaser</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers and Other Advisors</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CERTAIN COVENANTS OF THE COMPANY</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access and Investigation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operation of the Acquired Corporations&rsquo; Business</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Solicitation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ADDITIONAL COVENANTS OF THE PARTIES</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Board Recommendation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filings, Consents and Approvals</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Benefits</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ESPP</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification of Officers and Directors</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder Litigation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Agreements</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover Laws</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 16 Matters</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11</FONT></TD>
    <TD STYLE="width: 86%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 14d-10 Matters</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange Delisting; Deregistration</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing Cooperation</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan Terminations.</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRPTA</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CONDITIONS PRECEDENT TO THE MERGER</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Restraints</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation of Offer</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TERMINATION</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Termination</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses; Termination Fees</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section 9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MISCELLANEOUS PROVISIONS</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Survival of Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire Agreement; Counterparts</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable Legal Requirements; Jurisdiction; Specific Performance; Remedies</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignability</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Third-Party Beneficiaries</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Taxes</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligation of Parent</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Recourse to Financing Sources</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Exhibits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit A</FONT></TD>
    <TD STYLE="width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Definitions</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-1</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Annexes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Annex I</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Offer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Annex I</U>I</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Certificate of Incorporation of the Surviving Corporation</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>THIS AGREEMENT AND PLAN
OF MERGER</B> (&ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of January 21, 2018, by and among: Celgene Corporation,
a Delaware corporation (&ldquo;<U>Parent</U>&rdquo;); Blue Magpie Corporation, a Delaware corporation and a wholly owned subsidiary
of Parent (&ldquo;<U>Purchaser</U>&rdquo;); and Juno Therapeutics, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;).
Certain capitalized terms used in this Agreement are defined in <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
has agreed to cause Purchaser to commence a tender offer (as it may be amended from time to time as permitted under this Agreement,
the &ldquo;<U>Offer</U>&rdquo;) to acquire all of the outstanding shares of Company Common Stock (the &ldquo;<U>Shares</U>&rdquo;),
other than the Excluded Shares, for $87.00 per share, net to the seller in cash, without interest (such amount, or any higher amount
per Share paid pursuant to the Offer, and as may be adjusted in accordance with <U>Section&nbsp;1.1(g)</U>, being the &ldquo;<U>Offer
Price</U>&rdquo;), upon the terms and subject to the conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
soon as practicable following the consummation of the Offer, Purchaser will be merged with and into the Company (the &ldquo;<U>Merger</U>&rdquo;),
with the Company continuing as the surviving corporation in the Merger (the &ldquo;<U>Surviving Corporation</U>&rdquo;), on the
terms and subject to the conditions set forth in this Agreement, whereby (i)&nbsp;each issued and outstanding Share not owned by
Parent, Purchaser or the Company as of the Effective Time (other than Excluded Shares and Dissenting Shares) shall be converted
into the right to receive the Offer Price, in cash, without interest, and (ii)&nbsp;the Company shall become a wholly owned Subsidiary
of Parent as a result of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors of the Company (the &ldquo;<U>Board of Directors</U>&rdquo;) has (i) determined that this Agreement and the
Transactions, including the Offer and the Merger, are fair to, and in the best interest of, the Company and its stockholders; (ii)
declared it advisable to enter into this Agreement; (iii) approved the execution, delivery and performance by the Company of this
Agreement and the consummation of the Transactions, including the Offer and the Merger; (iv) resolved that the Merger shall be
effected under Section 251(h) of the DGCL; and (v) resolved to recommend that the stockholders of the Company tender their Shares
to Purchaser pursuant to the Offer (the &ldquo;<U>Company Board Recommendation</U>&rdquo;), in each case, on the terms and subject
to the conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors of each of Parent and Purchaser have approved this Agreement and declared it advisable for Parent and Purchaser,
respectively, to enter into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(E)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent,
Purchaser and the Company acknowledge and agree that the Merger shall be effected pursuant to Section 251(h) of the DGCL and shall,
subject to the satisfaction of the conditions set forth in this Agreement, be consummated as soon as practicable following the
consummation of the Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In consideration of the
mutual covenants, representations, warranties and agreements set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Parties to this Agreement, intending to be legally bound, agree as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
1<BR>
<BR>
<U>THE OFFER</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Offer</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Commencement
of the Offer</B>. Provided that this Agreement shall not have been terminated in accordance with <U>Section 8</U>, as promptly
as practicable after the date of this Agreement but in no event more than ten (10) business days after the date of this Agreement
(subject to the Company having timely provided any information required to be provided by it pursuant to <U>Sections 1.1(e)</U>
and <U>1.2(b)</U>), Purchaser shall (and Parent shall cause Purchaser to) commence (within the meaning of Rule 14d-2 under the
Exchange Act) the Offer to purchase all of the outstanding Shares (other than the Parent-Owned Shares and the Shares to be cancelled
pursuant to <U>Sections 2.5(a)(i)</U> (collectively, the &ldquo;<U>Excluded Shares</U>&rdquo;)), at a price per Share equal to
the Offer Price, net to the seller in cash, without interest and subject to any withholding of Taxes in accordance with <U>Section
2.6(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Terms
and Conditions of the Offer</B>. The obligations of Purchaser to, and of Parent to cause Purchaser to, accept for payment, and
pay for, any Shares validly tendered pursuant to the Offer are subject only to the terms and conditions set forth in this Agreement,
including the satisfaction of the Minimum Condition, the Termination Condition, and the other conditions set forth in <U>Annex
I</U> (collectively, the &ldquo;<U>Offer Conditions</U>&rdquo;) (without limiting the right of Purchaser to terminate, extend or
modify the Offer in accordance with the terms of this Agreement). The Offer shall be made by means of an offer to purchase (the
&ldquo;<U>Offer to Purchase</U>&rdquo;) that contains the terms set forth in this Agreement, the Minimum Condition, the Termination
Condition and the other Offer Conditions. Purchaser expressly reserves the right to (i) increase the Offer Price (ii) waive any
Offer Condition; and (iii) make any other changes in the terms and conditions of the Offer not inconsistent with the terms of this
Agreement; <U>provided</U>, <U>however</U>, notwithstanding anything to the contrary contained in this Agreement, without the prior
written consent of the Company, Parent and Purchaser shall not (A) decrease the Offer Price; (B) change the form of consideration
payable in the Offer; (C) decrease the maximum number of Shares sought to be purchased in the Offer; (D) impose conditions or requirements
to the Offer in addition to the Offer Conditions; (E) amend, modify or waive the Minimum Condition, Termination Condition or the
conditions set forth in <U>clause (e)</U> or <U>(g)</U> of <U>Annex I</U>; (F) otherwise amend or modify any of the other terms
of the Offer in a manner that adversely affects, or would reasonably be expected to adversely affect, any holder of Shares in its
capacity as such; (G) terminate the Offer or accelerate, extend or otherwise change the Expiration Date, in each case, except as
provided in <U>Sections 1.1(c)</U> or <U>1.1(d)</U>; or (H) provide any &ldquo;subsequent offering period&rdquo; (or any extension
thereof) within the meaning of Rule 14d-11 promulgated under the Exchange Act. The Offer may not be withdrawn prior to the Expiration
Date (or any rescheduled Expiration Date) of the Offer, unless this Agreement is terminated in accordance with <U>Section 8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Expiration
and Extension of the Offer</B>. The Offer shall initially be scheduled to expire at one minute after 11:59 p.m., Eastern Time on
the date that is twenty (20) business days (determined as set forth in Rule 14d-1(g)(3) and Rule 14e-1(a) under the Exchange Act)
following the Offer Commencement Date (unless otherwise agreed to in writing by Parent and the Company) (the &ldquo;<U>Initial
Expiration Date</U>&rdquo;, and such date or such subsequent date to which the Initial Expiration Date of the Offer is extended
in accordance with the terms of this Agreement, the &ldquo;<U>Expiration Date</U>&rdquo;). Notwithstanding anything to the contrary
contained in this Agreement, but subject to the Parties&rsquo; respective termination rights under <U>Section 8</U>: (i)&nbsp;if,
as of the then-scheduled Expiration Date, any Offer Condition is not satisfied and has not been waived by Purchaser or Parent,
to the extent waivable by Purchaser or Parent, Purchaser may, in its discretion (and without the consent of the Company or any
other Person), extend the Offer on one or more occasions, for an additional period of up to ten (10) business days per extension,
to permit such Offer Condition to be satisfied; (ii) Purchaser shall, and Parent shall cause Purchaser to, extend the Offer from
time to time for: (A) any period required by any Legal Requirement, any interpretation or position of the SEC, the staff thereof
or NASDAQ applicable to the Offer; and (B) periods of up to fifteen (15) business days per extension, until any waiting period
(and any extension thereof) applicable to the consummation of the Offer under the HSR Act and any foreign antitrust or competition-related
Legal Requirement shall have expired or been terminated; (iii) if, as of the scheduled Expiration Date, any Offer Condition other
than the Minimum Condition or the Termination Condition is not satisfied and has not been waived, at the request of the Company,
Purchaser shall, and Parent shall cause Purchaser to, extend the Offer on one or more occasions for an additional period of up
to ten (10) business days per extension to permit such Offer Condition to be satisfied; <U>provided</U>, <U>however</U>, that Purchaser
shall be required to extend the Offer pursuant to this <U>clause (iii)</U> only if such condition or conditions are capable of
being satisfied on or before the End Date; and (iv) if, as of the scheduled Expiration Date, all of the Offer Conditions have been
satisfied or waived (if permitted hereunder), except that the Minimum Condition has not been satisfied, Purchaser shall, and Parent
shall cause Purchaser to, extend the Offer on one or more occasions for an additional period of up to ten (10) business days per
extension to permit such Offer Condition to be satisfied, it being understood and agreed that Purchaser shall not be required to
extend the Offer pursuant to this <U>clause (iv)</U> on more than three (3) occasions that provide, in the aggregate, for an additional
period of at least thirty (30) business days to permit such Offer Condition to be satisfied pursuant to this <U>clause (iv)</U>,
but may, in its sole and absolute discretion, elect to do so; <U>provided</U>, <U>however</U>, that, in the case of each of <U>clauses
(i) &ndash; (iv)</U> above, in no event shall Purchaser: (1) be required to extend the Offer beyond the earlier to occur of (x)
the valid termination of this Agreement in compliance with <U>Section 8</U> and (y) the End Date (such earlier occurrence, the
&ldquo;<U>Extension Deadline</U>&rdquo;); or (2)&nbsp;be permitted to extend the Offer beyond the Extension Deadline without the
prior written consent of the Company. Purchaser shall not terminate the Offer, or permit the Offer to expire, prior to the Extension
Deadline without the prior written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination
of Offer</B>. Nothing in this <U>Section 1.1</U> shall be deemed to impair, limit or otherwise restrict in any manner the right
of the Company, Parent or Purchaser to terminate this Agreement pursuant to <U>Section 8</U>. In the event that this Agreement
is validly terminated pursuant to <U>Section 8</U>, Purchaser shall (and Parent shall cause Purchaser to) immediately, irrevocably
and unconditionally terminate the Offer and shall not acquire any Shares pursuant to the Offer. If the Offer is terminated or withdrawn
by Purchaser in accordance with the terms of this Agreement, Purchaser shall immediately return, and shall cause any depository
acting on behalf of Purchaser to return, in accordance with applicable Legal Requirements, all tendered Shares to the registered
holders thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Offer
Documents</B>. As promptly as practicable on the date of commencement of the Offer (within the meaning of Rule 14d-2 under the
Exchange Act), Parent and Purchaser shall (i) file with the SEC a tender offer statement on Schedule TO with respect to the Offer
(together with all amendments and supplements thereto and including exhibits thereto, the &ldquo;<U>Schedule TO</U>&rdquo;) that
will contain or incorporate by reference the Offer to Purchase and form of the related letter of transmittal; and (ii) cause the
Offer to Purchase and related documents to be disseminated to holders of Shares as and to the extent required by applicable Legal
Requirements. Parent and Purchaser agree that they shall cause the Schedule TO and all exhibits, amendments or supplements thereto
(which together constitute the &ldquo;<U>Offer Documents</U>&rdquo;) filed by either Parent or Purchaser with the SEC (A)&nbsp;to
comply in all material respects with the Exchange Act and other applicable Legal Requirements; and (B)&nbsp;to not contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>,
that no covenant is made by Parent or Purchaser with respect to information supplied by or on behalf of the Company for inclusion
or incorporation by reference in the Offer Documents. Each of Parent, Purchaser and the Company agrees to respond promptly to any
comments (including oral comments) of the SEC or its staff with respect to the Offer Documents or the Offer and to promptly correct
any information provided by it for use in the Offer Documents if and to the extent that such information shall have become false
or misleading in any material respect, and Parent further agrees to take all steps necessary to cause the Offer Documents as so
corrected to be filed with the SEC and to be disseminated to holders of Shares, in each case, as and to the extent required by
applicable federal securities laws. The Company consents to the inclusion of the Company Board Recommendation in the Offer Documents.
The Company shall promptly furnish or otherwise make available to Parent and Purchaser or Parent&rsquo;s legal counsel all information
concerning the Company and the Company&rsquo;s stockholders that may be required or reasonably requested in connection with any
action contemplated by this <U>Section 1.1(e)</U>. The Company and its counsel shall be given reasonable opportunity to review
and comment on the Offer Documents (including any response to any comments (including oral comments) of the SEC or its staff with
respect thereto) prior to the filing thereof with the SEC, and Parent and Purchaser shall give reasonable and good faith consideration
to any such comments made by the Company or its counsel. Parent and Purchaser agree to provide the Company and its counsel with
any comments (including oral comments) Parent, Purchaser or their counsel may receive from the SEC or its staff with respect to
the Offer Documents promptly after receipt of those comments (including oral comments).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Funds</B>.
Without limiting the generality of <U>Section 9.11</U>, Parent shall cause to be provided to Purchaser, on a timely basis, all
of the funds necessary to purchase all Shares that Purchaser becomes obligated to purchase pursuant to the Offer, and shall cause
Purchaser to perform, on a timely basis, all of Purchaser&rsquo;s obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Adjustments</B>.
If, between the date of this Agreement and the Offer Acceptance Time, the outstanding Shares are changed into a different number
or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation
of shares, reclassification, recapitalization or other similar transaction, then the Offer Price shall be appropriately adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Acceptance</B>.
On the terms and subject to the conditions of the Offer and this Agreement, including the satisfaction or, to the extent waivable
by Purchaser or Parent, waiver by Purchaser or Parent of each of the Offer Conditions, Purchaser shall (and Parent shall cause
Purchaser to) (i) promptly after (and in any event no later than the first business day after) the Expiration Date irrevocably
accept for payment all Shares tendered (and not validly withdrawn) pursuant to the Offer (the time of such acceptance, the &ldquo;<U>Offer
Acceptance Time</U>&rdquo;) and (ii)&nbsp;promptly after (and in any event no later than the second business day after) the Offer
Acceptance Time pay for such Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Actions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Schedule
14D-9</B>. As promptly as practicable on the date of commencement of the Offer, following the filing of the Schedule TO, the Company
shall (1) file with the SEC and disseminate to holders of Shares, in each case as and to the extent required by applicable federal
securities laws, a Tender Offer Solicitation/Recommendation Statement on <U>Schedule 14D-9</U> (together with any exhibits, amendments
or supplements thereto, the &ldquo;<U>Schedule 14D-9</U>&rdquo;) that, subject to <U>Section 6.1(b)</U>, shall reflect the Company
Board Recommendation and include the fairness opinion of the Company&rsquo;s financial advisor referenced in <U>Section 3.23</U>
and the notice and other information required by Section 262(d)(2) of the DGCL and (2) cause the <U>Schedule 14D-9</U> and related
documents to be disseminated to the holders of Shares as and to the extent required by applicable Legal Requirements, including
by setting the Stockholder List Date as the record date for purposes of receiving the notice required by Section 262(d)(2) of the
DGCL. The Company agrees that it shall cause the <U>Schedule 14D-9</U> (i)&nbsp;to comply in all material respects with the Exchange
Act and other applicable Legal Requirements and (ii)&nbsp;to not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; <U>provided</U>, <U>however</U>, that no covenant is made by the Company with respect
to information supplied by or on behalf of Parent or Purchaser for inclusion or incorporation by reference in the <U>Schedule 14D-9</U>.
Each of Parent, Purchaser and the Company agrees to respond promptly to any comments (including oral comments) of the SEC or its
staff with respect to the <U>Schedule 14D-9</U> and to promptly correct any information provided by it for use in the <U>Schedule
14D-9</U> if and to the extent that such information shall have become false or misleading in any material respect, and the Company
further agrees to take all steps necessary to cause the <U>Schedule 14D-9</U> as so corrected to be filed with the SEC and to be
disseminated to holders of Shares, in each case as and to the extent required by applicable federal securities laws. Parent and
Purchaser shall promptly furnish or otherwise make available to the Company or the Company&rsquo;s legal counsel all information
concerning Parent or Purchaser that may be required or reasonably requested in connection with any action contemplated by this
<U>Section 1.2(a)</U>. Parent and its counsel shall be given reasonable opportunity to review and comment on the <U>Schedule 14D-9</U>
(including any response to any comments (including oral comments) of the SEC or its staff with respect thereto) prior to the filing
thereof with the SEC and the Company shall give reasonable and good faith consideration to any such comments made by Parent or
its counsel. The Company agrees to provide Parent and its counsel with any comments (including oral comments) the Company or its
counsel may receive from the SEC or its staff with respect to the <U>Schedule 14D-9</U> promptly after receipt of those comments
(including oral comments).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Stockholder
Lists</B>. The Company shall promptly furnish Parent with a list of its stockholders, mailing labels and any available listing
or computer file containing the names and addresses of all record holders of Shares and lists of securities positions of Shares
held in stock depositories, in each case accurate and complete as of the most recent practicable date, and shall provide to Parent
such additional information (including updated lists of stockholders, mailing labels and lists of securities positions) and such
other assistance as Parent may reasonably request in connection with the Offer and the Merger (the date of the list used to determine
the Persons to whom the Offer Documents, the Schedule 14D-9 and the Schedule 13E-3 are first disseminated, which date shall not
be more than ten (10) days prior to the date the Offer Documents, the Schedule 14D-9 and the Schedule 13E-3 are first disseminated,
the &ldquo;<U>Stockholder List Date</U>&rdquo;). Subject to applicable Legal Requirements, and except for such steps as are necessary
to disseminate the Offer Documents and any other documents necessary to consummate the Transactions, Parent and Purchaser and their
agents shall hold in confidence the information contained in any such labels, listings and files, shall use such information only
in connection with the Offer and the Merger and, if this Agreement shall be terminated, shall, upon request by the Company, deliver,
and shall use their reasonable best efforts to cause their agents to deliver, to the Company (or destroy) all copies and any extracts
or summaries from such information then in their possession or control, and, if requested by the Company, promptly certify to the
Company in writing that all such material has been returned or destroyed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Share
Registry</B>. The Company shall register (and shall instruct its transfer agent to register) the transfer of the Shares accepted
for payment by Purchaser effective immediately after the Offer Acceptance Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedule
13E-3</B>. Parent shall include the information required by Rule 13e-3 under the Exchange Act with
respect to the Transactions in the Schedule TO included in the Offer Documents in satisfaction of its and Purchaser&rsquo;s obligations
under the Exchange Act and the Company shall separately file a Rule 13e-3 Transaction Statement on Schedule 13E-3 with respect
to the Transactions (together with the information required by Rule 13e-3 under the Exchange Act included in the Schedule TO, and
including all amendments, supplements and exhibits thereto, the &ldquo;<U>Schedule 13E-3</U>&rdquo;) simultaneously with the filing
of the Schedule 14D-9. Parent, Purchaser and the Company shall cooperate in good faith to determine the information regarding the
Company that is necessary to include in the Schedule 13E-3 in order to satisfy applicable federal securities laws. Each of the
Company, Parent and Purchaser shall promptly correct any information provided by it for use in the Schedule 13E-3 if and to the
extent that such information shall have become false or misleading in any material respect. The Parties shall take all steps necessary
to cause the Schedule 13E-3, as so corrected, to be filed with the SEC and disseminated to the holders of Shares, in each case
as and to the extent required by applicable federal securities laws. Each Party shall promptly furnish or otherwise make available
to the other Parties or their legal counsel all information concerning the Company and the Company&rsquo;s stockholders (in the
case of the Company) or Parent and Purchaser (in the case of Parent) that may be required or reasonably requested in connection
with any action contemplated by this <U>Section 1.3</U>. Each Party and their counsel shall be given reasonable opportunity to
review and comment on the Schedule 13E-3 (including any response to any comments (including oral comments) of the SEC or its staff
with respect thereto) prior to the filing thereof with the SEC, and each Party shall give reasonable and good faith consideration
to any such comments made by the Parties or their counsel. Each of the Parties agrees to provide the other Parties and their counsel
with any comments (including oral comments) such Party or their counsel may receive from the SEC or its staff with respect to the
Schedule 13E-3 promptly after receipt of those comments (including oral comments).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
2<BR>
<BR>
<U>MERGER TRANSACTION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merger
of Purchaser into the Company</B>. Upon the terms and subject to the conditions set forth in this
Agreement and in accordance with Section 251(h) of the DGCL, at the Effective Time, the Company and Parent shall consummate the
Merger, whereby Purchaser shall be merged with and into the Company, the separate existence of Purchaser shall cease, and the Company
will continue as the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect
of the Merger</B>. The Merger shall have the effects set forth in this Agreement and in the applicable
provisions of the DGCL. Without limiting the generality of the foregoing, at the Effective Time, all of the property, rights, privileges,
immunities, powers and franchises of the Company and Purchaser shall vest in the Surviving Corporation, and all of the debts, liabilities
and duties of the Company and Purchaser shall become the debts, liabilities and duties of the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closing;
Effective Time</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
this Agreement shall have been terminated pursuant to <U>Section 8</U>, and unless otherwise mutually agreed in writing between
the Company, Parent and Purchaser, the consummation of the Merger (the &ldquo;<U>Closing</U>&rdquo;) shall take place at the offices
of Skadden, Arps, Slate, Meagher &amp; Flom LLP, 525 University Avenue, Suite 1400, Palo Alto, California 94301, as soon as practicable
following the Offer Acceptance Time except if the conditions set forth in <U>Section 7.1</U> shall not be satisfied or, to the
extent permissible by applicable Legal Requirements, waived as of such date, in which case the Closing shall take place on the
first business day on which all conditions set forth in <U>Section 7.1</U> are satisfied or, to the extent permissible by applicable
Legal Requirements, waived, unless another date or place is agreed to in writing by the Company and Parent. The date on which the
Closing occurs is referred to in this Agreement as the &ldquo;<U>Closing Date</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the provisions of this Agreement, as soon as practicable on the Closing Date, the Company and Purchaser shall file or cause
to be filed a certificate of merger with the Secretary of State of the State of Delaware with respect to the Merger, in such form
as required by, and executed and acknowledged in accordance with, the relevant provisions of the DGCL, and the Parties shall take
all such further actions as may be required by applicable Legal Requirements to make the Merger effective. The Merger shall become
effective upon the date and time of the filing of that certificate of merger with the Secretary of State of the State of Delaware
or such later date and time as is agreed upon in writing by the Parties and specified in the certificate of merger (such date and
time, the &ldquo;<U>Effective Time</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificate of Incorporation and Bylaws; Directors and Officers</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Time, the certificate of incorporation of the Company shall by virtue of the Merger and without any further action,
be amended and restated to read in its entirety as set forth on <U>Annex II</U> and, as so amended and restated, shall be the certificate
of incorporation of the Surviving Corporation until thereafter changed or amended as provided therein or by applicable Legal Requirements,
subject to <U>Section 6.5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Time, the bylaws of the Surviving Corporation shall be amended and restated to conform to the bylaws of Purchaser
as in effect immediately prior to the Effective Time, until thereafter changed or amended as provided therein or by applicable
Legal Requirements, subject to <U>Section 6.5(a)</U>, except that references to the name of Purchaser shall be replaced by references
to the name of the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Time, the directors and officers of the Surviving Corporation shall be the respective individuals who served as
the directors and officers of Purchaser as of immediately prior to the Effective Time, until their respective successors are duly
elected and qualified, or their earlier death, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversion of Shares</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Purchaser, the Company or any
stockholder of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Shares owned immediately prior to the Effective Time by the Company (or held in the Company&rsquo;s treasury) shall be cancelled
and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
any Shares owned at the commencement of the Offer and immediately prior to the Effective Time by Parent, Purchaser or any other
direct or indirect wholly owned Subsidiary of Parent (collectively, the &ldquo;<U>Parent-Owned Shares</U>&rdquo;) shall remain
outstanding and shall continue as shares of common stock of the Surviving Corporation and the holder thereof immediately prior
to the Effective Time shall remain the holder thereof immediately following the Effective Time, and (B) all Shares irrevocably
accepted for purchase by Purchaser pursuant to the Offer shall be cancelled and retired and shall cease to exist, and, in each
case (but in the case of the Shares described in <U>subclause (B)</U>, following payment in respect thereof), no consideration
shall be delivered in exchange therefor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as provided in <U>clauses (i)</U> and <U>(ii)</U> above and subject to <U>Section&nbsp;2.5(b)</U>, each Share outstanding immediately
prior to the Effective Time (other than any Dissenting Shares, which shall have only those rights set forth in <U>Section 2.7</U>)
shall be converted into the right to receive the Offer Price (the &ldquo;<U>Merger Consideration</U>&rdquo;), in each case without
any interest thereon and subject to any withholding of Taxes in accordance with <U>Section 2.6(e)</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
shares of common stock, $0.01 par value per share, of Purchaser then outstanding shall be converted into that number of shares
of common stock of the Surviving Corporation equal to the sum of (A) that number of Shares that are cancelled pursuant to <U>Section
2.5(a)(ii)(B)</U>, (B) that number of Shares that are converted into the right to receive the Merger Consideration pursuant to
<U>Section 2.5(a)(iii)</U>, and (C) that number of Dissenting Shares that are cancelled pursuant to <U>Section 2.7</U>. From and
after the Effective Time, all Shares other than the Parent-Owned Shares shall no longer be outstanding and shall automatically
be cancelled and shall cease to exist, and each applicable holder of such Shares shall cease to have any rights with respect thereto,
except, in the case of Shares that are converted into the right to receive the Merger Consideration pursuant to <U>Section 2.5(a)(iii)</U>,
the right to receive the Merger Consideration therefor upon the surrender of such shares of Company Common Stock in accordance
with <U>Section 2.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
between the date of this Agreement and the Effective Time, the outstanding Shares are changed into a different number or class
of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of
shares, reclassification, recapitalization or other similar transaction, then the Merger Consideration shall be appropriately adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Surrender of Certificates; Stock Transfer Books</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Offer Acceptance Time, Parent shall designate a bank or trust company reasonably acceptable to the Company to act as agent
(the &ldquo;<U>Depository Agent</U>&rdquo;) for the holders of Shares to receive the aggregate Offer Price to which holders of
such Shares shall become entitled pursuant to <U>Section 1.1(b)</U> and to act as agent (the &ldquo;<U>Paying Agent</U>&rdquo;)
for the holders of Shares to receive the aggregate Merger Consideration to which holders of such Shares shall become entitled pursuant
to <U>Section 2.5</U>. Promptly after (and in any event no later than the second business day after) the Offer Acceptance Time,
Parent shall deposit, or shall cause to be deposited, with the Depository Agent cash sufficient to make the payment of the aggregate
Offer Price payable pursuant to <U>Section 1.1(h)</U>. On or prior to the Closing Date, Parent shall deposit, or shall cause to
be deposited, with the Paying Agent cash sufficient to pay the aggregate Merger Consideration payable pursuant to <U>Section 2.5</U>
(together with the amount deposited pursuant the immediately preceding sentence, the &ldquo;<U>Payment Fund</U>&rdquo;). The Payment
Fund shall not be used for any purpose other than to pay the aggregate Offer Price in the Offer and the aggregate Merger Consideration
in the Merger. The Payment Fund shall be invested by the Paying Agent as directed by the Surviving Corporation; <U>provided</U>
that such investments shall be (i) in obligations of or guaranteed by the United States of America; (ii) in commercial paper obligations
rated A-1 or P-1 or better by Moody&rsquo;s Investors Service, Inc. or Standard &amp; Poor&rsquo;s Corporation, respectively; (iii)
in certificates of deposit, bank repurchase agreements or banker&rsquo;s acceptances of commercial banks with capital exceeding
$1 billion; or (iv) in money market funds having a rating in the highest investment category granted by a recognized credit rating
agency at the time of acquisition or a combination of the foregoing and, in any such case, no such instrument shall have a maturity
exceeding three (3) months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after the Effective Time (but in no event later than five (5) business days thereafter), the Surviving Corporation shall cause
to be delivered to each Person who was, at the Effective Time, a holder of record of (i) Shares represented by a certificate evidencing
such Shares (the &ldquo;<U>Certificates</U>&rdquo;) or (ii) Book-Entry Shares, who, in each case was entitled to receive the Merger
Consideration pursuant to <U>Section 2.5</U>, (A)&nbsp;a form of letter of transmittal, which shall be in reasonable and customary
form and shall specify that delivery shall be effected, and risk of loss and title to the Certificates shall pass, only upon proper
delivery of the Certificates (or affidavits of loss in lieu thereof in accordance with <U>Section 2.6(f)</U>, if applicable) to
the Paying Agent, or a customary agent&rsquo;s message in respect to Book-Entry Shares; and (B) instructions for use in effecting
the surrender of the Certificates or Book-Entry Shares in exchange for the Merger Consideration issuable and payable in respect
of such Shares pursuant to <U>Section 2.5</U>. Upon surrender to the Paying Agent of Certificates (or affidavits of loss in lieu
thereof in accordance with <U>Section 2.6(f)</U>, if applicable) or Book-Entry Shares, together with such letter of transmittal
in the case of Certificates, duly completed and validly executed in accordance with the instructions thereto, and such other documents
as may be required pursuant to the instructions, the holder of such Certificates or Book-Entry Shares shall be entitled to receive
in exchange therefor the Merger Consideration for each Share formerly evidenced by such Certificates or Book-Entry Shares, and
such Certificates and Book-Entry Shares shall then be cancelled. No interest shall accrue or be paid on the Merger Consideration
payable upon the surrender of any Certificates or Book-Entry Shares for the benefit of the holder thereof. If the payment of any
Merger Consideration is to be made to a Person other than the Person in whose name the surrendered Certificates formerly evidencing
the Shares is registered on the stock transfer books of the Company, it shall be a condition of payment that the Certificate so
surrendered shall be endorsed properly or otherwise be in proper form for transfer and that the Person requesting such payment
shall have paid all transfer and other similar Taxes required by reason of the payment of the Merger Consideration to a Person
other than the registered holder of the Certificate surrendered, or shall have established to the satisfaction of the Surviving
Corporation that such Taxes either have been paid or are not applicable. None of Parent, Purchaser and the Surviving Corporation
shall have any liability for the transfer and other similar Taxes described in this <U>Section 2.6(b)</U> under any circumstance.
Payment of the applicable Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in whose name
such Book-Entry Shares are registered. Until surrendered as contemplated by this <U>Section&nbsp;2.6</U>, each Certificate and
Book-Entry Share shall be deemed at any time after the Effective Time to represent only the right to receive the applicable Merger
Consideration as contemplated by <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
any time following twelve (12) months after the Effective Time, Parent shall be entitled to require the Paying Agent to deliver
to it any funds (with respect to the aggregate Merger Consideration to which holders of Shares shall become entitled pursuant to
<U>Section 2.5</U>) which had been made available to the Paying Agent and not disbursed to holders of Certificates or Book-Entry
Shares (including all interest and other income received by the Paying Agent in respect of all funds made available to it), and,
thereafter, such holders shall be entitled to look to the Surviving Corporation (subject to abandoned property, escheat and other
similar Legal Requirements) only as general creditors thereof with respect to the Merger Consideration that may be payable upon
due surrender of the Certificates or Book-Entry Shares held by them, without any interest thereon. Notwithstanding the foregoing,
neither the Surviving Corporation nor the Paying Agent shall be liable to any holder of Certificates or Book-Entry Shares for the
Merger Consideration delivered in respect of such share to a public official pursuant to any abandoned property, escheat or other
similar Legal Requirements. Any amounts remaining unclaimed by such holders at such time at which such amounts would otherwise
escheat to or become property of any Governmental Body shall become, to the extent permitted by applicable Legal Requirements,
the property of the Surviving Corporation or its designee, free and clear of all claims or interest of any Person previously entitled
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the close of business on the day of the Effective Time, the stock transfer books of the Company with respect to the Shares shall
be closed and thereafter there shall be no further registration of transfers of Shares on the records of the Company. From and
after the Effective Time, the holders of the Shares outstanding immediately prior to the Effective Time shall cease to have any
rights with respect to such Shares except as otherwise provided herein or by applicable Legal Requirements. If, after the Effective
Time, Certificates or Book-Entry Shares are presented to the Surviving Corporation for any reason, they shall be cancelled and
exchanged as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Company, the Surviving Corporation, Parent and Purchaser, and their Affiliates, shall be entitled to deduct and withhold
(or cause the Paying Agent or the Depository Agent to deduct and withhold) from the Offer Price, the Merger Consideration payable
to any holder of the Shares or any holder of Company Options, Company RSUs or Company Restricted Shares, or any other consideration
otherwise payable pursuant to this Agreement such amounts as it is required by any Legal Requirement to deduct and withhold with
respect to Taxes. To the extent that amounts are so withheld and properly remitted to the appropriate Governmental Body, such withheld
amounts shall be treated for all purposes of this Agreement as having been paid to the holder of the Shares, holder of Company
Options, Company RSUs or Company Restricted Shares, or other recipient of consideration hereunder in respect of which such deduction
and withholding was made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the holder of the Shares
formerly represented by that Certificate, or by a representative of that holder, claiming that Certificate to be lost, stolen or
destroyed and, if required by the Surviving Corporation, the posting by that holder of a bond, in such reasonable amount as Parent
may direct, as indemnity against any claim that may be made against it with respect to such Certificate (which shall not exceed
the Merger Consideration payable with respect to such Certificate), the Paying Agent will pay (less any amounts entitled to be
deducted or withheld pursuant to <U>Section 2.6(e)</U>), in exchange for such lost, stolen or destroyed Certificate, the applicable
Merger Consideration to be paid in respect of the Shares formerly represented by such Certificate, as contemplated by this <U>Section
2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dissenters&rsquo;
Rights</B>. Notwithstanding anything in this Agreement to the contrary, Shares outstanding immediately
prior to the Effective Time, and held by holders who are entitled to appraisal rights under Section 262 of the DGCL and have properly
exercised and perfected their respective demands for appraisal of such Shares in the time and manner provided in <U>Section 262</U>
of the DGCL and, as of the Effective Time, have neither effectively withdrawn nor lost their rights to such appraisal and payment
under the DGCL (the &ldquo;<U>Dissenting Shares</U>&rdquo;), shall not be converted into the right to receive Merger Consideration,
but shall, by virtue of the Merger, be automatically cancelled and no longer outstanding, shall cease to exist and shall be entitled
to only such consideration as shall be determined pursuant to Section 262 of the DGCL; <U>provided</U> that if any such holder
shall have failed to perfect or shall have effectively withdrawn or lost such holder&rsquo;s right to appraisal and payment under
the DGCL, such holder&rsquo;s Shares shall be deemed to have been converted as of the Effective Time into the right to receive
the Merger Consideration (less any amounts entitled to be deducted or withheld pursuant to <U>Section 2.6(e)</U>), and such Shares
shall not be deemed to be Dissenting Shares. The Company shall give prompt notice to Parent and Purchaser of any demands received
by the Company for appraisal of any Dissenting Shares, withdrawals of such demands and any other instruments served pursuant to
Section 262 of the DGCL, in each case prior to the Effective Time. Parent and Purchaser shall have the right to direct and participate
in all negotiations and proceedings with respect to such demands, and the Company shall not, without the prior written consent
of Parent and Purchaser, settle or offer to settle, or make any payment with respect to, any such demands, or agree or commit to
do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>2.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment
of Company Options, Company RSUs, Company Restricted Shares, Company PRSUs and Company Performance Restricted Shares</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each vested Company Option that is then outstanding and unexercised (including each unvested
Company Option which, pursuant to <U>Section 2.8(l)</U> below, would become vested prior to or at the Offer Acceptance Time or
Effective Time) and which has a per share exercise price that is less than the Offer Price (each, a &ldquo;<U>Vested in the Money
Option</U>&rdquo;) shall be cancelled and converted into the right to receive a cash payment equal to (i) the excess of (x) the
Offer Price over (y) the exercise price payable per Share under such Vested in the Money Option, multiplied by (ii) the total number
of Shares subject to such Vested in the Money Option immediately prior to the Offer Acceptance Time. For the avoidance of doubt,
at the Offer Acceptance Time, each Company Option that has a per-share exercise price that is greater than or equal to the Offer
Price, if any, shall be cancelled with no consideration payable in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each Company Option (other than a Vested in the Money Option or a Company Option that has a
per-share exercise price that is greater than or equal to the Offer Price) that is then outstanding and unexercised, whether or
not vested, shall be assumed and converted into an option to purchase a number of shares of Parent Common Stock (each, an &ldquo;<U>Adjusted
Option</U>&rdquo;), on the same terms and subject to the same conditions as were applicable to such Company Option immediately
prior to the Offer Acceptance Time, equal to the product of (i) the total number of Shares subject to such Company Option immediately
prior to the Offer Acceptance Time multiplied by (ii) the Equity Award Conversion Ratio, with any fractional shares rounded down
to the next lower whole number of shares. The exercise price per share of such Adjusted Option shall be equal to the quotient of
(A) the exercise price per Share subject to such Company Option immediately prior to the Offer Acceptance Time divided by (B) the
Equity Award Conversion Ratio, with any fractional cents rounded up to the next higher number of whole cents. The exercise price
per share of any such Adjusted Option and the number of shares of Parent Common Stock relating to any such Adjusted Option shall
be determined in a manner consistent with the requirements of Section 409A of the Code, and, in the case of Company Options that
are intended to qualify as incentive stock options within the meaning of Section 422 of the Code, consistent with the requirements
of Section 424 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each then-outstanding award of vested and unsettled Company RSUs (including any Company RSU,
which pursuant to <U>Section 2.8(l)</U> below, would become vested prior to or at the Offer Acceptance Time or Effective Time)
(the &ldquo;<U>Cashed-Out Company RSUs</U>&rdquo;), shall be canceled and the holder thereof shall be entitled to receive a cash
payment equal to the product of (i) the Merger Consideration and (ii) the number of Shares subject to such Cashed-Out Company RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each then outstanding award of Company RSUs (other than any Cashed-Out Company RSUs) shall
be assumed and converted into a restricted stock unit denominated in shares of Parent Common Stock (each, an &ldquo;<U>Adjusted
Restricted Stock Unit</U>&rdquo;), on the same terms and conditions as were applicable under such Company RSU immediately prior
to the Offer Acceptance Time, and relating to a number of shares of Parent Common Stock equal to the product of (i) the total number
of Shares subject to such Company RSUs immediately prior to the Offer Acceptance Time multiplied by (ii) the Equity Award Conversion
Ratio, with any fractional shares rounded down to the next lower whole number of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each then-outstanding award of Company Restricted Shares, which pursuant to <U>Section 2.8(l)</U>
below, would become vested prior to or at the Offer Acceptance Time or Effective Time (the &ldquo;<U>Cashed-Out Company Restricted
Shares</U>&rdquo;), shall be canceled and the holder thereof shall be entitled to receive a cash payment equal to the product of
(i) the Merger Consideration and (ii) the number of Shares subject to such Cashed-Out Company Restricted Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each then outstanding award of Company Restricted Shares (other than any Cashed-Out Company
Restricted Shares) shall be assumed and converted into a number of shares of Parent Common Stock (each, an &ldquo;<U>Adjusted Restricted
Share</U>&rdquo;), on the same terms and conditions as were applicable under such Company Restricted Share immediately prior to
the Offer Acceptance Time, and relating to a number of shares of Parent Common Stock equal to the product of (i) the total number
of Shares subject to such Company Restricted Shares immediately prior to the Offer Acceptance Time multiplied by (ii) the Equity
Award Conversion Ratio, with any fractional shares rounded down to the next lower whole number of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each award of Company PRSUs that is subject to performance-based vesting restrictions as of
immediately prior to the Offer Acceptance Time shall vest as to 50% of the total number of Company PRSUs subject to such award,
and such vested portion shall be cancelled (the &ldquo;<U>Cashed-Out Company PRSUs</U>&rdquo;) and converted into the right to
receive a cash payment equal to the product of (i) the Merger Consideration and (ii) the number of Company PRSUs that become vested
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each portion of an award of Company PRSUs for which vesting does not accelerate and become
cancelled in exchange for the payment described in <U>Section 2.8(g)</U>, and that is outstanding and unvested immediately prior
to the Offer Acceptance Time shall be assumed and converted into a restricted stock unit denominated in shares of Parent Common
Stock (each, an &ldquo;<U>Adjusted PRSU</U>&rdquo;), and relating to a number of shares of Parent Common Stock equal to the product
of (i) the total number of Shares subject to such Company PRSUs immediately prior to the Offer Acceptance Time multiplied by (ii)
the Equity Award Conversion Ratio, with any fractional shares rounded down to the next lower whole number of shares. The Adjusted
PRSUs shall continue to be subject to the same terms and conditions as were applicable to such Company PRSU immediately prior to
the Offer Acceptance Time except that (i) 60% of the Adjusted PRSUs shall vest on the one-year anniversary of the Effective Time
and (ii) the remaining 40% of the Adjusted PRSUs shall vest on the earlier of (A) the second anniversary of the Effective Time
and (B) the first approval by the FDA of JCAR017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each award of Company Performance Restricted Shares that is subject to performance-based vesting
restrictions as of immediately prior to the Offer Acceptance Time shall vest as to 50% of the total number of Shares subject to
such award, and such vested portion shall be cancelled (the &ldquo;<U>Cashed-Out Company Performance Restricted Shares</U>&rdquo;)
and converted into the right to receive a cash payment equal to the product of (i) the Merger Consideration and (ii) the number
of Company Performance Restricted Shares that become vested hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each portion of an award of Company Performance Restricted Shares for which vesting does not
accelerate and become cancelled in exchange for the payment described in <U>Section 2.8(i)</U>, and that is outstanding and unvested
immediately prior to the Offer Acceptance Time shall be assumed and converted into a number of shares of Parent Common Stock (each,
an &ldquo;<U>Adjusted Performance Restricted Share</U>&rdquo;), and relating to a number of shares of Parent Common Stock equal
to the product of (i) the total number of Shares subject to such Company Performance Restricted Shares immediately prior to the
Offer Acceptance Time multiplied by (ii) the Equity Award Conversion Ratio, with any fractional shares rounded down to the next
lower whole number of shares. The Adjusted Performance Restricted Shares shall continue to be subject to the same terms and conditions
as were applicable to such Company Performance Restricted Shares immediately prior to the Offer Acceptance Time except that (i)
60% of the Adjusted Performance Restricted Shares shall vest on the one-year anniversary of the Effective Time and (ii) the remaining
40% of the Adjusted Performance Restricted Shares shall vest on the earlier of (A) the second anniversary of the Effective Time
and (B) the first approval by the FDA of JCAR017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
soon as reasonably practicable after the Effective Time (but in any event no later than the earlier of (i)&nbsp;the second
payroll period or (ii)&nbsp;thirty (30)&nbsp;days following the Effective Time), Parent shall cause the Surviving Corporation
to, and the Surviving Corporation shall, pay the aggregate consideration payable pursuant to <U>Sections 2.8(a)</U>, <U>2.8(c)</U>
and <U>2.8(e)</U>, <U>2.8(g)</U> and <U>2.8(i)</U> above, net of any applicable withholding Taxes, payable with respect to
Vested in the Money Options, Cashed-Out Company RSUs, Cashed-Out Company Restricted Shares, Cashed-Out Company PRSUs and
Cashed-Out Company Performance Restricted Shares through, to the extent applicable, the Surviving Corporation&rsquo;s payroll
(subject to any required tax withholdings) to the holders of Vested in the Money Options, Cashed-Out Company RSUs, Cashed-Out
Company Restricted Shares, Cashed-Out Company PRSUs and/or Cashed-Out Company Performance Restricted Shares; <U>provided</U>
that such payment with respect to Cashed-Out Company RSUs shall be made at such other time or times following the Effective
Time consistent with the terms of the applicable award agreement to the extent necessary to avoid the imposition of
additional income tax under Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the Offer Acceptance Time, each unvested Company Option that is then outstanding and unexercised, each award of Company
RSUs that is then outstanding, and each award of Company Restricted Shares that is then outstanding (i) if granted twelve (12)
months or more prior to the Effective Time, shall become vested pursuant to its terms or, if greater, with respect to 25% of the
total number of Shares subject to such award (provided, that, for purposes of this Section 2.8(l)(i), any award (or the applicable
portion thereof) that has a regularly scheduled time-based vesting event occurring on the date of the Effective Time shall not
be considered unvested for purposes of applying the vesting acceleration provision in this section 2.8(l)(i) to such award (or
applicable portion thereof) that becomes vested on such regularly scheduled vesting date), (ii) if granted following the date of
this Agreement but prior to the Effective Time, shall become vested pursuant to its terms or, if greater, with respect to 25% of
the total number of Shares subject to such award (the &ldquo;<U>Pre-Closing Non-Performance Awards</U>&rdquo;) or (iii) if granted
less than twelve (12) months prior to the Effective Time other than the Pre-Closing Non-Performance Awards, shall become vested
pursuant to its terms or, if greater, with respect to that number of Shares subject thereto, such that, following such vesting,
the award will be unvested with respect to that number of Shares which would have become vested and resulted in the award being
100% vested had the holder of the award remained continuously employed for an additional twenty-four (24) months following the
Effective Time; provided, that, with respect to any awards referred to in subsections (i) and (iii), if, as of the 24-month anniversary
of the Effective Time, any portion of such awards remains unvested, such unvested portion shall become immediately vested on such
24-month anniversary date, provided that the employee has remained employed through such 24-month anniversary date. Prior to the
Effective Time, the Company shall take all actions that are necessary (under the Company Equity Plans and award agreements pursuant
to which Company Options, Company RSUs, Company Restricted Shares, Company PRSUs and Company Performance Restricted Shares are
outstanding or otherwise) to effect the transactions described in this <U>Section 2.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Offer Acceptance Time, Parent shall use its best efforts to provide for the reservation, issuance and listing of Parent
Common Stock as is necessary to effectuate the transactions contemplated by this <U>Section 2.8</U>. Parent shall prepare and,
at or prior to the Offer Acceptance Time, file with the SEC a registration statement on an appropriate form, or a post-effective
amendment to a registration statement previously filed under the Securities Act, with respect to shares of Parent Common Stock
subject to the Adjusted Options, Adjusted Restricted Stock Units, Adjusted Restricted Shares, Adjusted PRSUs and Adjusted Performance
Restricted Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the Effective Time, Parent will assume the Company Equity Plans (the &ldquo;<U>Assumed Plans</U>&rdquo;) and be able to grant stock
awards, to the extent permissible by applicable Legal Requirement and NASDAQ regulations, under the terms of the Assumed Plans
to issue the reserved but unissued shares of Company Common Stock under the Assumed Plans. The shares subject to the unexercised
portions of any award granted thereunder that expires, terminates or is canceled, and shares of Company Common Stock issued pursuant
to an award that are reacquired by Parent pursuant to the terms of the award under which such shares were issued that would otherwise
return to the Assumed Plans pursuant to their respective terms, will return and may be used for awards to be granted under the
respective Assumed Plan, except that (i) shares of Company Common Stock covered by such awards will be shares of Parent Common
Stock and (ii) all references to a number of shares of Company Common Stock will be (A) changed to reference Parent Common Stock
and (B) converted to a number of shares of Parent Common Stock equal to the product of the number of shares of Company Common Stock
multiplied by the Equity Award Conversion Ratio, rounded down to the next lower whole number of shares of Parent Common Stock.
None of the Acquired Corporations shall take any action that would otherwise preclude Parent from being able to grant awards under
the Assumed Plans, including adopting resolutions to terminate either of the Assumed Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>2.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further
Action</B>. The Parties agree to take all necessary action to cause the Merger to become effective
in accordance with this <U>Section 2</U> as soon as practicable following the consummation of the Offer without a meeting of the
Company&rsquo;s stockholders, as provided in Section 251(h) of the DGCL. If, at any time after the Effective Time, any further
action is reasonably determined by Parent to be necessary or desirable to carry out the purposes of this Agreement or to vest the
Surviving Corporation with full right, title and possession of and to all rights and property of Purchaser and the Company, the
officers and directors of the Surviving Corporation and Parent shall be fully authorized (in the name of Purchaser, in the name
of the Company and otherwise) to take such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
3<BR>
<BR>
<U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company hereby represents
and warrants to Parent and Purchaser as follows (it being understood that each representation and warranty contained in this <U>Section
3</U> is subject to (a) exceptions and disclosures set forth in the section or subsection of the Company Disclosure Schedule corresponding
to the particular Section or subsection in this <U>Section 3</U>; (b) any exception or disclosure set forth in any other section
or subsection of the Company Disclosure Schedule to the extent it is reasonably apparent on the face of such disclosure that such
exception or disclosure is applicable to qualify such representation and warranty; and (c) disclosure in the Company SEC Documents
filed since January 1, 2017 and publicly available prior to the date of this Agreement (other than any information in the &ldquo;Risk
Factors&rdquo; or &ldquo;Forward-Looking Statements&rdquo; sections of such Company SEC Documents or other general cautionary or
forward-looking statements in any other sections of such Company SEC Documents); <I>provided</I> that this <U>clause (c)</U> shall
not be applicable to <U>Section 3.3(a)</U>, <U>Section 3.3(c)</U> and <U>Section 3.20</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; text-indent: 0.5in"><B>3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due
Organization; Subsidiaries, Etc</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is a corporation duly organized, validly existing and, except as would not have, and would not reasonably be expected to
have, a Material Adverse Effect, in good standing under the laws of the State of Delaware. Each Acquired Corporation has all necessary
power and authority: (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted; and (ii)&nbsp;to
own and use its assets in the manner in which its assets are currently owned and used. Each Acquired Corporation is duly qualified
or licensed to do business as a foreign corporation, and is in good standing in each jurisdiction where the nature of its business
requires such qualification or licensing, except where the failure does not have, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company owns beneficially and of record all of the equity interests of its Subsidiaries, free and clear of all Encumbrances and
transfer restrictions, except for Encumbrances or transfer restrictions of general applicability as may be provided under the Securities
Act or applicable securities laws. Except for the equity interests of such Subsidiaries held by the Company, no Acquired Corporation
owns, directly or indirectly, any capital stock or equity interests in, or subscriptions, options, calls, warrants or rights (whether
or not currently exercisable) to acquire, or other securities convertible into or exchangeable or exercisable for, any capital
stock or equity interests of any Entity. All of the issued and outstanding capital stock or equivalent equity interests of each
of the Company&rsquo;s Subsidiaries are duly authorized and validly issued, and are fully paid (to the extent required under the
applicable governing documents) and nonassessable. <U>Section 3.1(b)(ii)</U> of the Company Disclosure Schedule sets forth an accurate
and complete list of the Company&rsquo;s Subsidiaries as of the date of this Agreement and their jurisdictions of incorporation
or formation, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificate
of Incorporation and Bylaws</B>. The Company has delivered or made available to Parent or Parent&rsquo;s
Representatives accurate and complete copies of the certificate of incorporation, bylaws and other charter and organizational documents
of each Acquired Corporation, including all amendments thereto, as in effect on the date hereof. Each Acquired Corporation is in
compliance in all material respects with the provisions of its certificate of incorporation, bylaws and other charter and organizational
documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalization,
Etc</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
authorized capital stock of the Company consists of: (i)&nbsp;495,000,000 Shares, of which 115,331,648 Shares had been issued and
were outstanding as of the close of business on January 18, 2018; and (ii)&nbsp;5,000,000 shares of Company Preferred Stock, of
which no shares have been issued or are outstanding. All of the issued and outstanding Shares are duly authorized and validly issued,
and are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the outstanding equity interests of the Acquired Corporations are entitled or subject to any preemptive right, right of repurchase
or forfeiture, right of participation, right of maintenance or any similar right, or are subject to any right of first refusal
in favor of any Acquired Corporation. There are no outstanding bonds, debentures, notes or other indebtedness of any Acquired Corporation
having a right to vote on any matters on which the holders of equity interests of the Acquired Corporations have a right to vote.
There is no Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or
otherwise disposing of (or from granting any option or similar right with respect to), any equity interests of the Acquired Corporations.
No Acquired Corporation is under any obligation, or bound by any Contract pursuant to which it may become obligated, to repurchase,
redeem or otherwise acquire any outstanding equity interests of the Acquired Corporations. The Shares constitute the only outstanding
class of securities of the Company registered under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the close of business on January 18, 2018: (i)&nbsp;11,345,068 Shares were subject to issuance pursuant to Company Options granted
and outstanding under the Company Equity Plans; (ii)&nbsp;3,077,336 Shares were subject to issuance pursuant to Company RSUs or
Company PRSUs granted and outstanding under the Company Equity Plans; (iii) 458,708 Shares of Company Restricted Shares or Company
Performance Restricted Shares were issued and outstanding under the Company Equity Plans; (iv) 9,337,390 Shares were reserved for
future issuance under Company Equity Plans; and (v) 7,391,289 Shares were reserved for future issuance under the Company ESPP.
As of the close of business on January 18, 2018, the weighted average exercise price of the Company Options outstanding as of that
date was $31.53. Other than as set forth in this <U>Section 3.3(c)</U> and those Company Options, Company RSUs, Company Restricted
Shares, Company PRSUs and Company Performance Restricted Shares issued since January 18, 2018 as expressly permitted by <U>Section
5.2(b)(iii)</U>, there is no issued, reserved for issuance, outstanding or authorized stock option, stock appreciation, phantom
stock, profit participation or similar rights or equity-based awards with respect to any Acquired Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
3.3(d)</U> of the Company Disclosure Schedule contains a true, correct and complete list, as of January 18, 2018, of the name of
each holder of Company Options, Company RSUs, Company Restricted Shares, Company PRSUs and Company Performance Restricted Shares,
the number of outstanding Company Options, Company RSUs, Company Restricted Shares, Company PRSUs and Company Performance Restricted
Shares held by such holder, the grant date of each such Company Option, Company RSU, Company Restricted Share, Company PRSUs and
Company Performance Restricted Shares, the number of Shares such holder is entitled to receive upon the exercise of each Company
Option and the corresponding exercise price, the expiration date of each Company Option, the vesting schedule of each Company Option,
Company RSU, Company Restricted Shares, Company PRSU and Company Performance Restricted Share and the Company Equity Plan pursuant
to which each such Company Option, Company RSU, Company Restricted Share, Company PRSU and Company Performance Restricted Share
was granted. Except as set forth in this <U>Section 3.3</U>, Company Options, Company RSUs, Company Restricted Shares, Company
PRSUs and Company Performance Restricted Shares issued since January 18, 2018 as expressly permitted by <U>Section 5.2(b)(iii)</U>
and any Shares issued upon exercise of Company Options or the settlement of Company RSUs outstanding as of the close of business
on January 18, 2018 or issued since January 18, 2018 as expressly permitted by <U>Section 5.2(b)(iii)</U>, there are no: (i)&nbsp;outstanding
shares of capital stock of or other securities of any Acquired Corporation; (ii)&nbsp;outstanding subscriptions, options, calls,
warrants or rights (whether or not currently exercisable) to acquire any shares of the capital stock, restricted stock unit, stock-based
performance unit or any other right that is linked to, or the value of which is in any way based on or derived from the value of
any shares of capital stock or other securities of any Acquired Corporation, in each case other than derivative securities not
issued by an Acquired Corporation; (iii)&nbsp;outstanding securities, instruments, bonds, debentures, notes or obligations that
are or may become convertible into or exchangeable for any shares of the capital stock or other securities of any Acquired Corporation,
in each case other than convertible or exchangeable securities not issued by an Acquired Corporation; or (iv)&nbsp;stockholder
rights plans (or similar plans commonly referred to as a &ldquo;poison pill&rdquo;) or Contracts under which any Acquired Corporation
is or may become obligated to sell or otherwise issue any shares of its capital stock or any other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SEC Filings; Financial Statements</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January 1, 2016, the Company has filed or furnished on a timely basis all reports, schedules, forms, statements and other documents
(including exhibits and all other information incorporated therein) required to be filed or furnished by the Company with the SEC
(as supplemented, modified or amended since the time of filing, collectively, the &ldquo;<U>Company SEC Documents</U>&rdquo;).
As of their respective dates, or, if amended prior to the date of this Agreement, as of the date of (and giving effect to) the
last such amendment (and, in the case of registration statements and proxy statements, on the date of effectiveness and the dates
of the relevant meetings, respectively), the Company SEC Documents complied in all material respects with the requirements of the
Securities Act, the Exchange Act or the Sarbanes-Oxley Act of 2001, as amended (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;), as
the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to those Company SEC Documents, and,
except to the extent that information contained in such Company SEC Document has been revised, amended, modified or superseded
(prior to the date of this Agreement) by a later filed Company SEC Document, none of the Company SEC Documents when filed or furnished
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
financial statements (including any related notes and schedules) contained or incorporated by reference in the Company SEC Documents:
(i)&nbsp;complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii)&nbsp;were
prepared in accordance with United States generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;) applied on a consistent
basis throughout the periods covered (except as may be indicated in the notes to such financial statements or, in the case of unaudited
interim financial statements, as may be permitted by the SEC on Form 10-Q, 8-K or any successor form under the Exchange Act); and
(iii)&nbsp;fairly presented, in all material respects, the financial position of the Company as of the respective dates thereof
and the results of operations and cash flows of the Company for the periods covered thereby (subject, in the case of the unaudited
financial statements, to the absence of notes and to normal and recurring year-end adjustments that are not, individually or in
the aggregate, material).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company maintains a system of internal control over financial reporting (as defined in Rule 13a-15 under the Exchange Act) which
is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with GAAP, and includes those policies and procedures that: (i) pertain to the maintenance
of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
(ii)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements
in conformity with GAAP and that receipts and expenditures are being made only in accordance with authorizations of management
and the Board of Directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use or disposition of the assets of the Company that could have a material effect on the financial statements. The Company&rsquo;s
management has completed an assessment of the effectiveness of the Company&rsquo;s system of internal control over financial reporting
in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act for the fiscal year ended December 31, 2016, and,
except as set forth in the Company SEC Documents filed prior to the date of this Agreement, that assessment concluded that those
controls were effective. To the knowledge of the Company, since January 1, 2017, neither the Company nor the Company&rsquo;s independent
registered accountant has identified or been made aware of: (1)&nbsp;any significant deficiency or material weakness in the design
or operation of the internal control over financial reporting utilized by the Company, which is reasonably likely to adversely
affect the Company&rsquo;s ability to record, process, summarize and report financial information; or (2) any fraud, whether or
not material, that involves the management or other employees of the Company who have a significant role in the Company&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company maintains and has since January 1, 2016 maintained, disclosure controls and procedures as defined in and required by Rule
13a-15 or 15d-15 under the Exchange Act that are reasonably designed to ensure that all information required to be disclosed in
the Company&rsquo;s reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the rules and forms of the SEC and that all such information is accumulated and communicated to the
Company&rsquo;s management as appropriate to allow timely decisions regarding required disclosure and to enable the principal executive
officer of the Company and the principal financial officer of the Company to make the certifications required under the Exchange
Act with respect to such reports. The Company is in compliance in all material respects with all current listing and corporate
governance requirements of NASDAQ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not a party to, nor does it have any obligation or other commitment to become a party to, &ldquo;off-balance sheet arrangements&rdquo;
(as defined in Item 303(a) of Regulation S-K under the Exchange Act) where the result, purpose or intended effect of such Contract
is to avoid disclosure of any material transaction involving, or material liabilities of, the Company in the Company SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC with respect
to the Company SEC Documents. To the knowledge of the Company, none of the Company SEC Documents is the subject of ongoing SEC
review and there are no inquiries or investigations by the SEC or any internal investigations pending or threatened, in each case
regarding any accounting practices of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
document required to be filed by the Company with the SEC in connection with the Offer, including the Schedule 14D-9 and the Schedule
13E-3 (the &ldquo;<U>Company Disclosure Documents</U>&rdquo;), and any amendments or supplements thereto, when filed, distributed
or otherwise disseminated to the Company&rsquo;s stockholders, as applicable, will comply as to form in all material respects with
the applicable requirements of the Exchange Act. The Company Disclosure Documents, at the time of the filing of such Company Disclosure
Documents or any supplement or amendment thereto with the SEC and at the time such Company Disclosure Documents or any supplements
or amendments thereto are first distributed or otherwise disseminated to the Company&rsquo;s stockholders, will not contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make
the statements made therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
information with respect to the Company that the Company furnishes to Parent or Purchaser specifically for use in the Schedule
TO and the Offer Documents, at the time of the filing of the Schedule TO and at the time of any distribution or dissemination of
the Offer Documents, will not contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, the Company makes no representation with respect to statements made or incorporated by reference therein based on
information supplied by or on behalf of Parent or Purchaser for inclusion or incorporation by reference in the Company Disclosure
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Absence
of Changes</B>. Except as expressly contemplated by this Agreement, from December 31, 2016 through
the date of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
has not occurred any Event that, individually or in the aggregate, has had or would reasonably be expected to have, a Material
Adverse Effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
the Acquired Corporations have operated in all material respects in the ordinary course of business and (ii) the Company has not
taken any action or failed to take any action that, had such action been taken or failed to have been taken after the date hereof,
would have required Parent&rsquo;s consent under <U>Sections 5.2(b)(i)(A)</U>, <U>5.2(b)(ii)</U>, <U>5.2(b)(xii), 5.2(b)(xiv)</U>
or <U>5.2(b)(xxii)</U> (but only with respect to any of the foregoing actions) had such action been taken after the execution of
this Agreement without the prior consent of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title
to Assets</B>. Each Acquired Corporation has good and valid title to all material assets owned
by it as of the date of this Agreement, and such assets are, in all material respects, sufficient to carry on the business of the
Acquired Corporations as currently conducted. All of said material assets are owned by the Acquired Corporations free and clear
of any Encumbrances (other than Permitted Encumbrances).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real
Property</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not have, individually or in the aggregate, a Material Adverse Effect, the Acquired Corporations own good and marketable
fee simple title to the real properties owned by the Acquired Corporations, in each case free and clear of any Encumbrances other
than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations hold valid and existing leasehold interests in the real property that is leased or subleased by the Acquired
Corporations from another Person (the &ldquo;<U>Leased Real Property</U>&rdquo;), in each case free and clear of any Encumbrances
other than Permitted Encumbrances. No Acquired Corporation has received any written notice regarding any material violation or
breach or default under any lease related to the Leased Real Property that has not since been cured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intellectual
Property</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
3.8(a)(i)</U> of the Company Disclosure Schedule sets forth a list as of the date of this Agreement of all material United States
and foreign: (A) issued Patents and Patent applications; (B) Trademark registrations and Trademark applications; and (C) Copyright
registrations and Copyright applications, in each case, that are Company-Owned IP (such Intellectual Property, the &ldquo;<U>Company-Owned
Registered IP</U>&rdquo;) and to the knowledge of the Company, <U>Section 3.8(a)(ii)</U> of the Company Disclosure Schedule sets
forth a list as of the date of this Agreement of all material United States and foreign: (A) issued Patents and Patent applications;
(B) Trademark registrations and Trademark applications; and (C) Copyright registrations and Copyright applications, in each case,
that are Company Licensed IP (such Intellectual Property, the &ldquo;<U>Company-Licensed Registered IP</U>&rdquo;). All Company-Owned
Registered IP is, and to the knowledge of the Company, Company-Licensed Registered IP is, in effect and subsisting, and to the
knowledge of the Company, other than any pending applications therefor, valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no orders, writs, injunctions, judgments, rulings or decrees of, or settlements with, any Governmental Body to which any Acquired
Corporation is subject adversely affecting the validity, transferability, scope, use, registrability or enforceability of any material
(i) Company-Owned IP and (ii) to the knowledge of the Company, Company Licensed IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries taken
as a whole, no Legal Proceeding (including any interference, opposition, reissue, reexamination, International Trade Commission
investigation and similar proceedings) is (or has since January 1, 2016 been) pending or, to the knowledge of the Company, threatened
in writing, by any Person challenging the claim construction, validity, enforceability, priority, inventorship or ownership of
any Company-Owned&nbsp;IP or to the knowledge of the Company, material Company Licensed IP (other than, in each case, in connection
with the prosecution of applications for registration of such Intellectual Property). Except as would not reasonably be expected
to be, individually or in the aggregate, material to the Company and its Subsidiaries taken as a whole, no Legal Proceeding is
(or has since January 1, 2016 been) (i) pending, or to the knowledge of the Company, threatened in writing, by any Person alleging
that any Acquired Corporation is infringing, misappropriating or otherwise violating the Intellectual Property of such Person;
or (ii) pending, or threatened in writing, by the Company that any Person is infringing, misappropriating or otherwise violating
any Company IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of the Company, (i)(A) the conduct of the business of the Acquired Corporations as currently conducted does not,
(B) the manufacture of JCAR017 and JCARH125, as currently conducted does not, and as contemplated to be conducted for purposes
of commercialization of JCAR017 and JCARH125 will not, and (C) the sale of JCAR017 and JCARH125 will not, in each case, infringe,
misappropriate or otherwise violate the Intellectual Property of any Person in any material respect; and (ii) no Person is infringing,
misappropriating or otherwise violating any Company-Owned IP or Company-Licensed IP, in any material respect. For purposes of this
paragraph (d), JCAR017 and JCARH125 refer to such products, including the manufacturing process therefor, as used in clinical trials
being conducted by the Company as of the date hereof. Notwithstanding anything to the contrary herein, the representations and
warranties set forth in this <U>Section 3.8(d)</U> and in <U>Section 3.8(c)</U> are the sole and exclusive representations and
warranties of the Company with respect to any actual or alleged infringement, misappropriation or other violation of Intellectual
Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries taken
as a whole, the Company owns (in each case, free from all Encumbrances other than Permitted Encumbrances), or has a valid license
to or other right to use, all of the Company-Owned IP, Company Licensed IP and other Intellectual Property used in the conduct
of the business of the Acquired Corporations as currently conducted; <U>provided</U> that this <U>Section 3.8(e)</U> is not a representation
or warranty with respect to infringement, misappropriation or other violation of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Acquired Corporations have taken commercially reasonable measures to protect the confidentiality of material Trade Secrets
constituting Company IP. To the Company&rsquo;s knowledge, since January 1, 2016, no material Trade Secret constituting Company-Owned
IP has been disclosed or accessed by any Person in a manner that has resulted in the loss of trade secret or other rights of any
Acquired Corporation thereto or therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations have taken commercially reasonable measures to maintain the confidentiality of all information that (i) alone
or in combination with other information held by the Acquired Corporations can be used to identify, contact or precisely locate
a natural person or can be linked to a natural person; or (ii) is governed, regulated or protected by one or more Legal Requirements
regarding the security of personally identifiable information (collectively, &ldquo;<U>Personal Information</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations are and since January 1, 2016 have been in compliance in all material respects with applicable Legal Requirements,
as well as their own policies, relating to privacy, data protection, and the collection and use of Personal Information collected,
used, or held for use by any Acquired Corporations, and no material claims or to the Company&rsquo;s knowledge, investigations
by Governmental Bodies, are pending or to the Company&rsquo;s knowledge, threatened in writing, against any Acquired Corporation
alleging a violation of any Information Privacy and Security Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January 1, 2016, there has been no security breach in the information technology systems used by or on behalf of any Acquired Corporation
and no unauthorized access, use, acquisition or disclosure of any Personal Information in their possession and control, except
as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries taken
as a whole. The Acquired Corporations have taken commercially reasonable actions to protect the security and integrity of their
servers, systems, sites, circuits, networks, interfaces, platforms and other information technology systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contracts</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
3.9(a)</U> of the Company Disclosure Schedule identifies each Contract to which any Acquired Corporation is a party, or by which
it is bound, that constitutes a Material Contract as of the date of this Agreement. For purposes of this Agreement, each of the
following to which any Acquired Corporation is a party or by which it is bound as of the date of this Agreement constitutes a &ldquo;<U>Material
Contract</U>&rdquo;:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract that is a settlement, conciliation or similar agreement pursuant to which (A) an Acquired Corporation will be required
after the date of this Agreement to pay any monetary obligations or (B) that contains material obligations or limitations on such
Acquired Corporation&rsquo;s conduct;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract, including any manufacturing, supply or distribution agreement, that requires by its terms or is reasonably likely to
require the payment or delivery of cash or other consideration by or to any Acquired Corporation in an amount having an expected
value in excess of $5,000,000 in the fiscal years ending December 31, 2017, December 31, 2018 or any fiscal year thereafter, and
which cannot be cancelled by such Acquired Corporation without more than ninety (90) days&rsquo; notice without payment in excess
of $1,000,000 as a result of such cancellation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract relating to Indebtedness in excess of $1,000,000 (whether incurred, assumed, guaranteed or secured by any asset) of any
Acquired Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract with any Person (A) constituting a material joint venture, partnership, collaboration or similar profit-sharing arrangement;
(B) pursuant to which any Acquired Corporation is or may be required to pay milestones, royalties or other contingent payments
based on the research, development, regulatory approval, sale, distribution or commercial manufacture of JCAR017 or JCARH125; or
(C) under which any Acquired Corporation grants to any Person any right of first refusal, right of first negotiation or similar
rights with respect to any Product or any material Intellectual Property; for purposes of this paragraph (a)(iv), JCAR017 and JCARH125
refer to such products, including the manufacturing process therefor, as used in clinical trials being conducted by the Company
as of the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract that by its express terms requires an Acquired Corporation, or any successor to, or acquirer of, an Acquired Corporation,
to make any payment to another Person as a result of a change of control of any Acquired Corporation (a &ldquo;<U>Change-of-Control
Payment</U>&rdquo;) or gives another Person a right to receive or elect to receive a Change-of-Control Payment, or terminate or
modify in any material respect the terms of a material Contract as a result of a change of control of any Acquired Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract that prohibits the declaration or payment of dividends or distributions in respect of the capital stock of an Acquired
Corporation, the pledging of the capital stock or other equity interests of an Acquired Corporation or the issuance of any guaranty
by an Acquired Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
material Contract pursuant to which any Acquired Corporation is granted by a third party, or grants to a third party, a license
or other rights to use Intellectual Property (other than any Contract (A)&nbsp;concerning commercially available software or other
commercially available technology; or (B) in which grants of rights to use Intellectual Property are incidental to and not material
to performance under such Contract) (each, an &ldquo;<U>IP Contract</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract that (A)&nbsp;materially limits the freedom or right of any Acquired Corporation or its Affiliates (or which, following
the consummation of the Merger could materially restrict or purports to materially restrict the ability of the Surviving Corporation
or Parent or any of their respective Affiliates) to engage in any line of business or to compete with any other Person in any location
or line of business; (B) contains any &ldquo;most favored nations&rdquo; terms and conditions (including with respect to pricing)
granted by any Acquired Corporation; (C) contains exclusivity obligations or restrictions or otherwise materially limits the freedom
or right of any Acquired Corporation or its Affiliates to research, develop, sell, distribute or manufacture any products or services
or any technology or other assets to or for any other Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
acquisition or divestiture Contract that contains continuing representations, covenants, indemnities or other obligations (including
&ldquo;earn-out&rdquo; or other contingent payment obligations);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract that relates to any swap, forward, futures, or other similar derivative transaction with a notional value in excess of
$1,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract with any Governmental Body involving payments to or from any Governmental Body in excess of $1,000,000, excluding such
contracts with academic or medical centers supported by Governmental Bodies;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
other Contract that is currently in effect and has been filed (or is required to be filed) by the Company as an exhibit pursuant
to Item 601(b)(10) of Regulation S-K under the Securities Act or that would be required to be disclosed under Item 404 of Regulation
S-K under the Securities Act; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Contract with any Affiliate, director, executive officer (as such term is defined in the Exchange Act), Person holding 5% or more
of the Shares, or, to the knowledge of the Company, any Affiliate (other than the Company) or immediate family member of any of
the foregoing, other than any Contract with Parent or any of its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
As of the date of this Agreement, the Company has either delivered or made available to Parent or Parent&rsquo;s Representatives
an accurate and complete copy of each Material Contract or has publicly made available such Material Contract in the Electronic
Data Gathering, Analysis and Retrieval (EDGAR) database of the SEC. (ii) No Acquired Corporation nor, to the knowledge of the Company,
the other party is in material breach of, or material default under, any Material Contract and no Acquired Corporation, or to the
knowledge of the Company, any other party to a Material Contract has taken or failed to take any action that with or without notice,
lapse of time or both would constitute a material breach of or material default under any Material Contract or give the other party
to any Material Contract the right to terminate or modify in any material respect the terms of such Material Contract. Each Material
Contract is, with respect to the Acquired Corporations and, to the knowledge of the Company, the other party, a valid and binding
agreement in full force and effect, enforceable in accordance with its terms, except as such enforcement may be subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating to or affecting
creditors&rsquo; rights, and by general equitable principles. (iii) Since January 1, 2017, the Acquired Corporations have not received
any written notice regarding any material violation or breach or default under any Material Contract that has not since been cured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undisclosed
Liabilities</B>. The Acquired Corporations do not have any liabilities of any nature (whether accrued,
absolute, contingent or otherwise), except for: (a)&nbsp;liabilities reflected or reserved against in the financial statements
or notes thereto included in the Company SEC Documents filed prior to the date of this Agreement; (b)&nbsp;liabilities or obligations
incurred pursuant to the terms of this Agreement; (c)&nbsp;liabilities for performance of obligations under Contracts binding upon
the Acquired Corporations (other than resulting from any breach or acceleration thereof) either delivered or made available to
Parent or Parent&rsquo;s Representatives prior to the date of this Agreement or entered into in the ordinary course of business
consistent with past practice; (d)&nbsp;liabilities incurred in the ordinary course of business consistent with past practice since
September 30, 2017; and (e)&nbsp;liabilities that have not had, and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
with Legal Requirements</B>. The Acquired Corporations and, to the knowledge of the Company, JW
(Cayman) Therapeutics Co. Ltd. and its Subsidiaries, are, and since January 1, 2016 have been, in compliance in all material respects
with all applicable Legal Requirements and, since January 1, 2016, none of the Acquired Corporations or, to the knowledge of the
Company, JW (Cayman) Therapeutics Co. Ltd. or any of its Subsidiaries, has been given written notice of, or been charged with,
any material violation of, any applicable Legal Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulatory Matters</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations have filed, maintained or furnished with the applicable regulatory authorities (including the FDA, European
Medicines Agency (&ldquo;<U>EMA</U>&rdquo;) or any other Governmental Body performing functions similar to those performed by the
FDA or EMA, or otherwise having jurisdiction over the safety, efficacy, approval, development, testing, labeling, manufacture,
storage, marketing, promotion, sale, commercialization, shipment, import, export or distribution of pharmaceutical or biological
products (such other Governmental Bodies collectively, the &ldquo;<U>Specified Governmental Bodies</U>&rdquo;) all required material
filings, declarations, listings, registrations, reports, submissions, applications, amendments, modifications, notices and other
documents, including adverse event reports. All such material filings, declarations, listings, registrations, reports, submissions,
applications, amendments, modifications, notices and other documents were in material compliance with applicable Legal Requirements
when filed, and no deficiencies have been asserted by any applicable Governmental Body with respect to any such filings, declarations,
listing, registrations, reports, submissions, applications, amendments, modifications, notices or other documents. Any updates,
changes, corrections or modifications to such materials required under applicable Legal Requirements have been submitted in compliance
with such Legal Requirements in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January 1, 2016, except as set forth in documents either delivered or made available to Parent or Parent&rsquo;s Representatives
prior to the date of this Agreement, all preclinical and clinical investigations sponsored or conducted by or on behalf of the
Acquired Corporations have been and are being conducted in material compliance with all applicable Legal Requirements, rules, regulations
and binding guidances, including Good Clinical Practices, Good Laboratory Practices, other Health Care Laws, applicable research
protocols, corrective action plans, and federal and state laws, rules, regulations and binding guidances relating to patient privacy
requirements or restricting the use and disclosure of individually identifiable health information. Since January 1, 2016, except
as has not had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no clinical
or pre-clinical trial sponsored or conducted by or on behalf of any Acquired Corporation has been terminated, delayed or suspended
prior to completion for safety or other non-business reasons, and neither the FDA, EMA or any other Specified Governmental Body,
clinical investigator or contract research organization that has participated in or is participating in, or institutional review
board or data safety monitoring board that has or has had jurisdiction over, a clinical or pre-clinical trial conducted or sponsored
by or on behalf of any Acquired Corporation has commenced or, to the Company&rsquo;s knowledge, threatened to initiate any action
to place a clinical hold order on, or otherwise terminate, materially delay or suspend any proposed or ongoing clinical or pre-clinical
trial conducted or proposed to be conducted by or on behalf of any Acquired Corporation, or alleged any violation of applicable
Health Care Laws in connection with any such clinical or pre-clinical trial. The Company periodically reviews clinical trial sites
participating in any Acquired Corporation-sponsored trial for compliance with applicable Health Care Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation or officer thereof or to the Company&rsquo;s knowledge, no employee, agent or clinical investigator thereof
has (i)&nbsp;made an untrue statement of a material fact or fraudulent statement to the FDA, EMA or any other Specified Governmental
Body; (ii)&nbsp;failed to disclose a material fact required to be disclosed to the FDA, EMA, or any other Specified Governmental
Body or (iii)&nbsp;committed any other act, made any statement or failed to make any statement, that (in any such case) establishes
a reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final
Policy, or for the EMA or any other Specified Governmental Body to invoke any similar policy. As of the date of this Agreement,
no Acquired Corporation is the subject of any pending or, to the Company&rsquo;s knowledge, threatened investigation or other action
by the FDA pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy or by the EMA
or any other Specified Governmental Body under any similar policy. Since January 1, 2016, no Acquired Corporation or officer thereof
nor to the knowledge of the Company, any employee, agent or clinical investigator thereof has been disqualified, suspended, debarred
or convicted of any crime or engaged in any conduct that would reasonably be expected to result in (A) debarment under 21 U.S.C.
Section 335a or any similar Legal Requirement or (B) exclusion under 42 U.S.C. Section 1320a-7 or any similar Legal Requirement
or (C) disqualification as a clinical investigator under 21 CFR 312.70 or any similar Legal Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to have a Material Adverse Effect, each Acquired Corporation is in compliance and has, since
January 1, 2016, been in compliance, in each case, in all material respects with all Legal Requirements applicable to the operation
of its business as currently conducted, including (i)&nbsp;the FDCA and the regulations promulgated thereunder; (ii)&nbsp;the Clinical
Laboratory Improvement Amendments of 1988; (iii)&nbsp;the Health Insurance Portability and Accountability Act of 1996, the Health
Information and Technology for Economic and Clinical Health Act, and the regulations promulgated pursuant thereto; and (iv)&nbsp;Legal
Requirements the violation of which is cause for exclusion from any federal health care program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Products are being, and since January 1, 2016 have been, developed, tested, labeled, manufactured, stored, imported and exported,
as applicable, in all material respects in compliance with all Health Care Laws. Since January 1, 2016, except as has not had,
and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: (i) no Acquired Corporation
is subject to any enforcement, regulatory or administrative proceedings against or affecting such Acquired Corporation relating
to or arising under any Health Care Law or other applicable Legal Requirement, and no such enforcement, regulatory or administrative
proceeding has been threatened, (ii) no Acquired Corporation has received notice of any pending or threatened claim, suit, proceeding,
hearing, enforcement, audit, investigation, arbitration or other Legal Proceeding, and, to the Company&rsquo;s knowledge, there
is not pending any allegation that any operation or activity of any Acquired Corporation relating to the business of the Acquired
Corporations or any Product is in violation of any Health Care Law or other applicable Legal Requirement, and (iii) no Acquired
Corporation has received any FDA Form-483 or other notices of violations, inspectional observations, warning letters, untitled
letters or other written administrative, regulatory or enforcement notice from any Specified Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January 1, 2016, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect: (i) no investigational new drug application or similar document filed by or on behalf of the Acquired Corporations
with the FDA, EMA or any other Specified Governmental Body has been placed on clinical hold or otherwise limited, terminated, or
suspended, and (ii) no Acquired Corporation has received any written notice from a Specified Governmental Body that any Product
cannot be developed, tested, labeled, manufactured, stored, marketed, promoted or distributed substantially in the manner presently
performed or contemplated by an Acquired Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, each
Acquired Corporation has prepared, submitted and implemented timely responses and, as applicable, any corrective action plans required
to be prepared and submitted in response to all (i) internal or third-party audits, inspections, investigations or examinations
of the Products or such Acquired Corporation&rsquo;s business; (ii) adverse event reports; (iii) material patient complaints; (iv)
medical incident reports relating to the Products; and (v) material corrective and preventive actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation has submitted any claim for payment to any government healthcare program in connection with any referrals
related to any Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
Business Practices</B>. No Acquired Corporation nor, to the knowledge of the Company, any of its
employees, Representatives or agents (in each case, acting in the capacity of an employee or Representative of such Acquired Corporation)
or JW (Cayman) Therapeutics Co. Ltd. or any of its Subsidiaries, has (i)&nbsp;used any material funds (whether of an Acquired Corporation,
JW (Cayman) Therapeutics or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses relating to
political activity; (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or to foreign
or domestic political parties or campaigns; or (iii)&nbsp;violated any provision of any Anti-Corruption Laws or any rules or regulations
promulgated thereunder, anti-money laundering laws or any rules or regulations promulgated thereunder or any applicable Legal Requirement
of similar effect. Since January 1, 2016, neither any Acquired Corporation nor, to the knowledge of the Company, JW (Cayman) Therapeutics
Co. Ltd. or any of its Subsidiaries, has received any written communication that alleges any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governmental
Authorizations</B>. The Acquired Corporations hold all material Governmental Authorizations necessary
to enable the Acquired Corporations to conduct their business in the manner in which such business is currently being conducted.
The material Governmental Authorizations held by the Acquired Corporations are valid and in full force and effect. The Acquired
Corporations are in compliance in all material respects with the terms and requirements of such Governmental Authorizations. No
suspension, revocation or cancellation of any such Governmental Authorization is pending or threatened, and to the knowledge of
the Company, there is no reasonable basis for the revocation, cancellation or non-renewal of any such Governmental Authorization
upon expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax
Matters</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Each
of the material Tax Returns required to be filed by or on behalf of an Acquired Corporation with any Governmental Body (the &ldquo;<U>Company
Returns</U>&rdquo;) have been timely filed (taking into account any extensions of time to file), have been prepared in accordance
with all applicable Legal Requirements and are accurate and complete in all material respects, and (ii)&nbsp;all material Taxes
required to be paid or withheld by an Acquired Corporation (whether or not shown on the Company Returns) have been paid or withheld
and timely paid to the relevant Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
most recent balance sheet included in the Company SEC Documents filed prior to the date of this Agreement reflects adequate accruals
and reserves for all liabilities of the Company for Taxes with respect to all periods through the date thereof in accordance with
GAAP, other than any Taxes the non-payment of which would not have a Material Adverse Effect. Each Acquired Corporation has established,
in the ordinary course of business consistent with past practice, reserves adequate for the payment of all material unpaid Taxes
accrued by such Acquired Corporation since the date of such balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&rsquo;s knowledge, as of the date of this Agreement, (i)&nbsp;there are no current examinations or audits of any Company
Return in progress involving material Taxes; and (ii) since January 1, 2016, no written claim has been received by any Acquired
Corporation from any Governmental Body in any jurisdiction where each Acquired Corporation, as applicable, does not file Tax Returns
that such Acquired Corporation is or may be subject to Taxes in that jurisdiction. The Acquired Corporations have delivered or
made available to Parent or Parent&rsquo;s Representatives accurate and complete copies of all audit reports and similar documents
(to which the Acquired Corporations have access) relating to Company Returns which have been requested by Parent. As of the date
of this Agreement, no extension or waiver of the statute of limitation period applicable to any of the Company Returns has been
granted and is currently in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this Agreement, to the knowledge of the Company, no Legal Proceeding involving the IRS or any other Governmental
Body is pending or has been threatened in writing against or with respect to any Acquired Corporation in respect of any material
Tax, and no deficiency of material Taxes has been asserted in writing as a result of any audit or examination by any Governmental
Body that has not been paid, accrued for or been contested in good faith and in accordance with applicable Legal Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation (i)&nbsp;has ever been a member of an affiliated group (within the meaning of Section 1504(a) of the Code)
filing a consolidated federal income Tax Return (other than a group the common parent of which is or was the Company or another
Acquired Corporation), and (ii)&nbsp;has any material liability for the Taxes of any other Person (other than the Acquired Corporations)
under Section 1.1502-6 of the Treasury Regulations (or any similar provision of state, local or non-U.S. law), or as a transferee
or successor or otherwise (other than pursuant to agreements not primarily related to Taxes and entered into in the ordinary course
of business consistent with past practice).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the two (2)-year period ending on the date hereof, none of the Acquired Corporations has been either a &ldquo;distributing corporation&rdquo;
or a &ldquo;controlled corporation&rdquo; in a distribution of stock intended to qualify for tax-free treatment under Section 355
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation has participated in any &ldquo;listed transaction&rdquo; within the meaning of Treasury Regulations Section
1.6011-4(b)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations will not be required to include any item of income in, or exclude any item of deduction from, the computation
of taxable income for any taxable period (or portion thereof) ending after the Closing Date, except as would not, individually
or in the aggregate, have a Material Adverse Effect, as a result of any (i)&nbsp;change in method of accounting for a taxable period
ending on or prior to the Closing Date; (ii)&nbsp;&rdquo;closing agreement&rdquo; as described in Section 7121 of the Code (or
any corresponding or similar provision of state, local or non-U.S. income Tax law) executed prior to the Closing; (iii)&nbsp;installment
sale or open transaction disposition made prior to the Closing; (iv)&nbsp;prepaid amount received prior to the Closing; (v)&nbsp;deferred
intercompany gain or excess loss account described in the Treasury Regulations under Section 1502 of the Code (or any corresponding
or similar provision of state, local or non-U.S. Tax law); or (vi)&nbsp;election under Section 108(i) of the Code made prior to
the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation is party to or bound by any Tax allocation or Tax sharing agreement with any Person, other than any agreement
not primarily related to Taxes and entered into in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no material liens or other Encumbrances with respect to Taxes upon any of the assets or properties of any Acquired Corporation,
other than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee Matters; Benefit Plans</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as required by applicable Legal Requirements, the employment of each of the Company&rsquo;s employees is terminable by the Company
at will.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not a party to any collective bargaining agreement or other Contract with a labor organization representing any of its
employees. Since January 1, 2016, there has not been any strike, lockout, or other union organizing activity, or any threat thereof,
by any employees of the Company with respect to their employment with the Company. Since January 1, 2016, the Company has complied
in all material respects with all applicable Legal Requirements related to employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
3.16(c)</U> of the Company Disclosure Schedule sets forth an accurate and complete list of the material Employee Plans (other than
any employment, termination or severance agreement for non-officer employees of the Company, equity grant notices, and related
documentation, with respect to employees of the Company and agreements with consultants entered into in the ordinary course of
business consistent with past practice). To the extent applicable, the Company has either delivered or made available to Parent
or Parent&rsquo;s Representatives prior to the execution of this Agreement with respect to each material Employee Plan accurate
and complete copies of: (i)&nbsp;all plan documents and all material amendments thereto, and all related trust or other funding
documents, and in the case of unwritten Employee Plans, written descriptions thereof; (ii)&nbsp;all determination letters or opinion
letters issued by the IRS or the United States Department of Labor (&ldquo;<U>DOL</U>&rdquo;); (iii)&nbsp;the most recent annual
actuarial valuation, if any, and the most recent annual report (Form Series 5500 and all schedules and financial statements attached
thereto); (iv)&nbsp;the most recent summary plan descriptions and any material modifications thereto; (v)&nbsp;the most recent
nondiscrimination tests required to be performed under the Code (including 401(k) and 401(m) tests) for each Employee Plan; and
(vi)&nbsp;all material correspondence to or from the IRS, the DOL or any other Governmental Body with respect to an Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any other Person that would be or, at any relevant time, would have been considered a single employer with the
Company under the Code or ERISA has ever maintained, contributed to, or been required to contribute to a plan subject to Title
IV of ERISA or Code Section 412, including any &ldquo;single employer&rdquo; defined benefit plan or any &ldquo;multiemployer plan,&rdquo;
each as defined in Section 4001 of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Employee Plans that is intended to be qualified under Section&nbsp;401(a) of the Code has obtained a favorable determination
letter (or opinion letter, if applicable) as to its qualified status under the Code and, to the knowledge of the Company, no event
has occurred that would reasonably be expected to affect materially and adversely the qualified status of any such Employee Plan.
Each of the Employee Plans has been operated in material compliance with its terms and applicable Legal Requirements, including
ERISA and the Code. No non-exempt &ldquo;prohibited transaction&rdquo; (within the meaning of Section 4975 of the Code and Section
406 of ERISA) has occurred or is reasonably expected to occur with respect to any Employee Plan. There are no pending, or, to the
knowledge of the Company, threatened or anticipated claims by or on behalf of any Employee Plan, by any employee or beneficiary
covered under any such plan, or otherwise involving any such plan (other than routine claims for benefits), except as has not resulted
in, or would not reasonably be expected to result in, individually or in the aggregate, material liability to the Company and its
Subsidiaries. No audit or investigation by any Governmental Body is pending or, to the knowledge of the Company, has been threatened
or proposed with respect to any Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
to the extent required under Section 601 et seq. of ERISA or 4980B of the Code (or any other similar state or local Legal Requirement),
neither the Company nor any Employee Plan has any present or future obligation to provide post-employment welfare benefits to or
make any payment to, or with respect to, any present or former employee, officer or director of the Company pursuant to any retiree
medical benefit plan or other retiree welfare plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as provided in <U>Section 2.8</U>, the consummation of the Transactions (including in combination with other events or circumstances)
will not (i)&nbsp;entitle any current or former employee, director, officer, independent contractor or other service provider of
the Company to severance pay or any other payment; (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount
of, compensation or benefits due to any such person; or (iii)&nbsp;directly or indirectly cause the Company to fund any benefits
under any Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Employee Plan that is subject to Section 409A of the Code has been administered in compliance with its terms and the operational
and documentary requirements of Section 409A of the Code and the regulations thereunder, except for any instances of noncompliance
that do not have and would not reasonably be expected to have a Material Adverse Effect. The Company does not have an obligation
to gross-up, indemnify or otherwise reimburse any current or former service provider to the Company for any Tax incurred by such
service provider pursuant to Section 409A or Section 4999 of the Code. No Employee Plan or other agreement or Contract between
the Company (or any of its Subsidiaries) and an employee or other individual has resulted in or could reasonably be expected to
result in the payment of any &ldquo;excess parachute payment&rdquo; within the meaning of Section 280G(b)(1) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has delivered or made available to Parent or Parent&rsquo;s Representatives copies of the Company Equity Plans and the
forms of award agreements under the Company Equity Plans. Each outstanding Company Option has an exercise price equal to or above
the fair market value on the date of grant (within the meaning of Section 409A of the Code) and is otherwise not subject to Section
409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Employee Plan maintained for the benefit of any employee or service provider (or former employee or service provider) who performs
services outside the United States is now and has been operated in compliance with its terms and all applicable Legal Requirements,
except as has not resulted in, or would not reasonably be expected to result in, individually or in the aggregate, material liability
to the Company and its Subsidiaries. No Employee Plan described in this <U>Section 3.16(j)</U> is a defined benefit pension plan
that is material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Environmental Matters</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Acquired Corporations are and have been in compliance in all material respects with all applicable Environmental Laws, which compliance
includes obtaining, maintaining or complying with all material Governmental Authorizations required under Environmental Laws for
the operation of their business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is no material Legal Proceeding relating to or arising under any Environmental Law that is pending or, to the knowledge of the
Company, threatened against any Acquired Corporation or Leased Real Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporation has received any written notice, report or other information of or entered into any legally-binding agreement,
order, settlement, judgment, injunction or decree involving uncompleted, outstanding or unresolved material violations, liabilities
or requirements on the part of any Acquired Corporation relating to or arising under Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of the Company there are and have been no Hazardous Materials present or Releases on, at, under or from any property
or facility, including the Leased Real Property, in a manner and concentration that would reasonably be expected to result in any
material claim against or liability of an Acquired Corporation under any Environmental Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Acquired Corporations has assumed, undertaken, or otherwise become subject to any material liability of another Person relating
to Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance</B>.
The Company has delivered or made available to Parent or Parent&rsquo;s Representatives an accurate and complete copy of all material
insurance policies relating to the business, assets and operations of the Acquired Corporations. The Acquired Corporations maintain
insurance coverage in such amounts and covering such risks as are in accordance in all material respects with normal industry practice
for companies of similar size and stage of development. To the Company&rsquo;s knowledge, all material insurance policies are in
full force and effect, no written notice of cancellation or material modification has been received (other than a notice in connection
with ordinary renewals), and there is no existing material default or event which, with the giving of notice or lapse of time or
both, would constitute a material default, by any insured thereunder. There is no material claim pending under any of the Company&rsquo;s
insurance policies as to which coverage has been questioned, denied or disputed by the underwriters of such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal
Proceedings; Orders</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no material Legal Proceedings pending and served (or, to the knowledge of the Company, pending and not served or threatened)
against any Acquired Corporation or any of their properties or assets. To the knowledge of the Company, there are no material Legal
Proceedings pending or threatened against any present or former officer or director of an Acquired Corporation in such individual&rsquo;s
capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&rsquo;s knowledge, there is no material order, writ, injunction or judgment to which an Acquired Corporation is subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&rsquo;s knowledge, no material investigation or review by any Governmental Body with respect to an Acquired Corporation
is pending or is being threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authority;
Binding Nature of Agreement</B>. The Company has the corporate power and authority to execute and
deliver and to perform its obligations under this Agreement and to consummate the Transactions. The Board of Directors has (a)
determined that this Agreement and the Transactions, including the Offer and the Merger, are fair to, and in the best interest
of, the Company and its stockholders; (b)&nbsp;declared it advisable to enter into this Agreement; (c)&nbsp;approved the execution,
delivery and performance by the Company of this Agreement and the consummation of the Transactions, including the Offer and the
Merger; (d)&nbsp;resolved that the Merger may be effected pursuant to Section 251(h) of the DGCL; and (e)&nbsp;resolved to recommend
that the stockholders of the Company tender their Shares to Parent or Purchaser, as applicable, pursuant to the Offer, which resolutions,
subject to <U>Section 6.1</U>, have not been subsequently withdrawn or modified in a manner adverse to Parent as of the date of
this Agreement. This Agreement has been duly executed and delivered by the Company, and assuming due authorization, execution and
delivery by Parent and Purchaser, this Agreement constitutes the legal, valid and binding obligation of the Company and is enforceable
against the Company in accordance with its terms, except as such enforcement may be subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other similar laws of general applicability relating to or affecting creditors&rsquo;
rights, and by general equitable principles. If the Merger is consummated in accordance with Section 251(h) of the DGCL as contemplated
hereby, no vote of the Company&rsquo;s stockholders or any holder of Shares is necessary to authorize or adopt this Agreement or
to consummate the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Takeover
Laws</B>. Assuming the accuracy of the representations and warranties of Parent and Purchaser set
forth in <U>Section 4.8</U>, the Board of Directors has taken and will take all actions so that the restrictions applicable to
business combinations contained in Section 203 of the DGCL and any other Takeover Law are, and will be, to the extent such restrictions
can be rendered inapplicable by action of the Board of Directors under Legal Requirements, inapplicable to the execution, delivery
and performance of this Agreement and to the consummation of the Offer, the Merger and the other Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Contravention;
Consents</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
compliance with the applicable provisions of the DGCL, the HSR Act, any applicable filing, notification or approval in any foreign
jurisdiction required by Antitrust Laws (if any), and the rules and regulations of the SEC and NASDAQ, the execution and delivery
of this Agreement by the Company and the consummation of the Transactions will not: (i)&nbsp;cause a violation of any of the provisions
of the certificate of incorporation or bylaws (or other organizational documents) of any Acquired Corporation; (ii)&nbsp;cause
a violation by any Acquired Corporation of any Legal Requirement or order applicable to an Acquired Corporation, or to which an
Acquired Corporation is subject; (iii)&nbsp;require any consent or notice under, conflict with, result in breach of, or constitute
a default under (or an event that with notice or lapse of time or both would become a default), or give rise to any right of purchase,
termination, amendment, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which
an Acquired Corporation is entitled under any provision of any Material Contract; or (iv)&nbsp;result in an Encumbrance (other
than a Permitted Encumbrance) of any of the property or assets of any Acquired Corporation, except in the case of <U>clauses (ii)</U>,
<U>(iii)</U> and <U>(iv)</U>, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for the filing of the certificate of merger with the Secretary of State of the State of Delaware or as may be required by the Exchange
Act (including the filing with the SEC of the Schedule 14D-9, the Schedule 13E-3 and such reports under the Exchange Act as may
be required in connection with this Agreement and the Transactions), the DGCL, the HSR Act and any filing, notification or approval
in any foreign jurisdiction required by Antitrust Laws (if any), the applicable rules and regulations of the SEC and NASDAQ, the
Acquired Corporations are not required to give notice to, make any filing with, or obtain any Consent from any Governmental Body
at any time prior to the Closing in connection with the execution and delivery of this Agreement by the Company, or the consummation
by the Company of the Merger or the other Transactions, except those notices, filings, or Consents that the failure to make or
obtain are not, individually or in the aggregate, reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Opinion
of Financial Advisor</B>. The Board of Directors has received an opinion of Morgan Stanley &amp;
Co. LLC, financial advisor to the Company, to the effect that, as of the date of such opinion, and based on and subject to the
assumptions, qualifications, limitations and other matters set forth therein, the Offer Price to be received by the holders of
Shares (other than the Excluded Shares) pursuant to this Agreement is fair, from a financial point of view, to such holders of
Shares. The Company will make available to Parent a signed copy of such opinion as soon as practicable following its receipt thereof.
It is understood and agreed that such opinion will be provided to Parent solely for informational purposes and such opinion is
for the benefit of the Board of Directors and may not be relied upon by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brokers
and Other Advisors</B>. Except for Morgan Stanley &amp; Co. LLC, no broker, finder, investment
banker, financial advisor or other Person is entitled to any brokerage, finder&rsquo;s, financial advisor&rsquo;s or other similar
fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements
made by or on behalf of the Company; <U>provided</U> that such fees, commissions and/or expenses payable to Morgan Stanley &amp;
Co. LLC shall not exceed those set forth in the engagement letter between the Company and Morgan Stanley &amp; Co. LLC which has
been provided or made available to Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
4<BR>
<BR>
<U>REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Parent and Purchaser represent
and warrant to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due
Organization</B>. Each of Parent and Purchaser is a corporation or other Entity duly organized,
validly existing and in good standing under the laws of its jurisdiction of organization and has all necessary power and authority:
(a)&nbsp;to conduct its business in the manner in which its business is currently being conducted; and (b)&nbsp;to own and use
its assets in the manner in which its assets are currently owned and used, except where the failure does not have, and would not
reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser</B>.
Purchaser was formed solely for the purpose of engaging in the Transactions and activities incidental thereto and has not engaged,
and prior to the Effective Time will not engage, in any business activities or conducted any operations other than in connection
with the Transactions and those incident to Purchaser&rsquo;s formation. Either Parent or a wholly owned Subsidiary of Parent owns
beneficially and of record all of the outstanding capital stock of Purchaser, free and clear of all Encumbrances and transfer restrictions,
except for Encumbrances or transfer restrictions of general applicability as may be provided under the Securities Act or applicable
securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authority;
Binding Nature of Agreement</B>. Each of Parent and Purchaser has the corporate power and authority
to execute and deliver and perform their obligations under this Agreement and to consummate the Transactions. The board of directors
of each of Parent and Purchaser has approved the execution, delivery and performance by Parent and Purchaser of this Agreement
and the consummation of the Transactions, including the Offer and the Merger. This Agreement constitutes the legal, valid and binding
obligation of Parent and Purchaser and assuming due authorization, execution and delivery by the Company, this Agreement is enforceable
in accordance with its terms against Parent and Purchaser, as applicable, except as such enforcement may be subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating to or affecting
creditors&rsquo; rights, and by general equitable principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Contravention;
Consents</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
compliance with the applicable provisions of the DGCL and the HSR Act, the execution and delivery of this Agreement by Parent and
Purchaser, and the consummation of the Transactions, will not: (i)&nbsp;cause a violation of any of the provisions of the certificate
of incorporation or bylaws (or other organizational documents) of Parent or Purchaser; (ii)&nbsp;cause a violation by Parent or
Purchaser of any Legal Requirement or order applicable to Parent or Purchaser, or to which Parent or Purchaser are subject; or
(iii)&nbsp;require any consent or notice under, conflict with, result in breach of, constitute a default under, or give rise to
any right of purchase, termination, amendment, cancellation, acceleration or other change of any right or obligation or the loss
of any benefit to which Parent or Purchaser is entitled under any provision of any Contract, except, in the case of <U>clauses
(ii)</U> and <U>(iii)</U>, as would not have or reasonably be expected to have, individually or in the aggregate, a Parent Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for the filing of the certificate of merger with the Secretary of State of the State of Delaware or as may be required by the Exchange
Act (including the filing with the SEC of the Offer Documents), Takeover Laws, the DGCL, the HSR Act and any filing, notification
or approval in any foreign jurisdiction required by Antitrust Laws (if any) and the applicable rules and regulations of the SEC
and any national securities exchange, neither Parent nor Purchaser, nor any of Parent&rsquo;s other Affiliates, is required to
give notice to, make any filing with or obtain any Consent from any Governmental Body at any time prior to the Closing in connection
with the execution and delivery of this Agreement by Parent or Purchaser, or the consummation by Parent or Purchaser of the Offer,
the Merger or the other Transactions, except those that the failure to make or obtain as would not have or reasonably be expected
to have, individually or in the aggregate, a Parent Material Adverse Effect. No vote of Parent&rsquo;s or Purchaser&rsquo;s stockholders
is necessary to approve this Agreement or any of the Transactions other than the approval and adoption of this Agreement by Parent
in its capacity as the sole stockholder of Purchaser, which shall be obtained following execution of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosure</B>.
None of the Offer Documents will contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading. None of the information with respect to Parent or Purchaser supplied or to be supplied by or on behalf of Parent
or Purchaser or any of their Subsidiaries, specifically for inclusion or incorporation by reference in the Schedule 14D-9 or the
Schedule 13E-3 will, (a)&nbsp;at the time such document is filed with the SEC; (b)&nbsp;at any time such document is amended or
supplemented; or (c)&nbsp;at the time such document is first published, sent or given to the Company&rsquo;s stockholders, contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading. For clarity, the representations
and warranties in this <U>Section&nbsp;4.5</U> will not apply to statements or omissions included or incorporated by reference
in the Offer Documents, the Schedule 14D-9 or the Schedule 13E-3 based upon information supplied to Parent by the Company or any
of its Representatives on behalf of the Company specifically for inclusion therein. The Offer Documents will comply as to form
in all material respects with the applicable requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Absence
of Litigation</B>. There is no Legal Proceeding pending and served or, to the knowledge of Parent,
pending and not served, against Parent or Purchaser, except as would not, and would not reasonably be expected to, individually
or in the aggregate, have a Parent Material Adverse Effect. To the knowledge of Parent or Purchaser, as of the date of this Agreement,
neither Parent nor Purchaser is subject to any continuing order of, consent decree, settlement agreement or similar written agreement
with, or continuing investigation by, any Governmental Body, or any order, writ, judgment, injunction, decree, determination or
award of any Governmental Body, except as would not, and would not reasonably be expected to, individually or in the aggregate,
have a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sufficiency
of Funds</B>. Parent currently has, or as of the Offer Acceptance Time and the Effective Time will
have (and will make available to Purchaser in a timely manner), available funds (including cash, cash equivalents, available lines
of credit or other sources of immediately available funds) in an amount sufficient to consummate the Transactions by payment in
cash of the aggregate Offer Price payable on the second business day following the Offer Acceptance Time, the aggregate Merger
Consideration payable following the Effective Time and the aggregate amounts payable to holders of Company Options, Company RSUs
and Company Restricted Shares following the Effective Time pursuant to <U>Section 2.8(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ownership
of Shares</B>. Except for the Parent-Owned Shares, neither Parent nor any of Parent&rsquo;s Affiliates
directly or indirectly owns, and at all times for the past three (3) years, neither Parent nor any of Parent&rsquo;s controlled
Affiliates has owned, beneficially or otherwise, any Shares or any securities, contracts or obligations convertible into or exercisable
or exchangeable for Shares. Neither Parent nor Purchaser is, nor for the past three (3) years has been, an &ldquo;interested stockholder&rdquo;
of the Company under Section&nbsp;203(c) of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acknowledgement
by Parent and Purchaser</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
Parent nor Purchaser is relying and neither Parent nor Purchaser has relied on any representations or warranties whatsoever regarding
the subject matter of this Agreement, express or implied, except for the representations and warranties in <U>Section 3</U>, including
the Company Disclosure Schedule. Such representations and warranties by the Acquired Corporations constitute the sole and exclusive
representations and warranties of the Acquired Corporations in connection with the Transactions and each of Parent and Purchaser
understands, acknowledges and agrees that all other representations and warranties of any kind or nature whether express, implied
or statutory are specifically disclaimed by the Acquired Corporations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the due diligence investigation of the Acquired Corporations by Parent and Purchaser and their respective Affiliates,
stockholders, directors, officers, employees, agents, Representatives or advisors, Parent and Purchaser and their respective Affiliates,
stockholders, directors, officers, employees, agents, Representatives and advisors have received and may continue to receive after
the date hereof from the Company, the other Acquired Corporations and their respective Affiliates, stockholders, directors, officers,
employees, consultants, agents, Representatives and advisors certain estimates, projections, forecasts and other forward-looking
information, as well as certain business plan information, regarding the Acquired Corporations and their respective businesses
and operations. Parent and Purchaser hereby acknowledge that there are uncertainties inherent in attempting to make such estimates,
projections, forecasts and other forward-looking statements, as well as in such business plans, and that Parent and Purchaser will
have no claim against the Acquired Corporations, or any of their respective Affiliates, stockholders, directors, officers, employees,
consultants, agents, Representatives or advisors, or any other Person with respect thereto unless any such information is expressly
included in a representation or warranty contained in this Agreement. Accordingly, Parent and Purchaser hereby acknowledge and
agree that neither the Acquired Corporations nor any of their respective Affiliates, stockholders, directors, officers, employees,
consultants, agents, Representatives or advisors, nor any other Person, has made or is making any express or implied representation
or warranty with respect to such estimates, projections, forecasts, forward-looking statements or business plans unless any such
information is expressly included in a representation or warranty contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brokers
and Other Advisors</B>. Except for J.P. Morgan Securities LLC, no broker, finder, investment banker,
financial advisor or other Person is entitled to any brokerage, finder&rsquo;s, financial advisor&rsquo;s or other similar fee
or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements
made by or on behalf of Parent, Purchaser, or any of their respective Subsidiaries except for Persons, if any, whose fees and expenses
shall be paid by Parent or Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
5<BR>
<BR>
<U>CERTAIN COVENANTS OF THE COMPANY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Access
and Investigation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the period from the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement pursuant
to <U>Section 8</U> (the &ldquo;<U>Pre-Closing Period</U>&rdquo;), upon reasonable advance notice to the Company, the Acquired
Corporations shall, and shall cause the respective Representatives of the Acquired Corporations to, provide Parent and Parent&rsquo;s
Representatives with reasonable access during normal business hours of the Company to the Company&rsquo;s Representatives, designated
personnel and assets and to all existing books, records, documents and information relating to the Acquired Corporations, and promptly
provide Parent and Parent&rsquo;s Representatives with all reasonably requested information regarding the business of the Acquired
Corporations and such additional financial, operating and other data and information regarding the Acquired Corporations, as Parent
may reasonably request, in each case for any reasonable business purpose related to the consummation of the Transactions; <U>provided</U>,
<U>however</U>, that any such access shall be conducted at Parent&rsquo;s expense, at a reasonable time, under the supervision
of appropriate personnel of the Acquired Corporations and in such a manner as not to unreasonably interfere with the normal operation
of the business of the Acquired Corporations. Nothing herein shall require any of the Acquired Corporations to disclose any information
to Parent if such disclosure would, in its reasonable discretion and after notice to Parent (i)&nbsp;jeopardize any attorney-client
or other legal privilege (so long as the Acquired Corporations have reasonably cooperated with Parent to permit such inspection
of or to disclose such information on a basis that does not waive such privilege with respect thereto); or (ii)&nbsp;contravene
any applicable Legal Requirement or Contract (so long as the Acquired Corporations have reasonably cooperated with Parent to permit
disclosure to the extent permitted by Legal Requirements or the contractual counterparty); <U>provided</U>, <U>however</U>, in
the case of <U>clause (ii)</U>, that the Parties shall cooperate in seeking to find a way to allow disclosure of such information
to the extent doing so could reasonably (in the good faith of the Company (after consultation with outside counsel)) be managed
through the use of customary &ldquo;clean room&rdquo; arrangements pursuant to which non-employee Representatives of Parent could
be provided access to such information. With respect to the information disclosed pursuant to this <U>Section 5.1</U>, Parent shall
comply with, and shall direct Parent&rsquo;s Representatives and Financing Sources to comply with, all of its obligations under
the Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in; color: #1F497D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to applicable Legal Requirements, each of the Company and Parent shall promptly notify the other of (A) any notice or other communication
received by such Party from any Governmental Body in connection with this Agreement, the Offer, the Merger or the other Transactions,
or from any Person alleging that the consent of such Person is or may be required in connection with the Offer, the Merger or the
other Transactions; or (B) any Legal Proceeding commenced or, to any Party&rsquo;s knowledge, threatened in writing against, such
Party or any of its Subsidiaries or otherwise relating to, involving or affecting such Party or any of its Subsidiaries, in each
case in connection with, arising from or otherwise relating to the Offer, the Merger or any other Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1.5in">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
The Company shall give prompt notice to Parent of any Event, that has had or would reasonably be expected to have a Material Adverse
Effect, or would reasonably be expected to make the satisfaction of any of the Offer Conditions impossible or unlikely, and (B)
Parent shall give prompt notice to the Company of any Event that has had or would reasonably be expected to have a Parent Material
Adverse Effect, or would reasonably be expected to make the satisfaction of any of the Offer Conditions impossible or unlikely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1.5in">(iii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the avoidance of doubt, the delivery of any notice pursuant to this <U>Section 5.1(b)</U> shall not cure any breach of any representation
or warranty requiring disclosure of such matter prior to the date of this Agreement or otherwise limit or affect the remedies available
hereunder to any Party. The failure to deliver any such notice shall not affect any Offer Condition or any of the conditions set
forth in <U>Section 7</U> or give rise to any right to terminate under <U>Section 8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operation
of the Acquired Corporations&rsquo; Business</B>. During the Pre-Closing Period, except (x) as
expressly required by this Agreement or as required by any applicable Legal Requirement; (y) with the written consent of Parent
(which consent shall not be unreasonably withheld, conditioned or delayed); or (z) as set forth in <U>Section 5.2</U> of the Company
Disclosure Schedule:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall, and shall cause each Acquired Corporation to, (i) conduct its business in the ordinary course consistent with past
practice and (ii) use commercially reasonable efforts to preserve intact its material assets, properties, contracts, licenses and
business organization and to preserve satisfactory business relationships with licensors, licensees, lessors, Governmental Bodies
and others having material business dealings with the Acquired Corporations; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Acquired Corporations shall not:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
establish a record date for, declare, set aside or pay any dividend or make any other distribution in respect of any shares of
its capital stock (including the Shares); or (B) repurchase, redeem or otherwise reacquire any of the Shares, or any rights, warrants
or options to acquire any of the Shares, other than: (1) repurchases of Shares outstanding as of the date hereof pursuant to the
Company&rsquo;s right (under written commitments in effect as of the date hereof that have been delivered or made available to
Parent) to purchase Shares held by a Company Associate only upon termination of such Person&rsquo;s employment or engagement by
the Company; (2) repurchases of Company Options, Company RSUs, Company PRSUs, Company Restricted Shares, or Company Performance
Restricted Shares (or Shares issued upon the exercise thereof) outstanding on the date hereof (in cancellation thereof) pursuant
to the terms of any such Company Option, Company RSU, Company PRSU, Company Restricted Share, or Company Performance Restricted
Share (in effect as of the date hereof) between the Company and a Company Associate or member of the Board of Directors only upon
termination of such Person&rsquo;s employment or engagement by any Acquired Corporation; or (3) in connection with withholding
to satisfy the exercise price and/or Tax obligations with respect to Company Options, Company RSUs, Company PRSUs, Company Restricted
Shares or Company Performance Restricted Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;split,
combine, subdivide or reclassify any Shares or other equity interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sell,
issue, grant, deliver, pledge, transfer, encumber or authorize the sale, issuance, grant, delivery, pledge, transfer or encumbrance
of (A)&nbsp;any capital stock, equity interest or other security; (B)&nbsp;any option, call, warrant, restricted securities or
right to acquire any capital stock, equity interest or other security; or (C)&nbsp;any instrument convertible into or exchangeable
for any capital stock, equity interest or other security (except that the Company (1)&nbsp;may issue Shares (a) as required to
be issued upon the exercise of Company Options or upon the vesting or lapse in restrictions of Company RSUs, Company PRSUs, Company
Restricted Shares, or Company Performance Restricted Shares outstanding as of the date of this Agreement in accordance with their
respective present terms; or (b) issuable to participants in the Company ESPP; and (2) may grant, with respect to its customary
annual equity award cycle, Company Options, Company RSUs, Company PRSUs, Company Restricted Shares and Company Performance Restricted
Shares to employees in the ordinary course of business consistent with past practice and not exceeding prior years&rsquo; aggregate
award amounts; <I>provided</I> that any such awards shall provide for vesting in equal annual installments over a four-year period
subject to the employee&rsquo;s continued service and none of such awards shall be subject to any vesting acceleration provisions
except as set forth in <U>Section 5.2(b)</U> of the Company Disclosure Schedule;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as contemplated by <U>Section 2.8,</U> or as required by any Legal Requirement or under any Employee Plan as in effect on the date
of this Agreement, establish, adopt, terminate or materially amend any Employee Plan (or any plan, program, arrangement or agreement
that would be an Employee Plan if it were in existence on the date hereof), or amend or waive any of it material rights under,
or accelerate the vesting under, any provision of any of the Employee Plans (or any plan, program, arrangement or agreement that
would be an Employee Plan if it were in existence on the date hereof) or grant any employee or director any increase in compensation,
bonuses or other benefits (except that the Company: (A) may provide increases in salary, wages or benefits to employees in the
ordinary course of business consistent with past practice; (B) may make usual and customary annual or quarterly bonus grants and
payments in the ordinary course of business consistent with past practice and not exceeding prior years&rsquo; aggregate bonus
amounts; and (C) enter into agreements with consultants and new hires (other than executive officers) in the ordinary course of
business consistent with past practice);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;commence
any clinical trial in respect of any Product except as set forth on <U>Section 5.2(b)(v)</U> of the Company Disclosure Schedule;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;terminate,
suspend, modify or otherwise take any step to limit the effectiveness or validity of any applicable material Governmental Authorization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;qualify
any new site for manufacturing of any Product; for the avoidance of doubt, this does not include the qualification of any reagent
manufacturer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amend
or permit the adoption of any amendment to its certificate of incorporation or bylaws or other charter or organizational documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;form
any Subsidiary, acquire any equity interest in any other Entity or enter into any joint venture, partnership or similar arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
or authorize any capital expenditure (except that the Acquired Corporations may make capital expenditures that do not exceed $1,000,000
individually or $5,000,000 in the aggregate);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;acquire,
lease, license, sublicense, pledge, sell or otherwise dispose of, divest or spin-off, abandon, waive, relinquish or permit to lapse
(other than any Patent expiring at the end of its statutory term), transfer, assign, guarantee, exchange or swap, mortgage or otherwise
subject to any Encumbrance (other than Permitted Encumbrances) any material right or other material asset or property (except (A)&nbsp;purchases
of supplies and raw materials in the ordinary course of business consistent with past practice; (B) licenses of, and other grants
of rights to, Intellectual Property in the ordinary course of business consistent with past practice to academic or non-profit
institutions, contract manufacturers, contract research organizations and other service providers if the grant of such license
is commercially reasonable in connection with the performance of services or sponsored research activities for and on behalf of
the Company; and (C)&nbsp;pursuant to dispositions of obsolete, surplus or worn out assets that are no longer useful in the conduct
of the business of the Acquired Corporations);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;lend
money or make capital contributions or advances to or make investments in, any Person, or incur or guarantee any Indebtedness (except
for advances to employees and consultants for travel and other business related expenses in the ordinary course of business consistent
with past practice and in compliance with the Company&rsquo;s policies related thereto);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
in the ordinary course of business consistent with past practice, (A) amend or modify in any material respect, or waive any material
rights under or voluntarily terminate, any Material Contract; or (B) enter into any Contract which if entered into prior to the
date hereof would have been a Material Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as required by applicable Legal Requirements or in the ordinary course of business consistent with past practice, (A)&nbsp;make
any material change to any accounting method or accounting period used for Tax purposes that has a material effect on Taxes; (B)&nbsp;make,
rescind or change any material Tax election; (C)&nbsp;file a material amended Tax Return; (D)&nbsp;enter into a closing agreement
with any Governmental Body regarding any material Tax liability or assessment; (E)&nbsp;settle, compromise or consent to any material
Tax claim or assessment or surrender a right to a material Tax refund; or (F) waive or extend the statute of limitations with respect
to any material Tax or material Tax Return;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;settle,
release, waive or compromise any Legal Proceeding or other claim (or threatened Legal Proceeding or other claim), other than any
settlement, release, waiver or compromise that (A)&nbsp;results solely in monetary obligations involving only the payment of monies
by the Acquired Corporations of not more than $1,000,000 in the aggregate (excluding monetary obligations that are funded by an
indemnity obligation to, or an insurance policy of, any Acquired Corporations); or (B) results in no monetary or other material
non-monetary obligation of any Acquired Corporation; <U>provided</U> that (x) the settlement, release, waiver or compromise of
any Legal Proceeding or claim brought by the stockholders of the Company against the Company and/or its directors relating to the
Transactions or a breach of this Agreement or any other agreements contemplated hereby shall be subject to <U>Section 2.7</U> or
<U>Section 6.6</U>, as applicable, and (y) the foregoing shall not permit the Company to settle, release, waive or compromise any
Legal Proceeding or claim that would impose any material restrictions or changes on the business or operation of, or the admission
of wrongdoing by, the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any collective bargaining agreement or other agreement with any labor organization (except to the extent required by applicable
Legal Requirements);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;adopt
or implement any stockholder rights plan or similar arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;adopt
a plan or agreement of complete or partial liquidation or dissolution, merger, consolidation, restructuring, recapitalization or
other reorganization of any of the Acquired Corporations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
amend or modify the compensation terms or any other obligations of the Company contained in the engagement letter with Morgan Stanley
&amp; Co. LLC in a manner adverse to the Company, any of its Subsidiaries or Parent, or (B) engage other financial advisors in
connection with the Transactions unless, in the case of this <U>clause (B)</U>, the Board of Directors determines in good faith,
after consultation with the Company&rsquo;s outside legal counsel, that failure to do so would be inconsistent with its fiduciary
duties to the Company&rsquo;s stockholders under applicable Legal Requirements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
incur, assume or otherwise become liable or responsible for any long-term debt or short-term debt, except for short-term debt incurred
in the ordinary course of business consistent with past practice to fund working capital requirements in an amount not to exceed
$1,000,000 at any time, (B) repay (other than in the ordinary course of business consistent with past practice), redeem or repurchase
any long-term or short-term debt or (C)&nbsp;cancel any material debt or claim owed to the Company or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any Contract or transaction between the Company or any of its Subsidiaries, on the one hand, and any Affiliate of the Company
or any of its Subsidiaries on the other hand, other than (A) in the ordinary course of business consistent with past practice and
on terms no less favorable to the Company or its Subsidiary, as applicable, than the terms governing such transactions with third
parties or (B) any Contract or transaction with Parent or any of its Affiliates; or (C) any Contract with the Company&rsquo;s directors
or executive officers permitted by <U>clauses (i)</U>, <U>(iii)</U> and <U>(iv)</U> of this <U>Section 5.2(b)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorize
any of, or agree or commit to take, any of the actions described in the foregoing <U>clauses (i)</U> through <U>(xxi)</U> of this
<U>Section 5.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding the foregoing, nothing contained
herein shall give to Parent or Purchaser, directly or indirectly, rights to control or direct the operations of the Acquired Corporations
prior to the Offer Acceptance Time. Prior to the Effective Time, each of Parent and the Company shall exercise, consistent with
the terms and conditions hereof, complete control and supervision of its and its, if applicable, Subsidiaries&rsquo; respective
operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Solicitation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purposes of this Agreement, &ldquo;<U>Acceptable Confidentiality Agreement</U>&rdquo; means any customary confidentiality agreement
that (i) contains confidentiality, use and other provisions that are not materially less favorable to the Company than those contained
in the Confidentiality Agreement and standstill provisions that are not materially less favorable to the Company than those contained
in the Voting and Standstill Agreement and (ii) does not prohibit the Company from providing any information to Parent in accordance
with this <U>Section 5.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as permitted by this <U>Section 5.3</U>, during the Pre-Closing Period the Acquired Corporations shall not, and shall cause their
officers and directors not to, and shall use reasonable best efforts to cause their other Representatives not to, directly or indirectly,
(i) continue any solicitation, knowing encouragement, discussions or negotiations with any Persons that may be ongoing with respect
to an Acquisition Proposal; (ii)&nbsp;(A) solicit, initiate or knowingly facilitate or encourage (including by way of furnishing
non-public information) any inquiries regarding, or the making of any proposal or offer that constitutes, or could reasonably be
expected to lead to, an Acquisition Proposal; (B) engage in, continue or otherwise participate in any discussions or negotiations
regarding, or furnish to any other Person any non-public information in connection with, or for the purpose of soliciting or knowingly
encouraging or facilitating, an Acquisition Proposal or any proposal or offer that could reasonably be expected to lead to an Acquisition
Proposal; (C) approve, adopt, endorse or recommend or enter into any letter of intent, acquisition agreement, agreement in principle
or similar agreement with respect to an Acquisition Proposal or any proposal or offer that could reasonably be expected to lead
to an Acquisition Proposal; or (D) exempt any Person (other than Parent and its Subsidiaries) from the restrictions on &ldquo;business
combinations&rdquo; or any similar provision contained in applicable Takeover Laws or the Company&rsquo;s organizational and other
governing documents; (iii) waive or release any Person from, forebear in the enforcement of, or amend any standstill agreement
or any standstill provisions of any other Contract; or (iv) resolve or agree to do any of the foregoing. As promptly as reasonably
practicable (and in any event within two (2) business days) following the date hereof, the Company shall request the prompt return
or destruction (to the extent provided for by the applicable confidentiality agreement) of all information or documents previously
furnished to any Person (other than Parent, its Affiliates and their respective Representatives) that has made, or has indicated
an intention to make, an Acquisition Proposal, and all material incorporating such information created by any such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
at any time on or after the date of this Agreement and prior to the Offer Acceptance Time any Acquired Corporation or any of their
Representatives receives an unsolicited <I>bona fide</I> written Acquisition Proposal from any Person or group of Persons, which
Acquisition Proposal was made or renewed on or after the date of this Agreement and did not result from a material breach of this
<U>Section 5.3</U>, (i) the Company and its Representatives may contact such Person or group of Persons solely to clarify the terms
and conditions thereof so as to determine whether such Acquisition Proposal is, or is reasonably likely to result in, a Superior
Offer; and (ii) if the Board of Directors determines in good faith, after consultation with financial advisors and outside legal
counsel, that such Acquisition Proposal constitutes or would reasonably be expected to lead to a Superior Offer and that the failure
to take such action described in <U>clauses (A)</U> and <U>(B)</U> below would be inconsistent with its fiduciary duties to the
Company&rsquo;s stockholders under applicable Legal Requirements, then the Company and its Representatives may (A) furnish, pursuant
to an Acceptable Confidentiality Agreement, information (including non-public information) with respect to the Acquired Corporations
to the Person or group of Persons who has made such Acquisition Proposal; <U>provided</U> that the Company shall, prior to or substantially
simultaneously with the provision of any non-public information concerning the Acquired Corporations to any such Person, provide
to Parent any such non-public information to the extent access to such information was not previously provided to Parent or its
Representatives; and (B) engage in or otherwise participate in discussions or negotiations with the Person or group of Persons
making such Acquisition Proposal; provided, in the case of <U>clauses (A)</U> and <U>(B)</U>, that at or prior to the first time
that the Company furnishes any information to or participates in any discussions or negotiations with any Person on or after the
date of this Agreement, the Company shall provide written notice to Parent of such determination in good faith of the Board of
Directors as provided for above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Pre-Closing Period, the Company shall (i) promptly (and in any event within 24 hours) notify Parent orally and in writing if
any inquiries, proposals or offers with respect to, or that would reasonably be expected to lead to, an Acquisition Proposal are
received by any Acquired Corporation or any of their Representatives and provide to Parent a copy of any written Acquisition Proposal
(including any proposed term sheet, letter of intent, acquisition agreement or other written materials with respect thereto, including
any financing arrangements) and a summary of any material unwritten terms and conditions thereof (and indicate the identity of
such Person or group of Persons), and (ii) keep Parent reasonably informed of any material developments, discussions or negotiations
regarding any Acquisition Proposal on a prompt basis (and in any event within 24 hours of such material development, discussion
or negotiation), including by providing copies of all written materials received by any Acquired Corporation or any of their Representatives
relating to such Acquisition Proposal after written notice of such Acquisition Proposal is delivered to Parent pursuant to this
<U>Section&nbsp;5.3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
in this <U>Section 5.3</U> or elsewhere in this Agreement shall prohibit the Company from (i) taking and disclosing to the stockholders
of the Company a position contemplated by Rule 14e-2(a), Rule 14d-9 or Item 1012(a) of Regulation M-A promulgated under the Exchange
Act, including any &ldquo;stop, look and listen&rdquo; communication pursuant to Rule 14d-9(f) promulgated under the Exchange Act,
or (ii) making any disclosure to the stockholders of the Company that is required by applicable Legal Requirements; <U>provided</U>,
<U>however</U>, that the Board of Directors shall not effect a Company Adverse Change Recommendation except in accordance with
<U>Section 6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
at any time on or after the date of this Agreement and prior to the Offer Acceptance Time, any Acquired Corporation or any of its
Representatives receives an unsolicited <I>bona fide</I> request for a waiver or release under any standstill or similar contract,
then the Company shall promptly (and in any event within 24 hours) notify Parent of such request. Notwithstanding anything to the
contrary in <U>Section 5.3(b)</U> or elsewhere in this Agreement, the Company may waive provisions of a standstill or similar contract
applicable to any Person or group (or its Representatives) in response to an unsolicited proposal that did not result from a breach
of this <U>Section 5.3 </U>that could reasonably be expected to lead to a Superior Offer if the Board of Directors determines in
good faith after consultation with the Company&rsquo;s outside counsel that failure to do so would be inconsistent with its fiduciary
duties to the Company&rsquo;s stockholders under applicable Legal Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees that in the event any of the Company&rsquo;s Subsidiaries or any Representative of the Company or any of its Subsidiaries
takes any action which, if taken by the Company, would constitute a breach of this <U>Section 5.3</U>, the Company shall be deemed
to be in breach of this <U>Section 5.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
6<BR>
<BR>
<U>ADDITIONAL COVENANTS OF THE PARTIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Board Recommendation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to <U>Section 6.1(b)</U>, the Company hereby consents to the inclusion of a description of the Company Board Recommendation in
the Offer Documents. During the Pre-Closing Period, subject to <U>Section 6.1(b)</U>, neither the Board of Directors nor any committee
thereof shall (i)(A) withdraw or withhold (or modify or qualify in a manner adverse to Parent or Purchaser), or publicly propose
to withdraw or withhold (or modify or qualify in a manner adverse to Parent or Purchaser), the Company Board Recommendation; or
(B) adopt, approve, recommend or declare advisable, or publicly propose to adopt, approve, recommend or declare advisable, any
Acquisition Proposal (any action described in this <U>clause (i)</U> being referred to as a &ldquo;<U>Company Adverse Change Recommendation</U>&rdquo;);
or (ii) approve, recommend or declare advisable, or propose to approve, recommend or declare advisable, or allow the Company to
execute or enter into any Contract, letter of intent, memorandum of understanding, agreement in principle or term sheet with respect
to, or that is intended to or would reasonably be expected to lead to, any Acquisition Proposal, or requiring, or reasonably expected
to cause, the Company to abandon, terminate, delay or fail to consummate, or that would otherwise materially impede, interfere
with or be inconsistent with, the Transactions (other than an Acceptable Confidentiality Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary contained in this Agreement, at any time prior to the Offer Acceptance Time, and subject to compliance
with the other provisions of this <U>Section 6.1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
any Acquired Corporation has received a <I>bona fide</I> written Acquisition Proposal from any Person that has not been withdrawn,
and after consultation with financial advisors and outside legal counsel, the Board of Directors shall have determined, in good
faith, that such Acquisition Proposal is a Superior Offer, (A) the Board of Directors may make a Company Adverse Change Recommendation;
or (B) provided that no Acquired Corporation or its Representatives are in material breach of any covenant or obligation set forth
in <U>Section 5.3</U> with respect to such Acquisition Proposal, the Company may terminate this Agreement pursuant to <U>Section
8.1(e)</U> to enter into a Specified Agreement with respect to such Superior Offer, in each case, if and only if: (1) the Board
of Directors determines in good faith, after consultation with the Company&rsquo;s outside legal counsel, that the failure to do
so would be inconsistent with the fiduciary duties of the Board of Directors to the Company&rsquo;s stockholders under applicable
Legal Requirements; (2) the Company shall have given Parent prior written notice of its intention to consider making a Company
Adverse Change Recommendation or terminating this Agreement pursuant to <U>Section 8.1(e)</U> at least four (4) business days prior
to making any such Company Adverse Change Recommendation or termination (a &ldquo;<U>Determination Notice</U>&rdquo;) (which notice
and any public disclosure thereof shall not, by itself, constitute a Company Adverse Change Recommendation or termination) and,
if desired by Parent, during such four (4)-business day period shall have negotiated in good faith with respect to any revisions
to the terms of this Agreement or another proposal to the extent proposed by Parent so that such Acquisition Proposal would cease
to constitute a Superior Offer; and (3) (a)&nbsp;the Company shall have provided to Parent information with respect to such Acquisition
Proposal in accordance with <U>Section 5.3(d)</U>; and (b) after giving effect to the proposals made by Parent during such period,
if any, after consultation with financial advisors and outside legal counsel, the Board of Directors shall have determined, in
good faith, that such Acquisition Proposal is a Superior Offer and that the failure to make the Company Adverse Change Recommendation
or terminate this Agreement pursuant to <U>Section 8.1(e)</U> would be inconsistent with the fiduciary duties of the Board of Directors
to the Company&rsquo;s stockholders under applicable Legal Requirements. Issuance of any &ldquo;stop, look and listen&rdquo; communication
by or on behalf of the Company pursuant to Rule 14d-9(f) shall not, in and of itself, be considered a Company Adverse Change Recommendation
and shall not require the giving of a Determination Notice or compliance with the procedures set forth in this <U>Section 6.1</U>.
The provisions of this <U>Section&nbsp;6.1(b)(i)</U> shall also apply to any change to any of the financial terms (including the
form, amount and timing of payment of consideration) or other material amendment to any Acquisition Proposal and require a new
Determination Notice, except that the references to four (4) business days shall be deemed to be the later to occur of two (2)
business days after the Company delivers such new Determination Notice to Parent and the end of the original four (4)-business
day period described above. In the event there is a Company Adverse Change Recommendation made in compliance with this <U>Section
6.1(b)(i)</U> with respect to a Superior Offer, the Company shall only enter into an Specified Agreement with respect thereto by
terminating this Agreement pursuant to <U>Section 8.1(e)</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other
than in connection with a Superior Offer (which shall be subject to <U>Section 6.1(b)(i)</U>), the Board of Directors may make
a Company Adverse Change Recommendation in response to an Intervening Event if: (A) the Board of Directors determines in good faith,
after consultation with the Company&rsquo;s outside legal counsel, that the failure to do so would be inconsistent with the fiduciary
duties of the Board of Directors to the Company&rsquo;s stockholders under applicable Legal Requirements; (B) the Company shall
have given Parent a Determination Notice (which notice and any public disclosure thereof shall not, by itself, constitute a Company
Adverse Change Recommendation) at least four (4) business days prior to making any such Company Adverse Change Recommendation and,
if desired by Parent, during such four (4)-business day period shall have negotiated in good faith with respect to any revisions
to the terms of this Agreement or another proposal to the extent proposed by Parent so that a Company Adverse Change Recommendation
would no longer be necessary; and (C) (1)&nbsp;the Company shall have specified in reasonable detail the facts and circumstances
that render a Company Adverse Change Recommendation necessary; and (2) after giving effect to the proposals made by Parent during
such period, if any, after consultation with outside legal counsel, the Board of Directors shall have determined, in good faith,
that the failure to make the Company Adverse Change Recommendation would be inconsistent with the fiduciary duties of the Board
of Directors to the Company&rsquo;s stockholders under applicable Legal Requirements. The provisions of this <U>Section 6.1(b)(ii)</U>
shall also apply to any material change to the facts and circumstances specified by the Company pursuant to <U>clause (C)(1)</U>
above and require a new Determination Notice, except that the references to four (4) business days shall be deemed to be the later
to occur of two (2) business days after the Company delivers such new Determination Notice to Parent and the end of the original
four (4)-business day period described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filings, Consents and Approvals</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties agree to use their reasonable best efforts to take promptly any and all steps necessary to avoid or eliminate each and
every impediment under the Antitrust Laws, that may be asserted by any Governmental Body, so as to enable the Closing to occur
as promptly as practicable, but in no case later than the End Date, including providing as promptly as reasonably practicable all
information required by any Governmental Body pursuant to its evaluation of the Transactions under the HSR Act or other applicable
Antitrust Laws. Subject to the terms of this <U>Section 6.2</U>, the Parties shall use their reasonable best efforts to obtain
from any Governmental Body all consents, approvals authorizations or orders required to be obtained under the Antitrust Laws or
to avoid the entry or enactment of any injunction or other order or decree relating to any Antitrust Law that would delay, restrain,
prevent, enjoin or otherwise prohibit consummation of the transactions contemplated by this Agreement. Notwithstanding anything
to the contrary in this Agreement, Parent and its Affiliates shall not be required to effect or undertake (or be required to agree
or consent to), and without the prior written consent of Parent, the Acquired Corporations shall not effect or undertake (and shall
not agree or consent to) any sale, license, divestiture or disposition or holding separate (through the establishment of a trust
or otherwise) of, or any other structural, behavioral or conduct remedy with respect to, or restriction on the conduct or operation
of, (in each case, whether before or after the Offer Acceptance Time or the Effective Time), any Entity, business, division, operation,
product or product line, asset or Intellectual Property right of Parent or any Acquired Corporation (or of any of Parent&rsquo;s
or any Acquired Corporation&rsquo;s respective Subsidiaries or other Affiliates). Notwithstanding the foregoing and any other provision
of this Agreement to the contrary, in no event shall Parent, Purchaser, the Acquired Corporations or any of their respective Subsidiaries
be obligated to litigate or participate in the litigation of any action, whether judicial or administrative, brought by any Governmental
Body challenging or seeking to restrain, prohibit or place conditions on the consummation of the Transactions; <I>provided</I>,
that Parent shall have the right, in its sole discretion, to litigate or participate in the litigation of any such action, and,
if Parent elects to take any such action, the Company shall reasonably cooperate with Parent in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms and conditions of this Agreement, each of the Parties shall (and shall cause their respective Affiliates, if applicable,
to): (i) promptly, but in no event later than ten (10) business days after the date hereof, make an appropriate filing of all notification
and report forms as required by the HSR Act with respect to the Transactions; and (ii)&nbsp;cooperate with each other in determining
whether, and promptly preparing and making, any other filings, notifications or other consents are required to be made with, or
obtained from, any other Governmental Bodies in connection with the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
limiting the generality of anything contained in this <U>Section 6.2</U>, during the Pre-Closing Period, each Party shall (i) give
the other Parties prompt notice of the making or commencement of any request, inquiry, investigation, action or Legal Proceeding
brought by a Governmental Body or brought by a third party before any Governmental Body, in each case, with respect to the Transactions
under the Antitrust Laws; (ii) keep the other Parties informed as to the status of any such request, inquiry, investigation, action
or Legal Proceeding; (iii) promptly inform the other Parties of, and to the extent practicable, provide advance notice of and the
opportunity to review and discuss in advance, and consider in good faith the view of the other in connection with, any written
or oral communication to or from the FTC, DOJ or any other Governmental Body in connection with any such request, inquiry, investigation,
action or Legal Proceeding; (iv) promptly furnish to the other Party, subject to an appropriate confidentiality agreement to limit
disclosure to counsel and outside consultants, with copies of documents provided to or received from any Governmental Body in connection
with any such request, inquiry, investigation, action or Legal Proceeding (other than &ldquo;4(c) or 4(d) documents&rdquo; as that
term is used in the rules and regulations under the HSR Act); (v) subject to an appropriate confidentiality agreement to limit
disclosure to counsel and outside consultants, consult and cooperate with the other Parties and consider in good faith the views
of the other Parties in connection with any analysis, appearance, presentation, memorandum, brief, argument, opinion or proposal
made or submitted in connection with any such request, inquiry, investigation, action or Legal Proceeding; and (vi)&nbsp;except
as may be prohibited by any Governmental Body or by any Legal Requirement, in connection with any such request, inquiry, investigation,
action or Legal Proceeding in respect of the Transactions, provide advance notice of and permit authorized Representatives of the
other Party to be present at each meeting or conference relating to such request, inquiry, investigation, action or Legal Proceeding
and to have access to and be consulted in connection with any argument, opinion or proposal made or submitted to any Governmental
Body in connection with such request, inquiry, investigation, action or Legal Proceeding; <U>provided</U>, <U>however</U>, Parent
shall, on behalf of the Parties, control and direct all aspects of the Parties&rsquo; efforts to obtain the required approvals
under the Antitrust Laws, including making the final determination as to the appropriate strategy relating to any matters relating
to the Antitrust Laws, including with respect to any filings, notifications, submissions and communications with or to any Governmental
Body; <U>provided further</U>, <U>however</U>, that in the event the Company reasonably objects to any filing, analysis, appearance,
presentation, memorandum, brief, argument, opinion or proposal made or submitted, or any other strategy, action or step taken in
connection with the Parties&rsquo; efforts to obtain the required approvals under the Antitrust Laws, then such matters shall be
escalated for discussion and resolution by the Chief Executive Officers, and if unable to be resolved in good faith during such
discussion, such matter shall thereafter be resolved by Parent (it being understood that any such resolution shall not relieve
any party of its express obligations hereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Pre-Closing Period, the Company shall, to the extent permissible under applicable Legal Requirements: (i) inform Parent&rsquo;s
Designated Regulatory Representative of, and provide Parent&rsquo;s Designated Regulatory Representative with a reasonable opportunity
to review and comment on, in advance, any material filing proposed to be made by or on behalf of any Acquired Corporation with
respect to JCARH125, and any material correspondence or other material communication proposed to be submitted or otherwise transmitted
to the FDA, EMA or other Specified Governmental Body by or on behalf of any Acquired Corporation, in each case relating to JCARH125
(it being understood that in no event shall the Company be required to delay any such filing, correspondence or communication);
and (ii) keep Parent&rsquo;s Designated Regulatory Representative reasonably informed of any material communication (written, electronic,
or oral) with or from the FDA, EMA or other Specified Governmental Body relating to JCARH125.&nbsp; For purposes hereof, &ldquo;<U>Designated
Regulatory Representative</U>&rdquo; shall mean a representative of Parent responsible for regulatory affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Parties shall not, and shall not permit their respective Subsidiaries to, enter into or consummate any transaction, agreement,
arrangement, or acquisition of any ownership interest or assets of any Person, the effect of which would reasonably be expected
to impair, materially delay or prevent any required approvals, or expiration of the waiting period, under the Antitrust Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee Benefits</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
a period of twelve (12) months following the Effective Time, Parent shall provide, or cause to be provided, to each employee of
the Company who is employed by the Acquired Corporations as of immediately prior to the Effective Time and who continue to be actively
employed by the Surviving Corporation (or any Affiliate thereof) during such twelve (12)-month period (the &ldquo;<U>Continuing
Employees</U>&rdquo;) (i) base salary and incentive opportunities (excluding equity-based incentive opportunities) that in each
case are no less favorable than the base salary and incentive opportunities (excluding equity-based incentive opportunities) applicable
to each such Continuing Employee immediately prior to the Effective Time; and (ii) employee benefits that are no less favorable,
in the aggregate, to those employee benefits provided to such Continuing Employee immediately prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
shall provide or shall cause to be provided to each Continuing Employee who incurs a termination of employment during the twelve
(12)-month period following the Effective Time with severance payments and benefits that are no less favorable than the severance
payments and benefits to which such employee would have been entitled with respect to such termination under those severance policies
of the Company set forth on <U>Section 3.16(c)</U> of the Company Disclosure Schedule as in effect immediately prior to the Effective
Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
shall, or shall cause the Surviving Corporation or any Affiliate of Parent or the Surviving Corporation, as applicable, to give
Continuing Employees full credit for Continuing Employees&rsquo; service with the Company and its Subsidiaries for purposes of
eligibility, vesting and determination of the level of benefits (including vacation/paid time off), under any benefit plans made
generally available to officers or employees or any class or level of officers or employees maintained by Parent, the Surviving
Corporation or any of their respective Affiliates in which a Continuing Employee participates to the same extent recognized by
the Company immediately prior to the Closing Date; <U>provided</U>, <U>however</U>, that such service shall not be recognized (i)
to the extent that such recognition would result in a duplication of benefits with respect to the same period of service, (ii)
under a newly established plan for Parent employees generally which prior service is not taken into account for any employees of
Parent, or (iii) with respect to any equity based compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
shall, or shall cause the Surviving Corporation or Parent&rsquo;s or the Surviving Corporation&rsquo;s Affiliates, as applicable,
to (i) waive any preexisting condition limitations otherwise applicable to Continuing Employees and their eligible dependents under
any plan of Parent or any Subsidiary of Parent that provides health benefits in which Continuing Employees may be eligible to participate
following the Closing Date (such plan, a &ldquo;<U>New Plan</U>&rdquo;), but only to the extent coverage under any such New Plan
replaces coverage under the analogous Employee Plan, other than any limitations that were in effect with respect to such employees
as of the Closing Date under the analogous Employee Plan; (ii) honor any deductible, co-payment and out-of-pocket maximums incurred
by the Continuing Employees and their eligible dependents under the health plans in which they participated immediately prior to
the Closing Date during the portion of the calendar year prior to the Closing Date in satisfying any deductibles, co-payments or
out-of-pocket maximums under health plans of Parent, the Surviving Corporation or any of their respective Affiliates in which they
are eligible to participate after the Closing Date in the same plan year in which such deductibles, co-payments or out-of-pocket
maximums were incurred; and (iii) waive any waiting period limitation or evidence of insurability requirement that would otherwise
be applicable under a New Plan to a Continuing Employee and his or her eligible dependents on or after the Closing Date, in each
case to the extent such Continuing Employee or eligible dependent had satisfied any similar limitation or requirement under an
analogous Employee Plan prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
acknowledges that, upon the Closing, a &ldquo;Change in Control&rdquo; (or &ldquo;Change of Control&rdquo; as the case may be)
shall have occurred for purposes of each of the Employee Plans in which such definition appears.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <U>Section 6.3</U> and <U>Section 6.14</U> are solely for the benefit of the Parties, and no provision of this
<U>Section 6.3</U> or <U>Section 6.14</U> is intended to, or shall, constitute the establishment or adoption of or an amendment
to any employee benefit plan for purposes of ERISA or otherwise, and no current or former employee or any other individual associated
therewith shall be regarded for any purpose as a third-party beneficiary of the Agreement or have the right to enforce the provisions
hereof. Nothing in this <U>Section 6.3</U>, <U>Section 6.14</U> or elsewhere in this Agreement shall be construed to create a right
in any Person to employment with Parent, the Surviving Corporation or any other Affiliate of the Surviving Corporation or to any
compensation or benefits and the employment of each Continuing Employee shall be &ldquo;at will&rdquo; employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ESPP</B>.
The Company shall take all actions necessary pursuant to the terms of the Company ESPP in order to (i) shorten the offering period
under the Company ESPP that would extend beyond the Effective Time (the &ldquo;<U>Current Offering</U>&rdquo;) such that a new
exercise date for such Current Offering shall occur prior to the Effective Time and shares shall be purchased on such new exercise
date with all amounts credited to participants&rsquo; accounts as of such new exercise date prior to the Effective Time, and (ii)
provide that each individual participating in the Company ESPP as of the date of this Agreement shall not be permitted to (A) during
the offering period in effect on the date of this Agreement, increase his or her payroll contribution rate pursuant to the Company
ESPP from the rate in effect on the date of this Agreement or (B) make separate nonpayroll contributions to the Company ESPP on
or following the date of this Agreement, except as may be required by applicable Legal Requirements. For the avoidance of doubt,
prior to the Effective Time, the Company shall provide to all plan participants the notices required pursuant to the last sentence
of Section 19(c) of the Company ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Officers and Directors</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
a period of six (6) years from the Effective Time, Parent agrees that all rights to indemnification, advancement of expenses and
exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time (whether asserted or claimed prior
to, at or after the Effective Time) now existing in favor of the current or former directors or officers of the Acquired Corporations
and any director or officer of the Acquired Corporations who commences serving in such capacity following the date hereof and prior
to the Effective Time in accordance with the terms hereof under (i) any indemnification or other similar agreements of the Acquired
Corporations listed in <U>Section 6.5(a)</U> of the Company Disclosure Schedule between the Company or any of its Subsidiaries
and any of their current or former directors and officers or any indemnification or similar agreement between the Company or any
of its Subsidiaries with any director or officer of the Acquired Corporations who commences serving in such capacity following
the date hereof and prior to the Effective Time in accordance with the terms hereof; <U>provided</U>, <U>however</U>, that any
such agreement entered into with any such Indemnified Person shall be in substantially the same form as the indemnification agreements
listed in <U>Section 6.5(a)</U> of the Company Disclosure Schedule, and (ii) the indemnification, expense advancement and exculpation
provisions in any certificate of incorporation or bylaws or comparable organizational document of the Company or any of its Subsidiaries,
in each case as in effect on the date of this Agreement, shall continue in full force and effect in accordance with their terms
(it being agreed that after the Closing such rights shall be mandatory rather than permissive, if applicable), and Parent shall
cause each of the Acquired Corporations to perform its obligations thereunder. Without limiting the foregoing, during the period
commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, Parent shall cause the Surviving Corporation
to, and the Surviving Corporation agrees that it will, indemnify and hold harmless each individual who is as of the date of this
Agreement, or who becomes prior to the Effective Time, a director or officer of the Company or who is as of the date of this Agreement,
or who thereafter commences prior to the Effective Time, serving at the request of the Company as a director or officer of another
Person (the &ldquo;<U>Indemnified Persons&rdquo;</U>), against all claims, losses, liabilities, damages, judgments, inquiries,
fines and reasonable fees, costs and expenses, including attorneys&rsquo; fees and disbursements, incurred in connection with any
claim, action, suit or proceeding, whether civil, criminal, administrative or investigative (including with respect to matters
existing or occurring at or prior to the Effective Time, including this Agreement and the transactions and actions contemplated
hereby), arising out of or pertaining to the fact that the Indemnified Person is or was a director or officer of the Company or
is or was serving at the request of the Company as a director or officer of another Person, whether asserted or claimed prior to,
at or after the Effective Time, to the fullest extent permitted under applicable Legal Requirements In the event of any such claim,
action, suit or proceeding, (A)&nbsp;each Indemnified Person will be entitled to advancement of expenses incurred in the defense
of any such claim, action, suit or proceeding from the Surviving Corporation, in accordance with the organizational documents and
any indemnification or other similar agreements of the Surviving Corporation, as in effect on the date of this Agreement; <U>provided</U>
that any Indemnified Person to whom expenses are advanced provides an undertaking, if and only to the extent required by the DGCL
or the Surviving Corporation&rsquo;s certificate of incorporation or bylaws (or comparable organizational documents) or any such
indemnification or other similar agreements to repay such advances if it is ultimately determined by final adjudication that such
Indemnified Person is not entitled to indemnification; and (B)&nbsp;the Surviving Corporation shall reasonably cooperate in the
defense of any such matter. Notwithstanding anything to the contrary set forth in this <U>Section 6.5(a)</U> or elsewhere in this
Agreement, if an Indemnified Person is prohibited in a written Contract with any Acquired Corporation from effecting a settlement
without the prior consent of such Acquired Corporation, neither the Surviving Corporation nor any of its Affiliates (including
Parent) shall be liable for any settlement effected without their prior written consent (which consent shall not be unreasonably
withheld, delayed or conditioned).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
a period of six (6) years from and after the Effective Time, Parent and the Surviving Corporation shall either cause to be maintained
in effect the current policies of directors&rsquo; and officers&rsquo; liability insurance and fiduciary liability insurance maintained
by the Acquired Corporations or provide substitute policies for the Acquired Corporations and their current and former directors
and officers who are currently covered by the directors&rsquo; and officers&rsquo; and fiduciary liability insurance coverage currently
maintained by the Acquired Corporations, in either case, of not less than the existing coverage and having other terms not less
favorable to the insured persons than the directors&rsquo; and officers&rsquo; liability insurance and fiduciary liability insurance
coverage currently maintained by the Acquired Corporations with respect to claims arising from facts or events that occurred at
or before the Effective Time (with insurance carriers having at least an &ldquo;A&rdquo; rating by A.M. Best with respect to directors&rsquo;
and officers&rsquo; liability insurance and fiduciary liability insurance), except that in no event shall Parent or the Surviving
Corporation be required to pay with respect to such insurance policies, in the aggregate for all six (6) years, an amount equal
to more than 300% of the aggregate annual premium most recently paid by the Acquired Corporations prior to the date of this Agreement,
which amount is set forth on <U>Section 6.5(b)</U> of the Company Disclosure Schedule (the &ldquo;<U>Maximum Amount&rdquo;</U>),
and if the Surviving Corporation is unable to obtain the insurance required by this <U>Section 6.5(b)</U> it shall obtain as much
comparable insurance as possible for the years within such six (6)-year period for a premium equal to the Maximum Amount. In lieu
of such insurance, prior to the Closing Date the Company may, at its option, purchase a &ldquo;tail&rdquo; directors&rsquo; and
officers&rsquo; liability insurance policy and fiduciary liability insurance policy for the Acquired Corporations and their current
and former directors and officers who are currently covered by the directors&rsquo; and officers&rsquo; and fiduciary liability
insurance coverage currently maintained by the Acquired Corporations, such tail to provide coverage in an amount not less than
the existing coverage and to have other terms not less favorable to the insured persons than the directors&rsquo; and officers&rsquo;
liability insurance and fiduciary liability insurance coverage currently maintained by the Acquired Corporations with respect to
claims arising from facts or events that occurred at or before the Effective Time; <U>provided</U> that in no event shall the cost
of any such tail policy exceed the Maximum Amount. Parent and the Surviving Corporation shall maintain such policies in full force
and effect, and continue to honor the obligations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the Surviving Corporation or any of its successors or assigns (i)&nbsp;consolidates with or merges into any other
Person and is not the continuing or surviving corporation or Entity of such consolidation or merger; or (ii)&nbsp;transfers or
conveys all or substantially all of its properties and assets to any Person, then, and in each such case, the Surviving Corporation
shall cause proper provision to be made so that the successors and assigns of the Surviving Corporation assume the obligations
set forth in this <U>Section 6.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <U>Section 6.5</U> (i)&nbsp;shall survive the acceptance of Shares for payment pursuant to the Offer and the
consummation of the Merger; (ii)&nbsp;are intended to be for the benefit of, and will be enforceable by, each indemnified or insured
party (including the Indemnified Persons), his or her heirs, successors, assigns and representatives; and (iii)&nbsp;are in addition
to, and not in substitution for, any other rights to indemnification, advancement of expenses, exculpation or contribution that
any such Person may have by contract or otherwise. Unless required by applicable Legal Requirement, this <U>Section 6.5</U> may
not be amended, altered or repealed after the Offer Acceptance Time in such a manner as to adversely affect the rights of any Indemnified
Person or any of their successors, assigns or heirs without the prior written consent of the affected Indemnified Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholder
Litigation</B>. Subject to entry into a customary joint defense agreement, the Company shall give Parent (a) the opportunity to
participate at Parent&rsquo;s sole expense in the defense of any litigation against the Company, its directors or officers, or
any Subsidiary of the Company and/or its respective directors or officers (each, a &ldquo;<U>Company Party</U>&rdquo;) relating
to the Transactions; (b) the right to review and comment on all material filings or responses to be made by the Company in connection
with any such litigation (and shall give reasonable consideration to Parent&rsquo;s comments and other advice with respect thereto);
and (c) the right to consult on any settlement with respect to such litigation, and no such settlement shall be agreed to without
Parent&rsquo;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed). The Company shall
promptly notify Parent of any such litigation and shall keep Parent reasonably and promptly informed with respect to the status
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1F497D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional
Agreements</B>. Subject to the terms and conditions of this Agreement, including <U>Section 6.2(a)</U>,
Parent and the Company shall use reasonable best efforts to take, or cause to be taken, all actions necessary to consummate the
Offer and the Merger and make effective the other Transactions. Without limiting the generality of the foregoing, subject to the
terms and conditions of this Agreement, each Party to this Agreement shall use reasonable best efforts to (a) make all filings
(if any) and give all notices (if any) required to be made and given by such Party pursuant to any Material Contract in connection
with the Offer and the Merger and the other Transactions; (b) seek each Consent (if any) required to be obtained pursuant to any
Material Contract by such Party in connection with the Transactions; and (c) seek to lift any restraint, injunction or other legal
bar to the Offer or the Merger brought by any third Person against such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosure</B>.
The initial press release relating to this Agreement shall be a joint press release issued by the Company and Parent and thereafter
Parent and the Company shall consult with each other before issuing any further press release(s) or otherwise making any public
statement or making any announcement to Company Associates (to the extent not previously issued or made in accordance with this
Agreement) with respect to the Offer, the Merger, this Agreement or any of the other Transactions and shall not issue any such
press release, public statement or announcement to Company Associates without the other Party&rsquo;s written consent. Notwithstanding
the foregoing: (a) each Party may, without such consultation or consent, make any public statement in response to questions from
the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make disclosures
in Company SEC Documents, so long as such statements are consistent with previous press releases, public disclosures or public
statements made jointly by the Parties (or individually, if approved by the other Party); (b) a Party may, without the prior consent
of the other Party but subject to giving advance notice to the other Party, issue any such press release or make any such public
announcement or statement as may be required by applicable Legal Requirements; (c) the Company need not consult with Parent in
connection with such portion of any press release, public statement or filing to be issued or made pursuant to <U>Section 5.3(e)</U>;
and (d) neither Party need consult with the other in connection with such portion of any press release, public statement or filing
to be issued with respect to any Determination Notice, Acquisition Proposal or Company Adverse Change Recommendation (but without
limiting the Company&rsquo;s obligations under <U>Section 5.3</U> or <U>Section 6.1</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Takeover
Laws</B>. If any Takeover Law may become, or may purport to be, applicable to the Transactions,
each of Parent and the Company and the members of their respective board of directors shall use their respective reasonable best
efforts to grant such approvals and take such actions as are necessary so that the Transactions may be consummated as promptly
as practicable on the terms and conditions contemplated hereby and otherwise act to lawfully eliminate the effect of any Takeover
Law on any of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section
16 Matters</B>. The Company and the Board of Directors, shall, to the extent necessary, take appropriate
action, prior to or as of the Offer Acceptance Time, to approve, for purposes of Section 16(b) of the Exchange Act, the disposition
and cancellation or deemed disposition and cancellation of Shares, Company Options, Company RSUs and Company Restricted Shares
in the Merger by applicable individuals and to cause such dispositions and/or cancellations to be exempt under Rule 16b-3 promulgated
under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rule
14d-10 Matters</B>. Prior to the Offer Acceptance Time and to the extent permitted by applicable
Legal Requirements, the compensation committee of the Board of Directors, at a meeting duly called and held, will approve, as an
&ldquo;employment compensation, severance or other employee benefit arrangement&rdquo; within the meaning of Rule 14d-10(d)(2)
under the Exchange Act, each agreement, arrangement or understanding between Purchaser, the Company or their respective Affiliates
and any of the officers, directors or employees of the Company that are effective as of the date of this Agreement or are entered
into after the date of this Agreement and prior to the Offer Acceptance Time pursuant to which compensation is paid to such officer,
director or employee and will take all other action reasonably necessary to satisfy the requirements of the non-exclusive safe
harbor set forth in Rule 14d-10(d)(2) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Exchange Delisting; Deregistration</B>. Prior to the Closing Date, the Company shall cooperate
with Parent and use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things,
reasonably necessary, proper or advisable on its part under applicable laws and rules and policies of NASDAQ to enable the delisting
by the Surviving Corporation of the Shares from NASDAQ and the deregistration of the Shares under the Exchange Act as promptly
as practicable after the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"><B>6.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing Cooperation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use its reasonable best efforts to provide, and to cause its Subsidiaries and each of their respective Representatives
to provide, to Parent and Purchaser, reasonable cooperation that may be reasonably requested by Parent and Purchaser and that is
necessary or customary, proper or advisable in connection with the arrangement of any loan transaction or capital markets debt
financing (whether public or private) undertaken by Parent in contemplation of the consummation of the Transaction (any such financing,
the &ldquo;<U>Financing</U>&rdquo;), including reasonable cooperation, in each case to the extent reasonably requested: (i) to
provide, within a reasonable amount of time following such reasonable request, to Parent, Purchaser and their Financing Sources
material financial and other pertinent information with respect to the Company and its Subsidiaries and the Transactions, including
information and projections prepared by the Company relating to the Acquired Corporations required in connection with the preparation
of the Finance Offering Documents and diligence documentation reasonably requested by persons in connection with the Financing;
(ii) to cooperate with the marketing efforts of Parent, Purchaser and their Financing Sources for any of the Financing, including
causing its Representatives to participate, during normal working hours and upon reasonable notice, in meetings, presentations,
road shows, due diligence sessions and sessions with rating agencies, a reasonable number of times; (iii) to assist with the preparation
of materials relating to the Acquired Corporations for rating agency presentations, lender presentations, offering documents, information
memoranda, road show presentations and similar documents (including assisting with the preparation of pro forma financial statements
meeting the requirements of SEC Regulation S-X) necessary, proper or advisable in connection with the Financing (collectively,
the &ldquo;<U>Finance Offering Documents</U>&rdquo;); (iv) to assist Parent in obtaining consents of the Company&rsquo;s auditors
for use of their reports in any materials relating to the Financing and customary &ldquo;comfort letters&rdquo; (including customary
negative assurances and &ldquo;bring-down&rdquo; letters from the Company&rsquo;s independent accountants on customary terms);
and (v) to provide all documentation and other information required under applicable &ldquo;know your customer&rdquo; and anti-money
laundering rules and regulations, including the PATRIOT Act. Notwithstanding the foregoing, (i) no obligation of the Company or
its Subsidiaries under any certificate, document or instrument executed pursuant to the foregoing shall be effective until the
Offer Acceptance Time (or such later time set forth in such certificate, document or instrument), and neither the Company nor its
Subsidiaries nor any of their respective Representatives shall be required to take any action under any such certificate, document
or instrument that is not contingent upon the consummation of the Offer (including the entry into any agreement that is effective
before consummation of the Offer) or that would be effective prior thereto or take any corporate actions prior to the Closing,
(ii) nothing herein shall require cooperation to the extent that such cooperation would, in the good faith determination of the
Company, interfere unreasonably with the business or operations of the Company or its Subsidiaries, (iii) neither the Company nor
any of its Subsidiaries shall be required to waive or amend any terms of this Agreement, (iv) neither the Company nor any of its
Subsidiaries shall be required to take any action that will conflict with or violate its organizational documents or any applicable
Legal Requirement, and (v) neither the Company nor any of its Subsidiaries shall be required to issue any offering or information
document (other than as required to comply with the Company&rsquo;s obligations pursuant to this <U>Section 6.13</U>). None of
the Company nor any of its Subsidiaries shall be required to take any action that would subject it to actual or potential liability,
to bear any cost or expense or to pay any commitment or other similar fee or make any other payment (other than reasonable out-of-pocket
costs that will be reimbursed by Parent pursuant to <U>clause (b)</U> or incur any other liability or provide or agree to provide
any indemnity in connection with the Financing or any of the foregoing that would be effective prior to the Closing. The Company
hereby consents to the use of the logos of the Company and its Subsidiaries in connection with the syndication or marketing of
the Financing; <I>provided</I> that such logos are used in a manner that is reasonable and customary in connection with a Financing,
and any in event, not intended to harm or disparage the Company, its Subsidiaries or their marks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
shall, promptly upon written request by the Company, reimburse the Company for all reasonable out-of-pocket costs incurred by the
Company or its Subsidiaries in connection with their cooperation and indemnify and hold harmless the Company, its Subsidiaries
and their respective Representatives from and against any and all losses, damages, claims, interest, awards, judgments, penalties,
settlements, costs or expenses (including reasonable attorneys&rsquo; fees) suffered or incurred by them to the extent such losses,
damages, claims, interest, awards, judgments, penalties, settlements, costs or expenses arose out of the actions taken by the Company,
its Subsidiaries or their respective Representatives pursuant to this <U>Section 6.13</U> (other than information provided by the
Company, its Subsidiaries or their respective Representatives in writing for express use therein), except to the extent such losses,
damages, claims, interest, awards, judgments, penalties, settlements, costs or expenses are determined by a final non-appealable
judgment of a court of competent jurisdiction to have arisen out of or resulted from the gross negligence or willful misconduct
of the Company, any of its Subsidiaries or any of their respective Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything herein to the contrary, Parent and Purchaser acknowledge and agree that obtaining the Financing is not a condition to
consummation of the Transactions, and that, irrespective and independently of the availability of the Financing, Parent and Purchaser
shall be obligated to pay for the tendered Shares and consummate the Merger and the other Transactions as provided herein, subject
to the satisfaction or waiver of the Offer Conditions or the conditions set forth in <U>Section 7</U>, as applicable. Notwithstanding
anything in this Agreement to the contrary, the condition set forth in <U>clause (c)</U> of <U>Annex I</U>, as it applies to the
Company&rsquo;s obligations pursuant to this <U>Section 6.13</U>, shall be deemed satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>6.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plan
Terminations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise requested by Parent at least ten (10) days prior to the Closing, the Company shall terminate any and all Employee Plans
intended to qualify under Section 401(a) of the Code that include a cash or deferred arrangement intended to satisfy the provisions
of Section 401(k) of the Code (the &ldquo;<U>Company 401(k) Plans</U>&rdquo;), such termination to be effective not later than
the day immediately preceding the Closing. In the event of such termination, the Company shall provide Parent with evidence that
such Company 401(k) Plans have been terminated pursuant to resolution (the form and substance of which shall be subject to prior
review and approval by Parent) of the Board of Directors. In the event of such termination, Parent shall cause each Continuing
Employee who is a participant in a Company 401(k) Plan to be allowed to participate, effective as soon as reasonably practicable
after the Closing, in a plan intended to be tax qualified which includes a cash or deferred arrangement intended to satisfy the
provisions of Section 401(k) of the Code that is sponsored and maintained by Parent or an Affiliate of Parent (the &ldquo;<U>Parent
401(k) Plan</U>&rdquo;). In addition, Parent shall, or shall cause an Affiliate to, take all actions deemed reasonably necessary
by Parent to cause the Parent 401(k) Plan to accept rollover contributions of &ldquo;eligible rollover distributions&rdquo; (within
the meaning of Section 401(a)(31) of the Code, inclusive of loans) from the Company 401(k) Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FIRPTA</B><FONT STYLE="color: red">.</FONT>
The Company shall provide Parent with a certificate complying with the requirements of Section 1.1445-2(c)(3)(i) of the Treasury
Regulations, dated as of or before the date on which the Offer Acceptance Time occurs, but in no event dated more than thirty (30)
days prior to the Closing Date, certifying that the Company is not and has not been a U.S. real property holding corporation during
the five-year period ending on the date of such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
7<BR>
<BR>
<U>CONDITIONS PRECEDENT TO THE MERGER</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The obligations of the
Parties to effect the Merger are subject to the satisfaction as of the Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Restraints</B>. There shall not have been issued by any Governmental Body of competent jurisdiction
and remain in effect any temporary restraining order, preliminary or permanent injunction or other order preventing the consummation
of the Merger, nor shall any Legal Requirement have been promulgated, enacted, issued or deemed applicable to the Merger by any
Governmental Body which prohibits or makes illegal the consummation of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consummation
of Offer</B>. The Offer Acceptance Time shall have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
8<BR>
<BR>
<U>TERMINATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination</B>.
This Agreement may be terminated prior to the Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
mutual written consent of Parent and the Company at any time prior to the Offer Acceptance Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
either Parent or the Company, at any time prior to the Offer Acceptance Time, if the Closing shall not have occurred on or prior
to midnight, Eastern Time, on July 23, 2018 (the &ldquo;<U>End Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that in the case
of this <U>Section 8.1(b)</U>, (i)&nbsp;if on the End Date all of the conditions set forth in <U>Annex I</U>, other than <U>clause
(e)</U> or <U>(g)</U> (solely in respect of the HSR Act) set forth in <U>Annex I</U> shall have been satisfied or waived by Parent
or Purchaser, to the extent waivable by Parent or Purchaser (other than the condition set forth in <U>clause (a)</U> of <U>Annex
I</U> and any other conditions that by their nature are to be satisfied at the Offer Acceptance Time, each of which is then capable
of being satisfied), then the End Date shall automatically be extended by a period of one hundred twenty (120) days (and all references
to the End Date herein and in <U>Annex I</U> shall be as so extended); and (ii)&nbsp;the right to terminate this Agreement pursuant
to this <U>Section 8.1(b)</U> shall not be available to any Party whose material breach of this Agreement has caused or resulted
in the Offer not being consummated by such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
either Parent or the Company if a Governmental Body of competent jurisdiction shall have issued an order decree or ruling, or shall
have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the acceptance for
payment of Shares pursuant to the Offer or the Merger or making the consummation of the Offer or the Merger illegal, which order,
decree, ruling or other action shall be final and nonappealable; <U>provided</U>, <U>however</U>, that the right to terminate this
Agreement pursuant to this <U>Section 8.1(c)</U> shall not be available to any Party whose material breach of this Agreement has
caused or resulted in the issuance of such final and nonappealable order, decree, ruling or other action;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
Parent at any time prior to the Offer Acceptance Time, if: (i)&nbsp;the Board of Directors shall have failed to include the Company
Board Recommendation in the Schedule&nbsp;14D-9 when mailed, or shall have effected a Company Adverse Change Recommendation; (ii)&nbsp;in
the case of a tender offer or exchange offer subject to Regulation 14D under the Exchange Act, other than the Offer, the Board
of Directors fails to recommend, in a Tender Offer Solicitation/Recommendation Statement on Schedule 14D-9, rejection of such tender
offer or exchange offer within ten (10) business days of the commencement of such tender offer or exchange offer; or (iii) the
Board of Directors fails to publicly reaffirm the Company Board Recommendation within ten (10) business days after Parent so requests
in writing; <U>provided</U>, that Parent may only make such request once with respect to any Acquisition Proposal (<U>provided</U>
that each time a Determination Notice is given, Parent shall be entitled to make a new request);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the Company, at any time prior to the Offer Acceptance Time, in order to accept a Superior Offer in accordance with the terms set
forth in <U>Section 6.1(b)(i)</U> and substantially concurrently enter into a binding written definitive acquisition agreement
providing for the consummation of such Superior Offer (a &ldquo;<U>Specified Agreement</U>&rdquo;); <U>provided</U> that the Company
shall have paid the Termination Fee pursuant to <U>Section 8.3(b)(i)</U> immediately before or substantially contemporaneously
with and as a condition to such termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
Parent at any time prior to the Offer Acceptance Time, if a breach of any representation or warranty contained in this Agreement
or failure to perform any covenant or obligation in this Agreement on the part of the Company shall have occurred such that a condition
set forth in <U>clause (b)</U> or <U>(c)</U> of <U>Annex I</U> would not be satisfied and cannot be cured by the Company by the
End Date, or if capable of being cured in such time period, shall not have been cured within thirty (30) days of the date Parent
gives the Company written notice of such breach or failure to perform; <U>provided</U>, <U>however</U>, that Parent shall not have
the right to terminate this Agreement pursuant to this <U>Section 8.1(f)</U> if either Parent or Purchaser is then in material
breach of any representation, warranty, covenant or obligation hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the Company at any time prior to the Offer Acceptance Time, if a breach of any representation or warranty contained in this Agreement
or failure to perform any covenant or obligation in this Agreement on the part of Parent or Purchaser shall have occurred, in each
case, if such breach or failure would reasonably be expected to prevent Parent or Purchaser from consummating the Transactions
and such breach or failure cannot be cured by Parent or Purchaser, as applicable, by the End Date, or, if capable of being cured
in such time period, shall not have been cured within thirty (30) days of the date the Company gives Parent written notice of such
breach or failure to perform; <U>provided</U>, <U>however</U>, that the Company shall not have the right to terminate this Agreement
pursuant to this <U>Section 8.1(g)</U> if the Company is then in material breach of any representation, warranty, covenant or obligation
hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the Company if (i) all of the Offer Conditions (other than the conditions that by their nature are to be satisfied at the Offer
Acceptance Time, but subject to such Offer Conditions being satisfied or waived at or prior to the Offer Acceptance Time) have
been satisfied or waived at the expiration of the Offer on the Expiration Date, (ii) if following the Offer Acceptance Time, Purchaser
shall have failed to purchase all Shares validly tendered (and not validly withdrawn) pursuant to the Offer within three (3) business
days following the Expiration Date; (iii) no later than two (2) business days after the Expiration Date, the Company has irrevocably
confirmed by written notice to Purchaser the Company&rsquo;s intention to terminate this Agreement pursuant to this <U>Section
8.1(h)</U> if Purchaser fails to consummate the Offer within three (3) business days following the Expiration Date (with such written
notice stating the basis for such termination) and (iv) at all times during such three (3) business day period, the Company stood
ready, willing and able to consummate the Transactions; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
Parent at any time prior to the Offer Acceptance Time in the event of a material breach of <U>Section 5.3</U> or <U>Section 6.1</U>
that either results in an Acquisition Proposal or materially hinders, materially delays or prevents the consummation of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect
of Termination</B>. In the event of the termination of this Agreement as provided in <U>Section
8.1</U>, written notice thereof shall be given to the other Party or Parties, specifying the provision hereof pursuant to which
such termination is made, and this Agreement shall be of no further force or effect and there shall be no liability on the part
of Parent, Purchaser or the Company or any of their respective former, current or future officers, directors, partners, stockholders,
managers, members or Affiliates following any such termination; <U>provided</U>, <U>however</U>, that (a) the final sentence of
<U>Section 1.2(b)</U>, the final sentence of <U>Section 5.1(a)</U>, <U>Section 6.13(b)</U>, this <U>Section 8.2</U>, <U>Section
8.3</U> and <U>Section 9</U> (other than <U>Section 9.5(b)</U>), and the definitions of all defined terms appearing in such Sections,
shall survive the termination of this Agreement and shall remain in full force and effect, (b) the Confidentiality Agreement shall
survive the termination of this Agreement and shall remain in full force and effect in accordance with its terms and (c) the termination
of this Agreement shall not relieve any Party from any liability for fraud or willful and material breach of this Agreement prior
to termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses;
Termination Fees</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth in <U>Section 6.13(b)</U> and this <U>Section 8.3</U>, all fees and expenses incurred in connection with this Agreement
and the Transactions shall be paid by the Party incurring such expenses, whether or not the Offer and Merger are consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by the Company pursuant to <U>Section&nbsp;8.1(e)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Parent pursuant to <U>Section 8.1(d)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;this
Agreement is terminated by Parent or the Company pursuant to <U>Section 8.1(b)</U> and at the time of such termination the condition
set forth in <U>clause (e)</U> of <U>Annex I</U> was satisfied (but in the case of a termination by the Company, only if at such
time Parent would not be prohibited from terminating this Agreement pursuant to the proviso to <U>Section 8.1(b)</U>) or by Parent
pursuant to <U>Section 8.1(f)</U>; (B)&nbsp;any Person shall have publicly disclosed a <I>bona fide</I> Acquisition Proposal, or
such Acquisition Proposal has otherwise been communicated to the Board of Directors or the Company&rsquo;s stockholders and shall
have become publicly known, after the date hereof and prior to such termination; and (C)&nbsp;within twelve (12) months of such
termination the Company shall have entered into a definitive agreement with respect to an Acquisition Proposal (which Acquisition
Proposal is subsequently consummated, whether during or following such twelve (12)-month period) or consummated an Acquisition
Proposal; <U>provided</U> that for purposes of this <U>clause (C)</U> the references to &ldquo;20%&rdquo; in the definition of
&ldquo;Acquisition Proposal&rdquo; shall be deemed to be references to &ldquo;50%&rdquo;; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Parent pursuant to <U>Section 8.1(i)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;then,
in any such event under <U>clause (i)</U>, <U>(ii)</U>, <U>(iii)</U> or <U>(iv)</U> of <U>Section 8.3(b)</U>, the Company shall
pay to Parent or its designee the Termination Fee by wire transfer of same day funds (i) in the case of <U>Section 8.3(b)(i)</U>,
prior to or substantially contemporaneously with (and as a condition to the effectiveness of) such termination, (ii) in the case
of <U>Section 8.3(b)(ii)</U> or <U>Section 8.3(b)(iv)</U>, as promptly as practicable (and in any event, within two (2) business
days after such termination), or (iii) in the case of <U>Section 8.3(b)(iii)</U>, prior to or substantially contemporaneously with
the consummation of the Acquisition Proposal referred to in <U>clause (C)</U> of <U>Section 8.3(b)(iii)</U>; it being understood
that in no event shall the Company be required to pay the Company Termination Fee on more than one occasion. As used herein, &ldquo;<U>Company
Termination Fee</U>&rdquo; shall mean a cash amount equal to $300,000,000. Payment of the Company Termination Fee pursuant to this
<U>Section 8.3(c)</U> shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred by Parent,
Purchaser, any of their respective Affiliates or any other Person in connection with this Agreement (and the termination hereof),
the Transactions (and the abandonment thereof) or any matter forming the basis for such termination, and none of Parent, Purchaser
or any of their respective Affiliates shall be entitled to bring or maintain any claim, action or proceeding against the Company
or any of its Affiliates arising out of or in connection with this Agreement, any of the Transactions or any matters forming the
basis for such termination, other than with respect to claims for, arising out of or in connection with fraud or willful and material
breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event of any termination described in <U>Section 8.3(b)</U>, (i)&nbsp;payment from the Company to Parent of the Company Termination
Fee pursuant to <U>Section 8.3(c)</U> shall be the sole and exclusive remedy of Parent, Purchaser or any of their respective Affiliates
against the Acquired Corporations and any of their respective former, current or future officers, directors, partners, stockholders,
managers, members or Affiliates (collectively, &ldquo;<U>Company Related Parties</U>&rdquo;) for any loss suffered as a result
of the failure of the Offer or the Merger to be consummated or for a breach or failure to perform hereunder or otherwise; and (ii)&nbsp;upon
payment of such amount(s), none of the Company Related Parties shall have any further liability or obligation relating to or arising
out of this Agreement or the Transactions, other than with respect to claims for, arising out of or in connection with fraud or
willful and material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Parent or the Company pursuant to <U>Section 8.1(b)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Parent or the Company pursuant to <U>Section 8.1(c)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>provided</U>, that in either case, at the
time of such termination of this Agreement, the Regulatory Condition has not been satisfied and the failure of the Regulatory Condition
to be satisfied did not result from any breach by the Company of any covenant or obligation set forth in this Agreement,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;then,
in any such event under <U>clause (e)(i)</U> or <U>(e)(ii)</U> above (after giving effect to the proviso therein), Parent shall
pay to the Company or its designee the Parent Termination Fee by wire transfer of same day funds as promptly as practicable (and
in any event, within two (2) business days after such termination); it being understood that in no event shall Parent be required
to pay the Parent Termination Fee on more than one occasion. As used herein, &ldquo;<U>Parent Termination Fee</U>&rdquo; shall
mean a cash amount equal to $600,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
payment by Parent of the Parent Termination Fee shall be the sole and exclusive remedy of the Company in the event of termination
of this Agreement under circumstances requiring the payment of the Parent Termination Fee pursuant to <U>clause (e)</U> above,
other than with respect to claims for, arising out of or in connection with fraud or in the case of a willful material breach or
intentional material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties acknowledge that the agreements contained in this <U>Section&nbsp;8.3</U> are an integral part of the transactions contemplated
by this Agreement and that, without these agreements, the Parties would not enter into this Agreement; accordingly, if the Company
or Parent, as applicable, fails to timely pay any amount due pursuant to <U>Section 8.3(c)</U> or <U>(e)</U>, respectively, and,
in order to obtain the payment, Parent commences a Legal Proceeding which results in a judgment against the Company for the Company
Termination Fee or the Company commences a Legal Proceeding which results in a judgment against Parent for the Parent Termination
Fee, as the case may be, the Company or Parent, as applicable, shall pay the other party its reasonable and documented costs and
expenses (including reasonable and documented attorneys&rsquo; fees) in connection with such suit, together with interest on such
amount at the prime rate as published in the Wall Street Journal in effect on the date such payment was required to be made through
the date such payment was actually received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Section
9<BR>
<BR>
<U>MISCELLANEOUS PROVISIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment</B>.
Prior to the Effective Time, this Agreement may be amended with the approval of the respective board of directors of the Company,
Parent and Purchaser at any time. This Agreement may not be amended except by an instrument in writing signed on behalf of each
of the Parties. Notwithstanding the foregoing, this <U>Section 9.1</U>, <U>Section 9.5(a)</U>, <U>Section 9.5(c)</U>, the last
sentence of <U>Section 9.7</U> and <U>Section 9.13</U> (and any related definitions insofar as they affect such Sections) may not
be amended, supplemented, waived or otherwise modified in a manner adverse to the Financing Sources, in each case, without the
prior written consent of the Financing Sources adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Waiver</B>.
No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the
part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power,
right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any
other or further exercise thereof or of any other power, right, privilege or remedy. No Party shall be deemed to have waived any
claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim,
power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such
Party and any such waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall
not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. At any time prior to the Effective Time,
Parent and Purchaser, on the one hand, and the Company, on the other hand, may (a)&nbsp;extend the time for the performance of
any of the obligations or other acts of the other; (b)&nbsp;waive any breach of the representations and warranties of the other
contained herein or in any document delivered pursuant hereto; or (c)&nbsp;waive compliance by the other with any of the agreements
or covenants contained herein. Any such extension or waiver shall be valid only if is expressly set forth in a written instrument
duly executed and delivered on behalf of the Party or Parties to be bound thereby, but such extension or waiver or failure to insist
on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect
to, any subsequent or other failure. The rights and remedies provided herein shall be cumulative and not exclusive of any rights
or remedies provided by any Legal Requirement except to the extent set forth in <U>Section 8.3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Survival of Representations and Warranties</B>. None of the representations and warranties contained
in this Agreement, the Company Disclosure Schedule or in any certificate or schedule or other document delivered by any Person
pursuant to this Agreement shall survive the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entire
Agreement; Counterparts</B>. This Agreement (including its Exhibits, Annexes or Schedules) and
the Confidentiality Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written
and oral, among or between any of the Parties and their respective Affiliates, with respect to the subject matter hereof and thereof.
The Confidentiality Agreement shall survive the execution and delivery of this Agreement except that the restrictions on contact
and restrictions on disclosure (to the extent to be included in SEC filings in connection with the Transactions) in the Confidentiality
Agreement shall terminate immediately following the execution and delivery of this Agreement solely for purposes of permitting
the actions contemplated hereby to be consummated. This Agreement may be executed in one or more counterparts, including by email
with .pdf attachments, all of which shall be considered one and the same agreement, and shall become effective when one or more
counterparts have been signed by each of the parties and delivered to the other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Applicable
Legal Requirements; Jurisdiction; Specific Performance; Remedies</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that
might otherwise govern under applicable principles of conflicts of laws thereof. Subject to <U>Section 9.5(c)</U>, in any action
or proceeding arising out of or relating to this Agreement or any of the Transactions: (i)&nbsp;each of the Parties irrevocably
and unconditionally consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware
and any state appellate court therefrom or, if (but only if) such court lacks subject matter jurisdiction, the United States District
Court sitting in New Castle County in the State of Delaware and any appellate court therefrom (collectively, the &ldquo;<U>Delaware
Courts</U>&rdquo;); and (ii)&nbsp;each of the Parties irrevocably consents to service of process by first class certified mail,
return receipt requested, postage prepaid, to the address at which such Party is to receive notice in accordance with <U>Section
9.9</U>. Each of the Parties irrevocably and unconditionally (1)&nbsp;agrees not to commence any such action or proceeding except
in the Delaware Courts; (2)&nbsp;agrees that any claim in respect of any such action or proceeding may be heard and determined
in the Delaware Courts; (3)&nbsp;waives, to the fullest extent it may legally and effectively do so, any objection that it may
now or hereafter have to the jurisdiction or laying of venue of any such action or proceeding in the Delaware Courts; and (4)&nbsp;waives,
to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in
the Delaware Courts. The Parties agree that a final judgment in any such action or proceeding shall be conclusive and may be enforced
in other jurisdictions by suit on the judgment or in any other manner provided by applicable Legal Requirements; <U>provided</U>,
<U>however</U>, that nothing in the foregoing shall restrict any Party&rsquo;s rights to seek any post-judgment relief regarding,
or any appeal from, such final trial court judgment. Notwithstanding anything herein to the contrary, (A) the Company (on behalf
of itself, its Subsidiaries and the directors, officers, employees, consultants, financial advisors, accountants, legal counsel,
investment bankers, and other agents, advisors and representatives of each of them) and each of the other Parties hereto agrees
that any claim, controversy or dispute of any kind or nature (whether based upon contract, tort or otherwise) against a Financing
Source that is in any way related to this Agreement, the Merger, the Offer or any of the other Transactions, including any dispute
arising out of or relating in any way to any Financing, shall be governed by, and construed in accordance with the laws of the
State of New York without regard to conflict of law principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations
Law); <U>provided</U> that (1) the interpretation of the definition of Material Adverse Effect and whether or not a Material Adverse
Effect has occurred, (2) the determination of the accuracy of any representations made in this Agreement and whether as a result
of any inaccuracy thereof Parent or Purchaser has the right to terminate its obligations under this Agreement, or to decline to
consummate the Transactions pursuant to this Agreement and (3) the determination of whether the Offer, the Merger and the other
Transactions have been consummated in accordance with the terms of this Agreement, in each case, shall be governed by, and construed
and interpreted solely in accordance with the laws of the State of Delaware without giving effect to conflicts of laws principles
that would result in the application of the law of any other state, and (B) each of the Parties hereto agrees (on behalf of itself,
its Subsidiaries and the directors, officers, employees, consultants, financial advisors, accountants, legal counsel, investment
bankers, and other agents, advisors and representatives of each of them) that it will not bring or support any action, cause of
action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or
in tort or otherwise, against the Financing Sources in any way relating to this Agreement, the Merger, the Offer or any of the
other Transactions, including any dispute arising out of or relating in any way to any Financing or the performance thereof or
the transactions contemplated thereby, in any forum other than exclusively in the Supreme Court of the State of New York, County
of New York, or, if under applicable law exclusive jurisdiction is vested in the federal courts, the United States District Court
for the Southern District of New York (and appellate courts thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur
in the event that the Parties do not perform their obligations under the provisions of this Agreement in accordance with its specified
terms or otherwise breach such provisions. Subject to the following sentence, the Parties acknowledge and agree that (i)&nbsp;the
Parties shall be entitled to an injunction or injunctions, specific performance, or other equitable relief, to prevent breaches
of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in <U>Section 9.5(a)</U>
without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement,
and (ii)&nbsp;the right of specific performance is an integral part of the Transactions and without that right, neither the Company
nor Parent would have entered into this Agreement. Each of the Parties agrees that it will not oppose the granting of an injunction,
specific performance and other equitable relief on the basis that the other Parties have an adequate remedy at law or an award
of specific performance is not an appropriate remedy for any reason at law or equity. The Parties acknowledge and agree that any
Party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement in accordance with this <U>Section 9.5(b)</U> shall not be required to provide any bond or other security in
connection with any such order or injunction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EACH
OF THE PARTIES IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES (WHETHER BASED
ON CONTRACT, TORT OR OTHERWISE), INCLUDING ANY COUNTERCLAIM, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY FINANCING OR THE
TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT
THEREOF OR THE ACTIONS OF ANY FINANCING SOURCE IN CONNECTION WITH ANY FINANCING (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM
AGAINST ANY FINANCING SOURCE). EACH PARTY (i)&nbsp;MAKES THIS WAIVER VOLUNTARILY AND (ii)&nbsp;ACKNOWLEDGES THAT SUCH PARTY HAS
BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS <U>SECTION 9.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assignability</B>.
This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective
successors and permitted assigns; <U>provided</U>, <U>however</U>, that neither this Agreement nor any of the rights hereunder
may be assigned by a Party without the prior written consent of the other Parties, and any attempted assignment of this Agreement
or any of such rights without such consent shall be void and of no effect; <I>provided further</I>, <I>however</I>, that Parent
may designate, by written notice to the Company, another wholly-owned direct or indirect Delaware corporate Subsidiary of Parent
to act as Purchaser, in which event all references to Purchaser in this Agreement shall be deemed references to such other Subsidiary;
<I>provided</I> such assignment shall not impede or delay the consummation of the Transactions or relieve Parent of its obligations
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Third-Party Beneficiaries</B>. Nothing in this Agreement, express or implied, is intended to or
shall confer upon any Person (other than the Parties) any right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement; except for: (a)&nbsp;if the Offer Acceptance Time occurs, (i)&nbsp;the right of the Company&rsquo;s stockholders
to receive the Offer Price or Merger Consideration, as applicable, pursuant to <U>Section 1</U> or <U>Section 2</U> following the
Offer Acceptance Time or the Effective Time, as applicable, in accordance with the terms of this Agreement; and (ii)&nbsp;the right
of the holders of Company Options, Company RSUs and Company Restricted Shares to receive the Merger Consideration pursuant to <U>Section
2.8</U> following the Effective Time in accordance with the terms of this Agreement; (b)&nbsp;the provisions set forth in <U>Section
6.5</U> of this Agreement; and (c)&nbsp;the limitations on liability of the Company Related Parties set forth in <U>Section 8.3(d)</U>.
Notwithstanding anything herein to the contrary, the Financing Sources shall be express third-party beneficiaries of this sentence
and the last sentence of <U>Section 9.1</U>, <U>Section 9.5</U> and <U>Section 9.13</U>, and each of such Sections shall expressly
inure to the benefit of the Financing Sources and the Financing Sources shall be entitled to rely on and enforce the provisions
of such Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfer
Taxes</B>. Except as otherwise provided in <U>Section 2.6(b)</U>, all transfer, documentary, sales,
use, stamp, registration and other similar Taxes and fees imposed on the Company with respect to the transfer of Shares pursuant
to the Offer or the Merger shall be borne by the Company and expressly shall not be a liability of holders of Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notices</B>.
Any notice or other communication required or permitted to be delivered to any Party under this Agreement shall be in writing and
shall be deemed properly delivered, given and received (a)&nbsp;upon receipt when delivered by hand; (b)&nbsp;two (2) business
days after being sent by registered mail or by courier or express delivery service; (c)&nbsp;if sent by email prior to 6:00 p.m.
recipient&rsquo;s local time, upon transmission when receipt is confirmed; or (d)&nbsp;if sent by email after 6:00 p.m. recipient&rsquo;s
local time and receipt is confirmed, the business day following the date of transmission; <U>provided</U> that in each case the
notice or other communication is sent to the physical or email address set forth beneath the name of such Party below (or to such
other physical or email address as such Party shall have specified in a written notice given to the other Parties):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">if to Parent or Purchaser (or following the Effective Time,
the Surviving Corporation):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">c/o Celgene Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">86 Morris Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Summit, New Jersey 07901</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Email: gmasoudi@celgene.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Proskauer Rose LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Eleven Times Square</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">New York, New York 10036-8299</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Robert A. Cantone</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 1.25in">Daniel I. Ganitsky</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.75in">Michael E. Ellis</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">Email:</TD><TD STYLE="text-align: justify">rcantone@proskauer.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 1.25in">dganitsky@proskauer.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.75in">mellis@proskauer.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">if to the Company (prior to the Effective Time):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Juno Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">400 Dexter Ave. N, Suite 1200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Seattle, Washington 98109</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Email: LegalNotice@junotherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Skadden, Arps, Slate, Meagher &amp; Flom LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">525 University Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Palo Alto, California 94301-1908</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Kenton J. King</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 1.25in">Graham Robinson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.75in">Amr Razzak</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">Email:</TD><TD STYLE="text-align: justify">kenton.king@skadden.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 1.25in">graham.robinson@skadden.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.75in">amr.razzak@skadden.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severability</B>.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the
offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction
declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such
determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term
or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid
or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does
not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or
provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and
other purposes of such invalid or unenforceable term or provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Obligation
of Parent</B>. Parent shall ensure that Purchaser duly performs, satisfies and discharges on a
timely basis each of the covenants, obligations and liabilities applicable to Purchaser under this Agreement, and Parent shall
be jointly and severally liable with Purchaser for the due and timely performance and satisfaction of each of said covenants, obligations
and liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0.5in"><B>9.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine
gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the
neuter gender shall include masculine and feminine genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall
not be applied in the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this Agreement, the words &ldquo;include&rdquo; and &ldquo;including,&rdquo; and variations thereof, shall not be deemed
to be terms of limitation, but rather shall be deemed to be followed by the words &ldquo;without limitation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise indicated, all references in this Agreement to &ldquo;Sections,&rdquo; &ldquo;Exhibits,&rdquo; &ldquo;Annexes&rdquo;
and &ldquo;Schedules&rdquo; are intended to refer to Sections of this Agreement and Exhibits, Annexes or Schedules to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this
Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Recourse to Financing Sources</B>. Notwithstanding anything herein to the contrary, the Company
(on behalf of itself, its Subsidiaries and the directors, officers, employees, consultants, financial advisors, accountants, legal
counsel, investment bankers, and other agents, advisors and representatives of each of them) acknowledges and agrees that it (and
such other Persons) shall have no recourse against the Financing Sources, and the Financing Sources shall be subject to no liability
or claims by the Company (or such other Persons), in connection with the Financing or in any way relating to this Agreement or
any of the transactions contemplated hereby or thereby, whether at law, in equity, in contract, in tort or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>[Signature page follows]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Parties have
caused this Agreement to be executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Company:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">JUNO THERAPEUTICS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Hans E. Bishop</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>Hans E. Bishop</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Parent:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CELGENE CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Mark Alles</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>Marl Alles</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Purchaser:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BLUE MAGPIE CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Marl Alles</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>Marl Alles</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[Signature Page to the Merger Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT A<BR>
<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of the Agreement
(including this <U>Exhibit A</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Acceptable Confidentiality
Agreement</U>. &ldquo;<U>Acceptable Confidentiality Agreement</U>&rdquo; is defined in <U>Section 5.3(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Acquired Corporations</U>.
&ldquo;<U>Acquired Corporations</U>&rdquo; shall mean the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Acquisition Proposal</U>.
&ldquo;<U>Acquisition Proposal</U>&rdquo; shall mean any proposal or offer from any Person (other than Parent and its Affiliates)
or &ldquo;group&rdquo;, within the meaning of Section 13(d) of the Exchange Act, relating to, in a single transaction or series
of related transactions, any (A)&nbsp;acquisition or license of assets of the Company equal to 20% or more of the Company&rsquo;s
consolidated assets or to which 20% or more of the Company&rsquo;s revenues or earnings on a consolidated basis are attributable;
(B) acquisition or exclusive license of any of the Key Products or any other license granting commercialization rights with respect
to a Key Product; (C)&nbsp;issuance or acquisition of 20% or more of the outstanding Company Common Stock; (D) recapitalization,
tender offer or exchange offer that if consummated would result in any Person or group beneficially owning 20% or more of the outstanding
Company Common Stock; or (E) merger, consolidation, amalgamation, share exchange, business combination, recapitalization, liquidation,
dissolution or similar transaction involving the Company that if consummated would result in any Person or group beneficially owning
20% or more of the outstanding Company Common Stock, in each case other than the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Adjusted Option</U>.
&ldquo;<U>Adjusted Option</U>&rdquo; is defined in Section 2.8(b) of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Adjusted Performance
Restricted Share</U>. &ldquo;<U>Adjusted Performance Restricted Share</U>&rdquo; is defined in <U>Section 2.8(j)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Adjusted PRSU</U>. &ldquo;<U>Adjusted
PRSU</U>&rdquo; is defined in <U>Section 2.8(h)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Adjusted Restricted
Share</U>. &ldquo;<U>Adjusted Restricted Share</U>&rdquo; is defined in <U>Section 2.8(f)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Adjusted Restricted
Stock Unit</U>. &ldquo;<U>Adjusted Restricted Stock Unit</U>&rdquo; is defined in <U>Section 2.8(d)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Affiliate</U>. &ldquo;<U>Affiliate</U>&rdquo;
shall mean, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common
control with, such Person. For this purpose, &ldquo;control&rdquo; (including, with its correlative meanings, &ldquo;controlled
by&rdquo; and &ldquo;under common control with&rdquo;) shall mean the possession, directly or indirectly, of the power to direct
or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other
ownership interests, by Contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Agreement</U>. &ldquo;<U>Agreement</U>&rdquo;
is defined in the preamble to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Anti-Corruption Laws</U>.
&ldquo;<U>Anti-Corruption Laws</U>&rdquo; shall mean the Foreign Corrupt Practices Act of 1977, as amended, the Anti-Kickback Act
of 1986, as amended, the UK Bribery Act of 2012, and the Anti-Bribery Laws of the People&rsquo;s Republic of China or any applicable
Legal Requirements of similar effect, and the related regulations and published interpretations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Antitrust Laws</U>.
&ldquo;<U>Antitrust Laws</U>&rdquo; shall mean the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal
Trade Commission Act, as amended, all applicable foreign anti-trust laws and all other applicable Legal Requirements issued by
a Governmental Body that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization
or restraint of trade or lessening of competition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Assumed Plans</U>. &ldquo;<U>Assumed
Plans</U>&rdquo; is defined in <U>Section 2.8(n)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Board of Directors</U>.
&ldquo;<U>Board of Directors</U>&rdquo; is defined in <U>Recital (C)</U> to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Book-Entry Shares</U>.
&ldquo;<U>Book-Entry Shares</U>&rdquo; shall mean non-certificated Shares represented by book-entry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>business day</U>. &ldquo;<U>business
day</U>&rdquo; shall mean a day except a Saturday, a Sunday or other day on which banks in the City of New York are authorized
or required by Legal Requirements to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Cashed-Out Company Performance
Restricted Shares</U>. &ldquo;<U>Cashed-Out Company Performance Restricted Shares</U>&rdquo; is defined in <U>Section 2.8(i)</U>
of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Cashed-Out Company Restricted
Shares</U>. &ldquo;<U>Cashed-Out Company Restricted Shares</U>&rdquo; is defined in <U>Section 2.8(e)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Cashed-Out Company PRSUs</U>.
&ldquo;<U>Cashed-Out Company PRSUs</U>&rdquo; is defined in <U>Section 2.8(g)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Cashed-Out Company RSUs</U>.
&ldquo;<U>Cashed-Out Company RSUs</U>&rdquo; is defined in <U>Section 2.8(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Certificates</U>. &ldquo;<U>Certificates</U>&rdquo;
is defined in <U>Section 2.6(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Change-of-Control Payment</U>.
&ldquo;<U>Change-of-Control Payment</U>&rdquo; is defined in <U>Section&nbsp;3.9(a)(v)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Closing</U>. &ldquo;<U>Closing</U>&rdquo;
is defined in <U>Section 2.3(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Closing Date</U>. &ldquo;<U>Closing
Date</U>&rdquo; is defined in <U>Section 2.3(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Code</U>. &ldquo;<U>Code</U>&rdquo;
shall mean the Internal Revenue Code of 1986, as amended and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company</U>. &ldquo;<U>Company</U>&rdquo;
is defined in the preamble to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company 401(k) Plans</U>.
&ldquo;<U>Company 401(k) Plans</U>&rdquo; is defined in <U>Section 6.14(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Adverse Change
Recommendation</U>. &ldquo;<U>Company Adverse Change Recommendation</U>&rdquo; is defined in <U>Section 6.1(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Associate</U>.
&ldquo;<U>Company Associate</U>&rdquo; shall mean each officer or other employee, or individual who is an independent contractor,
consultant or director, of or to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Board Recommendation</U>.
&ldquo;<U>Company Board Recommendation</U>&rdquo; is defined in <U>Recital (C)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Common Stock</U>.
&ldquo;<U>Company Common Stock</U>&rdquo; shall mean the common stock, $0.0001 par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Disclosure Documents</U>.
&ldquo;<U>Company Disclosure Documents</U>&rdquo; is defined in <U>Section 3.4(g)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Disclosure Schedule</U>.
&ldquo;<U>Company Disclosure Schedule</U>&rdquo; shall mean the disclosure schedule that has been prepared by the Company in accordance
with the requirements of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Equity Plans</U>.
&ldquo;<U>Company Equity Plans</U>&rdquo; shall mean the Company 2014 Equity Incentive Plan and the Company 2013 Equity Incentive
Plan, as amended and not including the Company ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company ESPP</U>. &ldquo;<U>Company
ESPP</U>&rdquo; shall mean the Company 2014 Employee Stock Purchase Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company IP</U>. &ldquo;<U>Company
IP</U>&rdquo; shall mean all (a) Company-Owned Intellectual Property; and (b) Company Licensed IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Licensed IP</U>.
&ldquo;<U>Company Licensed IP</U>&rdquo; shall mean all Intellectual Property licensed, or with respect to which rights are granted,
to any Acquired Corporation pursuant to any IP Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company-Owned IP</U>.
&ldquo;<U>Company-Owned IP</U>&rdquo; shall mean all Intellectual Property that is owned by any Acquired Corporation, including
any such Intellectual Property that is jointly owned with any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company-Owned Registered
IP</U>. &ldquo;<U>Company-Owned Registered IP</U>&rdquo; is defined in <U>Section 3.8(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company-Licensed Registered
IP</U>. &ldquo;<U>Company-Owned Registered IP</U>&rdquo; is defined in <U>Section 3.8(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Options</U>.
&ldquo;<U>Company Options</U>&rdquo; shall mean all stock options to purchase Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Party</U>. &ldquo;<U>Company
Party</U>&rdquo; is defined in <U>Section 6.6</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Performance
Restricted Shares</U>. &ldquo;<U>Company Performance Restricted Shares</U>&rdquo; shall mean Shares issued by the Company subject
to performance-based vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Preferred Stock</U>.
&ldquo;<U>Company Preferred Stock</U>&rdquo; shall mean the preferred stock, $0.0001 par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company PRSUs</U>. &ldquo;<U>Company
PRSUs</U>&rdquo; shall mean restricted stock units with respect to Shares subject to performance-based vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Related Parties</U>.
&ldquo;<U>Company Related Parties</U>&rdquo; is defined in <U>Section 8.3(d)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Restricted Shares</U>.
&ldquo;<U>Company Restricted Shares</U>&rdquo; shall mean Shares issued by the Company subject to vesting (other than performance-based
vesting) or other restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company Returns</U>.
&ldquo;<U>Company Returns</U>&rdquo; is defined in <U>Section 3.15(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company RSUs</U>. &ldquo;<U>Company
RSUs</U>&rdquo; shall mean restricted stock units with respect to Shares, other than restricted stock units subject to performance-based
vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Company SEC Documents</U>.
&ldquo;<U>Company SEC Documents</U>&rdquo; is defined in <U>Section 3.4(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><U>Company Termination Fee</U>. &ldquo;<U>Company
Termination Fee</U>&rdquo; is defined in <U>Section 8.3(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Confidentiality Agreement</U>.
&ldquo;<U>Confidentiality Agreement</U>&rdquo; shall mean Article 8 of the Amended and Restated Master Research and Collaboration
Agreement, dated August 13, 2015, by and among the Company, Parent and Celgene RIVOT Ltd., as modified by (i) the Amended and Restated
Letter Agreement, dated December 21, 2017, by and among the Company and Parent, and (ii) the Amended Letter Agreement, dated January
21, 2018, by and between the Company and Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Consent</U>. &ldquo;<U>Consent</U>&rdquo;
shall mean any approval, consent, ratification, permission, waiver or authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Continuing Employees</U>.
&ldquo;<U>Continuing Employees</U>&rdquo; is defined in <U>Section 6.3(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Contract</U>. &ldquo;<U>Contract</U>&rdquo;
shall mean any binding agreement, contract, subcontract, lease, understanding, instrument, bond, debenture, note, option, warrant,
license, sublicense, commitment or undertaking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Copyrights</U>. &ldquo;<U>Copyrights</U>&rdquo;
is defined in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Current Offering</U>.
&ldquo;<U>Current Offering</U>&rdquo; is defined in <U>Section 6.4</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Delaware Courts</U>.
&ldquo;<U>Delaware Courts</U>&rdquo; is defined in <U>Section 9.5(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Depository Agent</U>.
&ldquo;<U>Depository Agent</U>&rdquo; is defined in <U>Section 2.6(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Designated Regulatory
Representative</U>. &ldquo;<U>Designated Regulatory Representative</U>&rdquo; is defined in <U>Section 6.2(d)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Determination Notice</U>.
&ldquo;<U>Determination Notice</U>&rdquo; is defined in <U>Section 6.1(b)(i)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>DGCL</U>. &ldquo;<U>DGCL</U>&rdquo;
shall mean the Delaware General Corporation Law, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Dissenting Shares</U>.
&ldquo;<U>Dissenting Shares</U>&rdquo; is defined in <U>Section 2.7</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>DOJ</U>. &ldquo;<U>DOJ</U>&rdquo;
shall mean the U.S. Department of Justice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>DOL</U>. &ldquo;<U>DOL</U>&rdquo;
is defined in <U>Section 3.16(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Effective Time</U>.
&ldquo;<U>Effective Time</U>&rdquo; is defined in <U>Section 2.3(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Employee Plan</U>. &ldquo;<U>Employee
Plan</U>&rdquo; shall mean any (a) &ldquo;employee benefit plan&rdquo; within the meaning of Section 3(3) of ERISA whether or not
subject to ERISA, (b)&nbsp;bonus, vacation, deferred compensation, incentive compensation, stock purchase, stock option, other
equity-based plan, severance pay, termination pay, death and disability benefits, hospitalization, medical, life or other insurance,
flexible benefits, supplemental unemployment benefits, profit-sharing, pension or retirement plan, policy, program, agreement or
arrangement, and (c)&nbsp;employment, consulting, severance or similar agreement, and each other employee benefit plan, or arrangement,
in each case that is (i)&nbsp;sponsored, maintained, contributed to or required to be contributed to by the Company or any of its
Subsidiaries for the benefit of any current or former employee of the Company or any of its Subsidiaries; (ii)&nbsp;with respect
to which the Company or any of its Subsidiaries has any liability; or (iii)&nbsp;to which the Company or any of its Subsidiaries
is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Encumbrance</U>. &ldquo;<U>Encumbrance</U>&rdquo;
shall mean any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, claim, option, right of first refusal,
preemptive right, community property interest or similar restriction of any nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>End Date</U>. &ldquo;<U>End
Date</U>&rdquo; is defined in <U>Section 8.1(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Entity</U>. &ldquo;<U>Entity</U>&rdquo;
shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited liability
partnership, joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint
stock company), firm, society or other enterprise, association, organization or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Environmental Law</U>.
&ldquo;<U>Environmental Law</U>&rdquo; shall mean any federal, state, local or foreign Legal Requirement relating to pollution
or protection of human health, worker health or the environment (including ambient air, surface water, ground water, land surface
or subsurface strata), including any law or regulation relating to emissions, discharges, Releases or threatened Releases of Hazardous
Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Equity Award Conversion
Ratio</U>. &ldquo;<U>Equity Award Conversion Ratio</U>&rdquo; means the quotient of (i) the Offer Price divided by (ii) the Parent
Trading Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>ERISA</U>. &ldquo;<U>ERISA</U>&rdquo;
shall mean the Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Event</U>. &ldquo;<U>Event</U>&rdquo;
is defined in the definition of Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Exchange Act</U>. &ldquo;<U>Exchange
Act</U>&rdquo; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Excluded Shares</U>.
&ldquo;<U>Excluded Shares</U>&rdquo; is defined in <U>Section 1.1(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Expiration Date</U>.
&ldquo;<U>Expiration Date</U>&rdquo; is defined in <U>Section 1.1(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Extension Deadline</U>.
&ldquo;<U>Extension Deadline</U>&rdquo; is defined in <U>Section 1.1(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>FDA</U>. &ldquo;<U>FDA</U>&rdquo;
shall mean the United States Food and Drug Administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>FDCA</U>. &ldquo;<U>FDCA</U>&rdquo;
shall mean the Federal Food, Drug and Cosmetic Act, as amended, and all related rules, regulations and guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Finance Offering Documents</U>.
&ldquo;<U>Finance Offering Documents</U>&rdquo; is defined in <U>Section 6.13(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Financing</U>. &ldquo;<U>Financing</U>&rdquo;
is defined in <U>Section 6.13(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Financing Sources</U>.
&ldquo;<U>Financing Sources</U>&rdquo; shall mean the agents, arrangers, lenders and other entities (other than Parent or any of
its Subsidiaries) that have committed to provide or arrange or otherwise entered into agreements in connection with any Financing,
including the parties (other than Parent or any of its Subsidiaries) to any commitment letter or engagement letter in respect of
any Financing or to any joinder agreements, indentures, credit agreements or other agreements entered pursuant thereto or relating
thereto, together with their Affiliates and the current, former or future officers, directors, employees, partners, trustees, shareholders,
equityholders, managers, members, limited partners, controlling persons, agents and representatives of each of them and the successors
and assigns of the foregoing Persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>FTC</U>. &ldquo;<U>FTC</U>&rdquo;
shall mean the U.S. Federal Trade Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>GAAP</U>. &ldquo;<U>GAAP</U>&rdquo;
is defined in <U>Section 3.4(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Good Clinical Practices</U>.
&ldquo;<U>Good Clinical Practices</U>&rdquo; shall mean FDA&rsquo;s standards for the design, conduct, performance, monitoring,
auditing, recording, analysis, and reporting of clinical trials, including those standards contained in 21 C.F.R. Parts 50, 54,
56 and 312, and all comparable standards of the EMA and any other applicable Specified Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><U>Good Laboratory Practices</U>. &ldquo;<U>Good
Laboratory Practices</U>&rdquo; means the FDA&rsquo;s standards for conducting nonclinical laboratory studies, including those
standards contained in 21 C.F.R. Part 58, and all comparable standards of the EMA and any other applicable Specified Governmental
Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><U>Good Manufacturing Practices</U>. &ldquo;<U>Good
Manufacturing Practices</U>&rdquo; means the requirements set forth in the quality systems regulations for drugs and biological
products contained in 21 C.F.R. Parts 210 and 211 and 600 and 610, and all comparable standards of the EMA and any other applicable
Specified Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Governmental Authorization</U>.
&ldquo;<U>Governmental Authorization</U>&rdquo; shall mean any: permit, license, certificate, approval, consent, grant, franchise,
permission, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under
the authority of any Governmental Body or pursuant to any Legal Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Governmental Body</U>.
&ldquo;<U>Governmental Body</U>&rdquo; shall mean any: (a)&nbsp;nation, state, commonwealth, province, territory, county, municipality,
district or other jurisdiction of any nature; (b)&nbsp;federal, state, local, municipal, foreign, international, multinational,
supranational or other government; or (c)&nbsp;governmental or quasi-governmental authority of any nature including any governmental
division, department, agency, commission, instrumentality, official, ministry, fund, foundation, center, organization, unit or
body and any court, arbitrator or other tribunal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Hazardous Materials</U>.
&ldquo;<U>Hazardous Materials</U>&rdquo; shall mean any waste, material, or substance that is listed, regulated or defined under
any Environmental Law and includes any pollutant, chemical substance, hazardous substance, hazardous waste, special waste, solid
waste, asbestos, mold, radioactive material, polychlorinated biphenyls, petroleum or petroleum-derived substance or waste.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Health Care Laws</U>.
&ldquo;<U>Health Care Laws</U>&rdquo; shall mean all health care Legal Requirements related to, as applicable, the safety, efficacy,
approval, development, testing, labeling, manufacture, storage, marketing, promotion, sale, commercialization, import, export or
distribution of pharmaceutical or biological products or otherwise applicable to the operation of the business of the Acquired
Corporations as currently conducted and as contemplated by the Acquired Corporations to be conducted, including, as applicable:
(i) the FDCA and the Public Health Service Act and regulations promulgated thereunder, including, as applicable, those requirements
relating to the FDA&rsquo;s current Good Manufacturing Practices, Good Laboratory Practices, Good Clinical Practices, investigational
use, pre-market approval and applications to market new pharmaceutical or biological products; (ii) the Clinical Laboratory Improvement
Amendments of 1988; (iii) federal and state anti-kickback laws (including the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320-7(b));
(iv) other Legal Requirements governing the development, conduct, monitoring, patient informed consent, auditing, analysis and
reporting of clinical trials; (v) Legal Requirements governing data gathering activities relating to the detection, assessment,
and understanding of adverse events (including pharmacovigilance and adverse event regulations and guidance of FDA and ICH); (vi)
the federal Medicare and Medicaid statutes, as applicable; (vii) any Legal Requirement the violation of which is cause for exclusion
from any federal health care program; and (viii) any comparable state, federal or foreign Legal Requirements relating to any of
the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>HSR Act</U>. &ldquo;<U>HSR
Act</U>&rdquo; shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Indebtedness</U>. &ldquo;<U>Indebtedness</U>&rdquo;
shall mean (a)&nbsp;any indebtedness for borrowed money (including the issuance of any debt security) to any Person, including
any capital leases; (b)&nbsp;any obligations evidenced by notes, bonds, debentures or similar Contracts to any Person other than
the Company; (c)&nbsp;any obligations in respect of letters of credit and bankers&rsquo; acceptances (other than letters of credit
used as security for leases); (d)&nbsp;all indebtedness created or arising under any conditional sale or other title retention
agreement with respect to property acquired or deferred purchase price of property or services (other than trade accounts payable
in the ordinary course); (e) net obligations of any interest rate swap, currency swap, forward currency or interest rate contracts
or other interest rate or currency hedging arrangements; or (f)&nbsp;any guaranty of any such obligations described in <U>clauses
(a)</U> through <U>(e)</U> of any Person other than the Company (other than, in any case, accounts payable to trade creditors and
accrued expenses, in each case, arising in the ordinary course of business consistent with past practice).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Indemnified Persons</U>.
&ldquo;<U>Indemnified Persons</U>&rdquo; is defined in <U>Section 6.5(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>INDs</U>. &ldquo;<U>INDs</U>&rdquo;
is defined in <U>Section 3.8(d)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Information Privacy
and Security Laws</U>. &ldquo;<U>Information Privacy and Security Laws</U>&rdquo; shall mean all applicable Legal Requirements
concerning the privacy, data protection, transfer or security of Personal Information, including, but not limited to, the following
and their implementing regulations: the U.S. Health Insurance Portability and Accountability Act of 1996, as amended by the U.S.
Health Information Technology for Economic and Clinical Health Act of 2009, including the regulations promulgated thereunder (collectively
&ldquo;<U>HIPAA&rdquo;</U>), the HITECH Act and the regulations promulgated pursuant thereto, the Gramm-Leach-Bliley Act, the Fair
Credit Reporting Act, the Fair and Accurate Credit Transaction Act, the Telephone Consumer Protection Act, Section 5 of the Federal
Trade Commission Act as it applies to the receipt, access, use, disclosure, and security of Personal Information, the CAN-SPAM
Act, Children&rsquo;s Online Privacy Protection Act, PCI DSS, state data breach notification laws, state data security laws, state
social security number protection laws, any Legal Requirements pertaining to privacy or data security and any applicable Legal
Requirements concerning requirements for website and mobile application privacy policies and practices, or any outbound communications
(including e-mail marketing, telemarketing and text messaging), tracking and marketing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Initial Expiration Date</U>.
&ldquo;<U>Initial Expiration Date</U>&rdquo; is defined in <U>Section 1.1(c)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Intellectual Property</U>.
&ldquo;<U>Intellectual Property</U>&rdquo; shall mean all intellectual property rights throughout the world, including all U.S.
and foreign (a)&nbsp;patents, patent applications, and all related continuations, continuations-in-part, divisionals, reissues,
re-examinations, substitutions, and extensions thereof (&ldquo;<U>Patents</U>&rdquo;); (b)&nbsp;trademarks, service marks, names,
corporate names, trade names, domain names, logos, slogans, trade dress, design rights, and other similar designations of source
or origin, together with the goodwill symbolized by any of the foregoing (&ldquo;<U>Trademarks</U>&rdquo;); (c)&nbsp;copyrights
and copyrightable subject matter (&ldquo;<U>Copyrights</U>&rdquo;); (d)&nbsp;trade secrets and all other confidential information,
ideas, know-how, proprietary processes, protocols, specifications, techniques, data, results, plans, formulae, formulations, compositions,
models, and methodologies (&ldquo;<U>Trade Secrets</U>&rdquo;); and (e)&nbsp;all applications and registrations for the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Intervening Event</U>.
&ldquo;<U>Intervening Event</U>&rdquo; shall mean an event, occurrence, fact or change that materially affects the business, assets
or operations of the Company (other than any event, occurrence, fact or change resulting from a breach of this Agreement by the
Company) occurring or arising after the date hereof that was not known or reasonably foreseeable to the Board of Directors as of
the date hereof, which event, occurrence, fact or change becomes known to the Board of Directors prior to the Offer Acceptance
Time, other than (i) changes in the Company Common Stock price, in and of itself (however, the underlying reasons for such changes
may constitute an Intervening Event), (ii) any Acquisition Proposal, (iii) the fact that, in and of itself, the Company exceeds
any internal or published projections, estimates or expectations of the Company&rsquo;s revenue, earnings or other financial performance
or results of operations for any period, in and of itself (however, the underlying reasons for such events may constitute an Intervening
Event), or (iv) the results of any clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>IP Contract</U>. &ldquo;<U>IP
Contract</U>&rdquo; is defined in <U>Section 3.9(a)(vii)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>IRS</U>. &ldquo;<U>IRS</U>&rdquo;
shall mean the Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Key Products</U>. &ldquo;<U>Key
Products</U>&rdquo; shall mean the products and product candidates of the Acquisition Corporations set forth on <U>Section 1</U>
of the Company Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>knowledge</U>. &ldquo;<U>knowledge</U>&rdquo;
with respect to an Entity shall mean, with respect to any matter in question, the actual knowledge of any person serving as an
&ldquo;officer&rdquo; (as defined in Section 16(a) of the Exchange Act) of such Entity, after reasonable inquiry under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Leased Real Property</U>.
&ldquo;<U>Leased Real Property</U>&rdquo; is defined in <U>Section 3.7(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Legal Proceeding</U>.
&ldquo;<U>Legal Proceeding</U>&rdquo; shall mean any action, suit, complaint, litigation, arbitration, proceeding (including any
civil, criminal, administrative or appellate proceeding) or hearing commenced, brought, conducted or heard by or before, or otherwise
involving, any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Legal Requirement</U>.
&ldquo;<U>Legal Requirement</U>&rdquo; shall mean any federal, state, local, municipal, foreign, international, multinational,
supranational or other law, statute, constitution, resolution, ordinance, common law, code, edict, decree, rule, regulation, ruling
or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any
Governmental Body (or under the authority of NASDAQ), the NYSE or other stock exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Material Adverse Effect</U>.
&ldquo;<U>Material Adverse Effect</U>&rdquo; shall mean any state of facts, condition, development, occurrence, circumstance, change,
effect or event (each, an &ldquo;<U>Event</U>&rdquo;) which, individually or in the aggregate, has had or would reasonably be expected
to have a material adverse effect on (a)&nbsp;the ability of the Company to consummate the Transactions on or before the End Date;
or (b)&nbsp;the business, assets, financial condition or results of operations of the Acquired Corporations, taken as a whole;
<U>provided</U>, <U>however</U>, that none of the following shall be deemed, either alone or in combination, to constitute or be
taken into account in determining whether there is, or would reasonably be expected to be, a Material Adverse Effect for purposes
of <U>clause (b)</U> above: (i)&nbsp;any change in the market price or trading volume of the Company&rsquo;s stock or in the Company&rsquo;s
credit ratings; <I>provided</I> that the underlying causes of any such change may be considered in determining whether a Material
Adverse Effect has occurred to the extent not otherwise excluded by another exception herein; (ii)&nbsp;any Event resulting from
the announcement, pendency or performance of the Transactions (other than for purposes of any representation or warranty contained
in <U>Section 3.22</U> and the condition set forth in <U>clause (b)(v)</U> of <U>Annex I</U> solely as such condition relates to
<U>Section 3.22</U>); (iii)&nbsp;any Event generally affecting the industries in which the Acquired Corporations operate, or the
economy generally, or other general business, financial, market, regulatory or political conditions in the United States or elsewhere
in the world; (iv)&nbsp;any Event arising directly or indirectly from or otherwise relating to fluctuations in the value of any
currency; (v)&nbsp;any Event arising directly or indirectly from or otherwise relating to any outbreak or escalation of hostilities,
act of terrorism, war, national or international calamity, natural disaster or any other similar event in the United States or
elsewhere in the world; (vi) the failure of the Company to meet internal or analysts&rsquo; expectations or projections; <U>provided</U>
that the underlying causes of such failure may be considered in determining whether a Material Adverse Effect has occurred to the
extent not otherwise excluded by another exception herein; (vii)&nbsp;any adverse effect arising directly from, or otherwise directly
relating to, any action taken by the Company at the written direction of an officer of Parent or any action expressly required
to be taken by the Company pursuant to the terms of this Agreement, or the failure of the Company to take any action that the Company
is expressly prohibited by the terms of the Agreement from taking to the extent Parent fails to give its timely consent thereto
after a written request therefor pursuant to <U>Section 5.2</U> and <U>Section 9.9</U>; (viii)&nbsp;any Event resulting or arising
from the identity of, or any facts or circumstances relating to, Parent, Purchaser or any of their respective Affiliates; (ix)&nbsp;any
Event arising directly or indirectly from or otherwise relating to any change in, or any compliance with or action taken for the
purpose of complying with any chance in, any Legal Requirement or GAAP (or interpretations of any Legal Requirement or GAAP); (x)&nbsp;any
Legal Proceeding described in <U>Section 2.7</U>; or (xi) any litigation arising from allegations of a breach of fiduciary duty
relating to this Agreement or the transactions contemplated by this Agreement <U>provided</U> that any Event referred to in the
foregoing <U>clauses (iii)</U>, <U>(iv)</U>, <U>(v)</U> and <U>(ix)</U> may be taken into account in determining whether there
is, or would reasonably be expected to be, a Material Adverse Effect to the extent such Event materially disproportionately affects
the Acquired Corporations relative to other participants in the industries in which the Acquired Corporations operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Material Contract</U>.
&ldquo;<U>Material Contract</U>&rdquo; is defined in <U>Section 3.9(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Maximum Amount</U>.
&ldquo;<U>Maximum Amount</U>&rdquo; is defined in <U>Section 6.5(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Merger</U>. &ldquo;<U>Merger</U>&rdquo;
is defined in <U>Recital (B)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Merger Consideration</U>.
&ldquo;<U>Merger Consideration</U>&rdquo; is defined in <U>Section 2.5(a)(iii)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Minimum Condition</U>.
&ldquo;<U>Minimum Condition</U>&rdquo; is defined in <U>Annex I</U> to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>NASDAQ</U>. &ldquo;<U>NASDAQ</U>&rdquo;
shall mean The NASDAQ Global Select Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>New Plan</U>. &ldquo;<U>New
Plan</U>&rdquo; is defined in <U>Section 6.3(d)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>NYSE</U>. &ldquo;<U>NYSE</U>&rdquo;
shall mean the New York Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer</U>. &ldquo;<U>Offer</U>&rdquo;
is defined in <U>Recital (A)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer Acceptance Time</U>.
&ldquo;<U>Offer Acceptance Time</U>&rdquo; is defined in <U>Section 1.1(h)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer Commencement Date</U>.
&ldquo;<U>Offer Commencement Date</U>&rdquo; shall mean the date on which Purchaser commences the Offer, within the meaning of
Rule 14d-2 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer Conditions</U>.
&ldquo;<U>Offer Conditions</U>&rdquo; is defined in <U>Section 1.1(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer Documents</U>.
&ldquo;<U>Offer Documents</U>&rdquo; is defined in <U>Section 1.1(e)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer Price</U>. &ldquo;<U>Offer
Price</U>&rdquo; is defined in <U>Recital (A)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Offer to Purchase</U>.
&ldquo;<U>Offer to Purchase</U>&rdquo; is defined in <U>Section 1.1(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parent</U>. &ldquo;<U>Parent</U>&rdquo;
is defined in the preamble to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parent 401(k) Plan</U>.
&ldquo;<U>Parent 401(k) Plan</U>&rdquo; is defined in <U>Section 6.14(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parent Material Adverse
Effect</U>. &ldquo;<U>Parent Material Adverse Effect</U>&rdquo; shall mean any Event that would or would reasonably be expected
to, individually or in the aggregate, materially impair, prevent or materially delay Parent&rsquo;s or Purchaser&rsquo;s ability
to consummate the Transactions in a timely manner on the terms set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parent-Owned Shares</U>.
&ldquo;<U>Parent-Owned Shares</U>&rdquo; is defined in <U>Section 2.5(a)(ii)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><U>Parent Termination Fee</U>. &ldquo;<U>Parent
Termination Fee</U>&rdquo; is defined in <U>Section 8.3(f)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parent Trading Price</U>.
&ldquo;<U>Parent Trading Price</U>&rdquo; shall mean the volume weighted average of the closing sale prices per share of Parent
Common Stock on the NASDAQ, as reported in the New York City edition of The Wall Street Journal (or, if not reported thereby, as
reported in another authoritative source) for the fifteen (15) full consecutive trading days ending on the last trading day prior
to the Offer Acceptance Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Parties</U>. &ldquo;<U>Parties</U>&rdquo;
shall mean Parent, Purchaser and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Patents</U>. &ldquo;<U>Patents</U>&rdquo;
is defined in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Paying Agent</U>. &ldquo;<U>Paying
Agent</U>&rdquo; is defined in <U>Section 2.6(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Payment Fund</U>. &ldquo;<U>Payment
Fund</U>&rdquo; is defined in <U>Section 2.6(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Permitted Encumbrance</U>.
&ldquo;<U>Permitted Encumbrance</U>&rdquo; shall mean (a) any Encumbrance for Taxes that are not due and payable or the validity
of which is being contested in good faith by appropriate proceedings; (b) any Encumbrance representing the rights of customers,
suppliers and subcontractors in the ordinary course of business consistent with past practice under the terms of any Contracts
to which the relevant Party is a party or under general principles of commercial or government contract law (including mechanics&rsquo;,
materialmen&rsquo;s, carriers&rsquo;, workmen&rsquo;s, warehouseman&rsquo;s, repairmen&rsquo;s, landlords&rsquo; and similar liens
granted or which arise in the ordinary course of business consistent with past practice); (c) in the case of any Contract, Encumbrances
that are restrictions against the transfer or assignment thereof that are included in the terms of such Contract; (d) in the case
of real property, Encumbrances that are easements, rights-of-way, encroachments, restrictions, conditions and other similar Encumbrances
incurred or suffered in the ordinary course of business consistent with past practice and which, individually or in the aggregate,
do not and would not materially impair the use (or contemplated use), utility or value of the applicable real property or otherwise
materially impair the present or contemplated business operations at such location, or zoning, entitlement, building and other
land use regulations imposed by Governmental Bodies having jurisdiction over such real property or that are otherwise set forth
on a title report; and (e) licenses of or other grants of rights to use or obligations in respect of Intellectual Property (i)
which (A) are written and not required to be set forth on the Company Disclosure Schedule or (B) after the date hereof, are expressly
permitted to be entered into under <U>Section 5.2(b)</U> of the Agreement or (ii) the terms and conditions of which have been provided
or made available to Parent or Parent&rsquo;s Representatives on or prior to the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Person</U>. &ldquo;<U>Person</U>&rdquo;
shall mean any individual, Entity or Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Personal Information</U>.
&ldquo;<U>Personal Information</U>&rdquo; is defined in <U>Section 3.8(g)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Pre-Closing Non-Performance
Awards</U>. &ldquo;<U>Pre-Closing Non-Performance Awards</U>&rdquo; is defined in <U>Section 2.8(l)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Pre-Closing Period</U>.
&ldquo;<U>Pre-Closing Period</U>&rdquo; is defined in <U>Section 5.1(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Products</U>. &ldquo;<U>Products</U>&rdquo;
shall mean all drug or biological products or product candidates being developed, tested, labeled, manufactured, stored, imported,
exported or distributed by any Acquired Corporation, including any CAR or TCR production candidate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Purchaser</U>. &ldquo;<U>Purchaser</U>&rdquo;
is defined in the preamble to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Regulatory Condition</U>.
&ldquo;<U>Regulatory Condition</U>&rdquo; means the Offer Conditions related to approvals under the HSR Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Release</U>. &ldquo;<U>Release</U>&rdquo;
shall mean any presence, emission, spill, seepage, leak, escape, leaching, discharge, injection, pumping, pouring, emptying, dumping,
disposal, migration, or release of Hazardous Materials from any source into or upon the environment, including the air, soil, improvements,
surface water, groundwater, the sewer, septic system, storm drain, publicly owned treatment works, or waste treatment, storage,
or disposal systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Representatives</U>.
&ldquo;<U>Representatives</U>&rdquo; shall mean officers, directors, employees, attorneys, accountants, investment bankers, consultants,
agents, financial advisors, other advisors and other representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Sarbanes-Oxley Act</U>.
&ldquo;<U>Sarbanes-Oxley Act</U>&rdquo; is defined in <U>Section 3.4(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Schedule 13E-3</U>.
&ldquo;<U>Schedule 13E-3</U>&rdquo; is defined in <U>Section 1.3</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Schedule 14D-9</U>.
&ldquo;<U>Schedule 14D-9</U>&rdquo; is defined in <U>Section 1.2(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Schedule TO</U>. &ldquo;<U>Schedule
TO</U>&rdquo; is defined in <U>Section 1.1(e)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>SEC</U>. &ldquo;<U>SEC</U>&rdquo;
shall mean the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Securities Act</U>.
&ldquo;<U>Securities Act</U>&rdquo; shall mean the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Shares</U>. &ldquo;<U>Shares</U>&rdquo;
is defined in <U>Recital (A)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Specified Agreement</U>.
&ldquo;<U>Specified Agreement</U>&rdquo; is defined in <U>Section 8.1(e)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Specified Governmental
Bodies</U>. &ldquo;<U>Specified Governmental Bodies</U>&rdquo; is defined in <U>Section 3.12(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Stockholder List Date</U>.
&ldquo;<U>Stockholder List Date</U>&rdquo; is defined in <U>Section 1.2(b)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Subsidiary</U>. An Entity
shall be deemed to be a &ldquo;<U>Subsidiary</U>&rdquo; of another Person if such Person directly or indirectly owns, beneficially
or of record, (a) an amount of voting securities or other interests in such Entity that is sufficient to enable such Person to
elect at least a majority of the members of such Entity&rsquo;s board of directors or other governing body; or (b) at least 50%
of the outstanding equity or financial interests of such Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Superior Offer</U>.
&ldquo;<U>Superior Offer</U>&rdquo; shall mean an unsolicited <I>bona fide</I> written Acquisition Proposal made after the date
hereof that the Board of Directors determines, in its good-faith judgment, after consultation with outside legal counsel and its
financial advisors, is reasonably likely to be consummated in accordance with its terms, taking into account all legal, regulatory
and financing aspects (including certainty of closing, termination fees, any expense reimbursement provisions and whether such
Acquisition Proposal is fully financed) of the proposal and the Person making the proposal and other aspects of the Acquisition
Proposal that the Board of Directors deems relevant, and if consummated, would result in a transaction more favorable to the Company&rsquo;s
stockholders (solely in their capacity as such) from a financial point of view than the Transactions and taking into account all
legal, regulatory and financing aspects (including certainty of closing, termination fees, any expense reimbursement provisions
and whether such Acquisition Proposal is fully financed) (including after giving effect to proposals, if any, made by Parent pursuant
to <U>Section 6.1(b)(i)</U>); <U>provided</U> that for purposes of the definition of &ldquo;Superior Offer,&rdquo; the references
to &ldquo;20%&rdquo; in the definition of Acquisition Proposal shall be deemed to be references to &ldquo;80%.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Surviving Corporation</U>.
&ldquo;<U>Surviving Corporation</U>&rdquo; is defined in <U>Recital (B)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Takeover Laws</U>. &ldquo;<U>Takeover
Laws</U>&rdquo; shall mean any &ldquo;moratorium,&rdquo; &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;supermajority,&rdquo;
&ldquo;affiliate transactions,&rdquo; or &ldquo;business combination statute or regulation&rdquo; or other similar state anti-takeover
laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Tax</U>. &ldquo;<U>Tax</U>&rdquo;
shall mean any tax (including any income tax, franchise tax, capital gains tax, gross receipts tax, value-added tax, surtax, estimated
tax, unemployment tax, national health insurance tax, excise tax, alternative or minimum tax, ad valorem tax, transfer tax, stamp
tax, sales tax, use tax, property tax, business tax, withholding tax or payroll tax), levy, assessment, tariff, impost, imposition,
duty (including any customs duty) or other tax or charge of any kind whatsoever, including any charge or amount (including any
fine, penalty or interest) related thereto, imposed, assessed or collected by or under the authority of any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Tax Return</U>. &ldquo;<U>Tax
Return</U>&rdquo; shall mean any return (including any information return), report, statement, declaration, estimate, schedule,
form, election, certificate or other document or information filed or required to be filed with any Governmental Body in connection
with the determination, assessment, collection or payment of any Tax and any attachments thereto or amendments thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Termination Condition</U>.
&ldquo;<U>Termination Condition</U>&rdquo; is defined in <U>Annex I</U> to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Trademarks</U>. &ldquo;<U>Trademarks</U>&rdquo;
is defined in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Trade Secrets</U>. &ldquo;<U>Trade
Secrets</U>&rdquo; is defined in the definition of Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Transactions</U>. &ldquo;<U>Transactions</U>&rdquo;
shall mean (a) the execution and delivery of the Agreement; and (b) all of the transactions contemplated by the Agreement, including
the Offer and the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Treasury Regulations</U>.
&ldquo;<U>Treasury Regulations</U>&rdquo; shall mean the regulations promulgated under the Code by the U.S. Department of the Treasury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Vested in the Money
Option</U>. &ldquo;<U>Vested in the Money Option</U>&rdquo; is defined in <U>Section 2.8(a)</U> of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><U>Voting and Standstill Agreement</U>. &ldquo;<U>Voting
and Standstill Agreement</U>&rdquo; shall mean the Voting and Standstill Agreement, dated June 29, 2015, by and among the Company,
Parent and Celgene RIVOT Ltd., as modified by the Amended Letter Agreement, dated January 21, 2018, by and between the Company
and Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANNEX I</U><BR>
<BR>
CONDITIONS TO THE OFFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The obligation of Purchaser
to accept for payment and pay for Shares validly tendered (and not validly withdrawn) pursuant to the Offer is subject to the satisfaction
of the conditions set forth in <U>clauses (a)</U> through <U>(h)</U> below. Accordingly, notwithstanding any other provision of
the Offer or the Agreement to the contrary, Purchaser shall not be required to accept for payment or (subject to any applicable
rules and regulations of the SEC, including Rule 14e-1(c) under the Exchange Act) pay for, and may delay the acceptance for payment
of, or (subject to any such rules and regulations) the payment for, any tendered Shares, and, to the extent permitted by the Agreement,
may terminate the Offer: (i)&nbsp;upon termination of the Agreement; and (ii)&nbsp;at any scheduled Expiration Date (subject to
any extensions of the Offer pursuant to <U>Section 1.1(c)</U> of the Agreement), if: (A)&nbsp;the Minimum Condition, the Termination
Condition and conditions set forth in <U>clauses (e)</U> and <U>(g)</U> shall not be satisfied by one minute after 11:59 p.m. Eastern
Time on the Expiration Date; or (B)&nbsp;any of the additional conditions set forth below shall not be satisfied or waived in writing
by Parent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall have been validly tendered in the Offer and &ldquo;received&rdquo; by the &ldquo;depositary&rdquo; (as such terms are defined
in Section 251(h) of the DGCL) and not validly withdrawn Shares that, considered together with all other Shares (if any) owned
by Parent and its &ldquo;affiliates&rdquo; (as defined in Section 251(h) of the DGCL), represent one more Share than 50% of the
total number of Shares outstanding at the time of the expiration of the Offer (the &ldquo;<U>Minimum Condition</U>&rdquo;). For
the avoidance of doubt, for purposes of determining whether the Minimum Condition has been satisfied, the Parties shall exclude
Shares tendered in the Offer pursuant to guaranteed delivery procedures that have not yet been &ldquo;received&rdquo; (as such
term is defined in Section 251(h)(6)(f) of the DGCL);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in <U>Sections 3.1(a)</U> (Due Organization; Subsidiaries, Etc.), <U>3.2</U>
(Certificate of Incorporation and Bylaws), <U>3.20</U> (Authority; Binding Nature of Agreement), <U>3.21</U> (Takeover Laws), <U>3.23</U>
(Opinion of Financial Advisor) and <U>3.24</U> (Brokers and Other Advisors) of the Agreement shall be true and correct (disregarding
for this purpose all &ldquo;Material Adverse Effect&rdquo; and &ldquo;materiality&rdquo; qualifications contained in such representations
and warranties) in all material respects as of the date of the Agreement and at and as of the Offer Acceptance Time as if made
on and as of the Offer Acceptance Time (except to the extent any such representation or warranty expressly relates to an earlier
date or period, in which case as of such date or period);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in the first sentence of <U>Section 3.3(a)</U> and <U>clauses (i) &mdash;
(iii)</U> of <U>Section 3.3(c)</U> solely as such representations relate to the Company (Capitalization, Etc.) of the Agreement
shall be true and correct (except for de minimis inaccuracies) in all respects as of the date of the Agreement and at and as of
the Offer Acceptance Time as if made on and as of the Offer Acceptance Time (except to the extent any such representation or warranty
expressly relates to an earlier date or period, in which case as of such date or period);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 91; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth the first two sentences of <U>Section 3.3(b)</U> and the second sentence
of <U>Section 3.3(d)</U> solely as such representations relate to the Company (Capitalization, Etc.) of the Agreement shall be
true and correct in all material respects as of the date of the Agreement and at and as of the Offer Acceptance Time as if made
on and as of the Offer Acceptance Time (except to the extent any such representation or warranty expressly relates to an earlier
date or period, in which case as of such date or period);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in <U>Section 3.5(a)</U> (Absence of Changes) of the Agreement shall be
true and correct in all respects as of the date of the Agreement and at and as of the Offer Acceptance Time as if made on and as
of the Offer Acceptance Time with respect to the earlier period set forth in <U>Section 3.5</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in the Agreement (other than those referred to in <U>clauses (i)</U> and
<U>(ii)</U> above) shall be true and correct (disregarding for this purpose all &ldquo;Material Adverse Effect&rdquo; and &ldquo;materiality&rdquo;
qualifications contained in such representations and warranties) as of the date of the Agreement and at and as of the Offer Acceptance
Time as if made on and as of the Offer Acceptance Time (except to the extent any such representation or warranty expressly relates
to an earlier date or period, in which case as of such date or period), except where the failure of such representations and warranties
to be so true and correct has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect under <U>clause (b)</U> of such definition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall have complied with or performed in all material respects the covenants and agreements it is required to comply with
or perform at or prior to the Offer Acceptance Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;since
the date of the Agreement, there shall not have occurred any Event which, individually or in the aggregate, has had, or would reasonably
be expected to have, a Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
waiting period (or any extension thereof) applicable to the Offer under the HSR Act shall have expired or been terminated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
and Purchaser shall have received a certificate executed on behalf of the Company by the Company&rsquo;s Chief Executive Officer
and Chief Financial Officer confirming that the conditions set forth in <U>clauses (b)</U>, <U>(c)</U>, and <U>(d)</U> of this
<U>Annex I</U> have been satisfied;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall not have been issued by any Governmental Body of competent jurisdiction and remain in effect any judgment, temporary restraining
order, preliminary or permanent injunction or other order, decree or ruling restricting, enjoining or otherwise preventing the
acquisition of or payment for Shares pursuant to the Offer or the consummation of the Merger, nor shall any Legal Requirement have
been promulgated, enacted, issued or deemed applicable to the Offer or the Merger by any Governmental Body which prohibits or makes
illegal the acquisition of or payment for Shares pursuant to the Offer or the consummation of the Merger; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Agreement shall not have been terminated in accordance with its terms (the &ldquo;<U>Termination Condition</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing conditions are for the sole benefit
of Parent and Purchaser and (except for the Minimum Condition, the Termination Condition and the conditions set forth in <U>clauses
(e)</U> and <U>(g)</U> above) may be waived by Parent and Purchaser, in whole or in part at any time and from time to time, in
the sole discretion of Parent and Purchaser. The failure by Parent or Purchaser at any time to exercise any of the foregoing rights
shall not be deemed a waiver of any such right and each such right shall be deemed an ongoing right which may be asserted at any
time and from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B><U>ANNEX II</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>FORM OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AMENDED AND RESTATED<BR>
CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>JUNO
THERAPEUTICS, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The name of the corporation is Juno Therapeutics, Inc. (the &ldquo;<U>Corporation</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">The address of its registered office in the State of Delaware is 251 Little Falls Drive, Wilmington,
Delaware, 19808, New Castle County, and the name of its registered agent at such address is Corporation Service Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">The nature of the business or purposes to be conducted or promoted is to engage in any lawful act
or activity for which corporations may be organized under the General Corporation Law of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">The total number of shares of stock which the Corporation shall have authority to issue is 500,000,000
shares, all of which shares shall be designated as common shares with a par value of $0.01 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">The Corporation is to have perpetual existence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">The business of the Corporation shall be managed by its Board of Directors. The bylaws may prescribe
the number of directors; may provide for the increase or reduction thereof; and may prescribe the number necessary to constitute
a quorum, which number may be less than a majority of the whole Board of Directors, but not less than the number required by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">To the fullest extent permitted by the General Corporation Law of Delaware, as it presently exists
or may hereafter be amended from time to time, a director of the Corporation shall not be personally liable to the Corporation
or its stockholders for monetary damages for breach of fiduciary duty as a director. If the General Corporation Law of Delaware
is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law
of Delaware, as so amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Subject to any provisions in the
bylaws<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT> related to indemnification of directors or officers of the Corporation,
the Corporation shall indemnify, to the fullest extent permitted by applicable law, any director or officer of the Corporation
who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether
civil, criminal, administrative or investigative (a &ldquo;<U>Proceeding</U>&rdquo;) by reason of the fact that he or she is or
was a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with
respect to employee benefit plans, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by such person in connection with any such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Corporation shall have the power
to indemnify, to the extent permitted by the General Corporation Law of Delaware, as it presently exists or may hereafter be amended
from time to time, any person who was or is a party or is threatened to be made a party to any Proceeding by reason of the fact
that he or she is or was a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including
service with respect to employee benefit plans, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by such person in connection with any such Proceeding. The Corporation shall
be required to indemnify a person in connection with a Proceeding (or part thereof) initiated by such person only if the Proceeding
(or part thereof) was authorized by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Neither any amendment nor repeal
of this Section 7, nor the adoption of any provision of this Corporation&rsquo;s Certificate of Incorporation inconsistent with
this Section 7, shall eliminate or reduce the effect of this Section 7 in respect of any matter occurring, or any cause of action,
suit or proceeding accruing or arising or that, but for this Section 7, would accrue or arise, prior to such amendment, repeal
or adoption of an inconsistent provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">Subject to such bylaws as may be adopted from time to time by the stockholders of the Corporation,
the Board of Directors is expressly authorized to adopt, alter, amend and repeal the bylaws of the Corporation, but any bylaw adopted
by the Board of Directors may be altered, amended or repealed by the stockholders of the Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">Subject to Section 7, the Corporation reserves the right to amend, alter, change or repeal any
provision contained in this Amended and Restated Certificate of Incorporation, in the manner now or hereafter prescribed by statute,
and all rights conferred upon the stockholders of the Corporation herein are granted subject to this reservation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">* * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>1</SUP></FONT>
Note: Bylaws of Blue Magpie Corporation to incorporate indemnification provisions from Juno Therapeutics, Inc. Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">THE UNDERSIGNED, said Juno Therapeutics, Inc.,
has caused this certificate to be executed by on this ___ day of __________, _____.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>JUNO THERAPEUTICS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
